Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,A1BG,Alpha-1B-glycoprotein,16076,107,1.49 [0.48-4.61],0.4910718208186385
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AAMDC,Mth938 domain-containing protein,15602,101,1.15 [0.80-1.65],0.4529043083175939
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AARSD1,Alanyl-tRNA editing protein Aarsd1,18402,129,0.99 [0.75-1.32],0.9696597200612648
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ABCA2,ATP-binding cassette sub-family A member 2,15526,102,1.23 [0.73-2.07],0.4433451198280694
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ABHD14B,Protein ABHD14B,18283,127,1.06 [0.80-1.40],0.7072279742013221
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ABL1,Tyrosine-protein kinase ABL1,18402,129,1.06 [0.84-1.34],0.6017787671377437
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ABO,Histo-blood group ABO system transferase,16073,108,1.02 [0.90-1.16],0.7282897811193949
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ABRAXAS2,BRISC complex subunit Abraxas 2,15526,102,1.04 [0.78-1.39],0.7947425986905889
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",18072,126,0.95 [0.77-1.16],0.6152055251074601
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",15770,101,1.01 [0.76-1.33],0.9593431266762884
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",16050,105,1.09 [0.88-1.34],0.4341067668458924
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ACAN,Aggrecan core protein,18293,127,0.99 [0.55-1.78],0.980373982744042
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ACE,Angiotensin-converting enzyme,16073,108,1.31 [0.68-2.54],0.4216054474699133
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ACE2,Angiotensin-converting enzyme 2,18163,124,0.84 [0.60-1.16],0.2819434402505488
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ACHE,Acetylcholinesterase,15698,103,0.94 [0.53-1.65],0.8234031719490325
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ACOT13,Acyl-coenzyme A thioesterase 13,16000,108,1.05 [0.89-1.23],0.559053995266443
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,18492,130,1.04 [0.77-1.42],0.7831396065350952
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ACP1,Low molecular weight phosphotyrosine protein phosphatase,15570,103,0.89 [0.58-1.37],0.6039862484937192
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ACP5,Tartrate-resistant acid phosphatase type 5,18567,128,0.86 [0.54-1.40],0.5524687806022448
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ACP6,Lysophosphatidic acid phosphatase type 6,18641,128,1.00 [0.79-1.26],0.9993784586124692
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ACRBP,Acrosin-binding protein,15996,108,1.11 [0.73-1.69],0.6397380655668624
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ACRV1,Acrosomal protein SP-10,15570,103,0.93 [0.78-1.12],0.4694499570335855
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ACSL1,Long-chain-fatty-acid--CoA ligase 1,15526,102,1.21 [0.76-1.92],0.4268427400043125
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ACTA2,"Actin, aortic smooth muscle",18163,124,1.36 [1.00-1.85],0.0510283319864218
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ACTN2,Alpha-actinin-2,15526,102,1.30 [0.99-1.71],0.0591527700082703
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ACTN4,Alpha-actinin-4,18183,127,0.50 [0.27-0.94],0.0303479906321441
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ACVRL1,Serine/threonine-protein kinase receptor R3,18303,124,2.67 [1.50-4.75],0.0008448467873869
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ACY1,Aminoacylase-1,18492,130,0.82 [0.63-1.07],0.1496912120508916
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,15526,102,1.08 [0.76-1.52],0.6683227063396388
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ACYP1,Acylphosphatase-1,15650,103,1.12 [0.83-1.49],0.4602679671114822
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADA,Adenosine deaminase,18712,130,0.81 [0.51-1.26],0.3489120287293161
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADA2,Adenosine deaminase 2,18408,127,1.22 [0.85-1.77],0.2838109670988065
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,15570,103,1.50 [0.87-2.59],0.1462139806596639
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,18163,124,1.23 [0.74-2.05],0.425982605490658
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,18340,127,1.46 [0.94-2.27],0.0924955385667231
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,18712,130,1.69 [1.05-2.73],0.0320860856095422
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,18627,131,1.70 [1.01-2.88],0.047019506674074
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,16000,108,1.79 [0.99-3.22],0.0527219478231121
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,15570,103,1.63 [1.02-2.59],0.0405151434979958
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,18719,128,0.76 [0.40-1.45],0.4024519694642702
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,18402,129,0.75 [0.52-1.09],0.1306598350952868
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,18163,124,1.12 [0.73-1.72],0.5983421794616371
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,15570,103,1.06 [0.62-1.81],0.8217923068548049
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,18535,130,0.88 [0.62-1.23],0.4452664082638844
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADAMTSL2,ADAMTS-like protein 2,16062,108,0.98 [0.55-1.73],0.9343519761278524
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADAMTSL4,ADAMTS-like protein 4,15602,101,0.80 [0.36-1.77],0.5788494721278553
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADAMTSL5,ADAMTS-like protein 5,16050,105,0.80 [0.50-1.29],0.3601713481606886
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,18072,126,0.93 [0.56-1.55],0.7747938735241857
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADD1,Alpha-adducin,15698,103,1.04 [0.80-1.37],0.753759516540524
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADGRB3,Adhesion G protein-coupled receptor B3,18303,124,1.62 [1.01-2.60],0.0449510633469287
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADGRD1,Adhesion G-protein coupled receptor D1,15698,103,0.95 [0.59-1.55],0.8435449904282241
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADGRE1,Adhesion G protein-coupled receptor E1,16000,108,1.15 [0.82-1.62],0.4079188039238789
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADGRE2,Adhesion G protein-coupled receptor E2,18552,130,1.17 [0.68-2.02],0.5747595607181022
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADGRE5,Adhesion G protein-coupled receptor E5,18629,128,0.96 [0.58-1.61],0.8890422786725354
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADGRF5,Adhesion G protein-coupled receptor F5,16050,105,1.48 [0.73-3.03],0.2781951793094409
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADGRG1,Adhesion G-protein coupled receptor G1,18402,129,0.96 [0.79-1.16],0.637909562324946
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADGRG2,Adhesion G-protein coupled receptor G2,18492,130,0.84 [0.47-1.52],0.5647647074071087
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADGRV1,Adhesion G-protein coupled receptor V1,15563,101,0.96 [0.72-1.28],0.7858736985151273
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADH1B,All-trans-retinol dehydrogenase,15698,103,0.98 [0.76-1.27],0.8823047076862454
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,18163,124,0.90 [0.73-1.10],0.3102835032189766
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADIPOQ,Adiponectin,16076,107,1.03 [0.78-1.34],0.8544241611592225
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADM,Pro-adrenomedullin,18664,128,2.42 [1.28-4.59],0.0067508183038789
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ADRA2A,Alpha-2A adrenergic receptor,15526,102,1.06 [0.82-1.37],0.6733813199963887
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AFAP1,Actin filament-associated protein 1,15698,103,1.13 [0.91-1.41],0.2677196666180164
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AFM,Afamin,16076,107,0.48 [0.19-1.19],0.1118071846805868
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AFP,Alpha-fetoprotein,18270,124,1.17 [0.91-1.49],0.216826606946465
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AGBL2,Cytosolic carboxypeptidase 2,15563,101,1.01 [0.82-1.23],0.9430300634543024
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AGER,Advanced glycosylation end product-specific receptor,18432,130,1.27 [0.87-1.87],0.2187987113310706
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AGR2,Anterior gradient protein 2 homolog,17962,124,1.25 [1.07-1.47],0.0060183131173131
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AGR3,Anterior gradient protein 3,18045,125,0.87 [0.66-1.15],0.3263395613870211
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AGRN,Agrin,18552,130,1.68 [1.09-2.58],0.019343597705881
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AGRP,Agouti-related protein,18712,130,1.21 [0.88-1.65],0.2376107263657759
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AGT,Angiotensinogen,16073,108,1.16 [0.49-2.75],0.7439404900392952
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AGXT,Serine--pyruvate aminotransferase,18492,130,0.87 [0.70-1.09],0.2357835020818725
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AHCY,Adenosylhomocysteinase,18492,130,1.13 [0.90-1.42],0.2941856262001237
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AHNAK,Neuroblast differentiation-associated protein AHNAK,15602,101,1.26 [0.70-2.28],0.4422191377591001
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AHNAK2,Protein AHNAK2,15602,101,1.32 [0.74-2.35],0.3459218057297099
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,15996,108,1.16 [0.91-1.48],0.2370676590995772
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AHSG,Alpha-2-HS-glycoprotein,16073,108,1.58 [0.81-3.09],0.1802700695324267
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AHSP,Alpha-hemoglobin-stabilizing protein,18455,131,0.84 [0.69-1.01],0.068405279917351
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AIDA,"Axin interactor, dorsalization-associated protein",15643,104,0.90 [0.71-1.15],0.3958378626164058
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AIF1,Allograft inflammatory factor 1,18072,126,1.11 [0.82-1.50],0.4876773156875938
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AIF1L,Allograft inflammatory factor 1-like,15602,101,0.96 [0.66-1.39],0.8272067908053192
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",18379,129,0.97 [0.84-1.13],0.6926422819016425
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AK1,Adenylate kinase isoenzyme 1,18492,130,0.95 [0.74-1.22],0.7073915206968753
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AK2,"Adenylate kinase 2, mitochondrial",16023,107,1.13 [0.95-1.34],0.1679547278721587
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AKAP12,A-kinase anchor protein 12,15698,103,0.83 [0.32-2.16],0.7018476812674468
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AKR1B1,Aldo-keto reductase family 1 member B1,18072,126,1.12 [0.91-1.39],0.2950432495711838
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AKR1B10,Aldo-keto reductase family 1 member B10,15643,104,0.85 [0.61-1.17],0.3179457195920315
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AKR1C4,Aldo-keto reductase family 1 member C4,18163,124,1.09 [0.80-1.48],0.603203307128495
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AKR7L,Aflatoxin B1 aldehyde reductase member 4,15570,103,0.83 [0.61-1.13],0.2348769644910194
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AKT1S1,Proline-rich AKT1 substrate 1,18093,124,1.02 [0.80-1.31],0.8503132282791346
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AKT2,RAC-beta serine/threonine-protein kinase,16031,108,1.04 [0.90-1.20],0.6228248793696782
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AKT3,RAC-gamma serine/threonine-protein kinase,17986,126,1.08 [0.82-1.42],0.5843782253742165
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ALCAM,CD166 antigen,18719,128,1.40 [0.62-3.18],0.4230131803827813
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ALDH1A1,Retinal dehydrogenase 1,18493,131,0.87 [0.64-1.19],0.3850990983082691
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ALDH2,"Aldehyde dehydrogenase, mitochondrial",15996,108,0.89 [0.59-1.33],0.5638308665986294
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",18457,132,1.00 [0.79-1.25],0.980225141108879
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",16031,108,1.22 [0.84-1.79],0.2919148917442008
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ALMS1,Alstrom syndrome protein 1,15770,101,1.07 [0.70-1.64],0.7642667322648065
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ALPI,Intestinal-type alkaline phosphatase,15570,103,1.07 [0.92-1.24],0.3707524776035777
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ALPP,"Alkaline phosphatase, placental type",18402,129,0.98 [0.84-1.14],0.7687504092322692
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AMBN,Ameloblastin,18183,127,0.81 [0.43-1.55],0.5278782526233031
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AMBP,Protein AMBP,18638,128,2.32 [1.06-5.07],0.0349140828247
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,16062,108,0.75 [0.37-1.50],0.4111577483238662
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AMFR,E3 ubiquitin-protein ligase AMFR,18093,124,1.14 [0.90-1.44],0.267491909098315
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AMIGO1,Amphoterin-induced protein 1,15643,104,1.07 [0.75-1.53],0.6962145593867075
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AMIGO2,Amphoterin-induced protein 2,18402,129,1.23 [0.63-2.40],0.5431235334809088
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AMN,Protein amnionless,18183,127,0.99 [0.70-1.38],0.9423463778497998
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AMOT,Angiomotin,15698,103,1.30 [0.79-2.15],0.3013549322259186
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AMOTL2,Angiomotin-like protein 2,15930,108,1.25 [0.90-1.73],0.177076145749523
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AMPD3,AMP deaminase 3,16023,107,0.99 [0.76-1.29],0.9443872172062936
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,15051,102,0.93 [0.63-1.38],0.7338554850297749
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AMY2A,Pancreatic alpha-amylase,17815,121,0.86 [0.61-1.20],0.3663023345835281
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AMY2B,Alpha-amylase 2B,17258,117,0.89 [0.63-1.25],0.4873933428791716
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ANG,Angiogenin,18467,129,1.28 [0.81-2.04],0.2882629478029956
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ANGPT1,Angiopoietin-1,18415,129,0.92 [0.76-1.10],0.3493584435747355
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ANGPT2,Angiopoietin-2,18664,128,1.66 [1.12-2.46],0.0120880016783364
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ANGPTL1,Angiopoietin-related protein 1,18210,126,1.72 [1.00-2.96],0.050276506308725
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ANGPTL2,Angiopoietin-related protein 2,18484,130,0.98 [0.66-1.46],0.9288010592479684
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ANGPTL3,Angiopoietin-related protein 3,18526,129,1.26 [0.80-1.99],0.3262666402190321
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ANGPTL4,Angiopoietin-related protein 4,18531,130,1.58 [1.12-2.25],0.0101770513445019
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ANGPTL7,Angiopoietin-related protein 7,18664,128,1.18 [0.76-1.85],0.4648869309002459
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ANK2,Ankyrin-2,15526,102,0.67 [0.47-0.97],0.0316985393310123
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,15570,103,1.19 [0.94-1.50],0.1513900630953455
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ANKRA2,Ankyrin repeat family A protein 2,15494,101,0.85 [0.59-1.22],0.3688696562700926
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ANKRD54,Ankyrin repeat domain-containing protein 54,18072,126,0.92 [0.69-1.23],0.5846551662966131
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,15602,101,0.82 [0.47-1.44],0.4949472736856407
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ANPEP,Aminopeptidase N,18554,128,0.77 [0.42-1.40],0.3914122320135144
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ANXA1,Annexin A1,15619,103,0.99 [0.64-1.54],0.9713991453723768
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ANXA10,Annexin A10,18093,124,0.96 [0.79-1.18],0.7224171798117963
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ANXA11,Annexin A11,18451,132,0.96 [0.76-1.20],0.7063646943822559
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ANXA2,Annexin A2,15379,101,1.17 [0.91-1.51],0.2201820206851456
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ANXA3,Annexin A3,18627,131,1.01 [0.81-1.25],0.9570070473931436
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ANXA4,Annexin A4,18413,130,0.99 [0.79-1.22],0.898763502530198
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ANXA5,Annexin A5,18030,124,0.91 [0.53-1.57],0.7459651304957753
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AOC1,Amiloride-sensitive amine oxidase [copper-containing],18183,127,1.07 [0.82-1.40],0.6165013486472456
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AOC3,Membrane primary amine oxidase,18580,129,0.88 [0.52-1.51],0.64939204711551
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AP1G2,AP-1 complex subunit gamma-like 2,15996,108,1.23 [0.98-1.53],0.071068271211039
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AP2B1,AP-2 complex subunit beta,15643,104,1.21 [0.83-1.76],0.3194151993214782
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AP3B1,AP-3 complex subunit beta-1,16000,108,1.21 [0.96-1.53],0.114038215149066
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AP3S2,AP-3 complex subunit sigma-2,16023,107,1.51 [1.07-2.15],0.0205656584819497
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,18402,129,1.00 [0.71-1.41],0.9860784924742584
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,APCS,Serum amyloid P-component,15932,107,1.08 [0.61-1.92],0.7945638444953116
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,18612,127,1.05 [0.81-1.36],0.7202153156896045
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,APLP1,Amyloid-like protein 1,18492,130,1.03 [0.75-1.40],0.8701152039044946
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,APOA1,Apolipoprotein A-I,16076,107,0.80 [0.38-1.66],0.5452997426872211
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,APOA2,Apolipoprotein A-II,16073,108,1.12 [0.77-1.62],0.5578637539702459
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,APOA4,Apolipoprotein A-IV,16076,107,1.29 [0.78-2.16],0.3227978545045814
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,APOB,Apolipoprotein B-100,16073,108,0.89 [0.40-1.96],0.7672949014126773
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,APOBR,Apolipoprotein B receptor,15602,101,0.89 [0.58-1.38],0.6088019199094499
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,APOC1,Apolipoprotein C-I,16051,107,0.81 [0.49-1.34],0.409994399429421
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,APOD,Apolipoprotein D,15365,105,1.13 [0.74-1.73],0.5596093898315095
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,APOE,Apolipoprotein E,16076,107,0.81 [0.58-1.14],0.2228400496487999
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,APOF,Apolipoprotein F,16073,108,2.02 [0.85-4.82],0.1122116465273378
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,APOH,Beta-2-glycoprotein 1,18493,131,1.42 [0.96-2.11],0.0811929933851075
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,APOL1,Apolipoprotein L1,16073,108,1.08 [0.76-1.55],0.6612995747671999
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,APOM,Apolipoprotein M,18558,129,1.02 [0.59-1.75],0.9471039907857942
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,APP,Amyloid-beta precursor protein,18467,129,0.84 [0.66-1.07],0.1517181059780249
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,APPL2,DCC-interacting protein 13-beta,15698,103,1.11 [0.93-1.31],0.2494351505003539
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,APRT,Adenine phosphoribosyltransferase,18310,127,1.24 [0.88-1.74],0.225579217634475
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ARAF,Serine/threonine-protein kinase A-Raf,15770,101,1.06 [0.81-1.38],0.6638424951049635
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AREG,Amphiregulin,18402,129,1.35 [0.91-2.01],0.1304145517704328
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ARF6,ADP-ribosylation factor 6,16000,108,1.11 [0.94-1.32],0.2187997622014023
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ARFIP1,Arfaptin-1,16031,108,1.05 [0.80-1.38],0.7199274039913053
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ARG1,Arginase-1,18383,122,0.83 [0.61-1.13],0.2343751367267257
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ARG2,"Arginase-2, mitochondrial",15996,108,0.95 [0.60-1.49],0.8149679375761099
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ARHGAP1,Rho GTPase-activating protein 1,18072,126,0.97 [0.69-1.37],0.8546667406696575
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ARHGAP25,Rho GTPase-activating protein 25,18072,126,1.11 [0.86-1.42],0.4321888079783963
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ARHGAP30,Rho GTPase-activating protein 30,15770,101,1.24 [0.86-1.79],0.2394962858404105
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ARHGAP45,Rho GTPase-activating protein 45,15698,103,1.11 [0.88-1.40],0.3846559410986844
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ARHGAP5,Rho GTPase-activating protein 5,15494,101,0.90 [0.69-1.17],0.4400517422941954
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ARHGEF1,Rho guanine nucleotide exchange factor 1,16023,107,1.07 [0.87-1.31],0.533698245005132
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ARHGEF10,Rho guanine nucleotide exchange factor 10,16031,108,1.24 [1.03-1.50],0.023029921776552
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ARHGEF12,Rho guanine nucleotide exchange factor 12,18488,132,1.02 [0.88-1.19],0.7790893804032936
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ARHGEF5,Rho guanine nucleotide exchange factor 5,15563,101,1.10 [0.86-1.40],0.4599984621899129
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ARID3A,AT-rich interactive domain-containing protein 3A,15563,101,0.75 [0.45-1.25],0.2629364316503988
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ARID4B,AT-rich interactive domain-containing protein 4B,18093,124,0.99 [0.67-1.46],0.949969196015208
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ARL13B,ADP-ribosylation factor-like protein 13B,15526,102,1.00 [0.76-1.32],0.9936166641842512
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,15526,102,1.36 [0.87-2.13],0.1787429615233085
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ARMCX2,Armadillo repeat-containing X-linked protein 2,15563,101,1.20 [0.93-1.56],0.1690457809820542
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ARNT,Aryl hydrocarbon receptor nuclear translocator,18183,127,1.21 [0.82-1.80],0.3327657309693955
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,15526,102,1.06 [0.75-1.50],0.7485836036942194
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ARSA,Arylsulfatase A,18493,131,1.37 [0.98-1.91],0.0649753075665902
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ARSB,Arylsulfatase B,18402,129,1.04 [0.78-1.37],0.7988345937294694
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ART3,Ecto-ADP-ribosyltransferase 3,18580,129,1.50 [0.97-2.31],0.0664700788804699
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ART5,Ecto-ADP-ribosyltransferase 5,15563,101,1.15 [0.89-1.48],0.275508598713791
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ARTN,Artemin,18183,127,1.18 [0.87-1.59],0.2874609672537993
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ASAH1,Acid ceramidase,15921,108,1.30 [0.90-1.87],0.1577641446084605
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ASAH2,Neutral ceramidase,18340,127,0.84 [0.64-1.10],0.2069469315896057
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ASGR1,Asialoglycoprotein receptor 1,18340,127,1.83 [1.12-3.01],0.016601836029724
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ASGR2,Asialoglycoprotein receptor 2,16073,108,2.02 [1.03-3.96],0.0397789615985549
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ASPN,Asporin,16050,105,0.89 [0.45-1.76],0.7338933078276302
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ASPSCR1,Tether containing UBX domain for GLUT4,16031,108,0.97 [0.73-1.28],0.8327799326960392
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ASRGL1,Isoaspartyl peptidase/L-asparaginase,15602,101,1.11 [0.92-1.34],0.2956832837699608
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ASS1,Argininosuccinate synthase,15526,102,0.81 [0.63-1.06],0.1215976619191678
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ATF2,Cyclic AMP-dependent transcription factor ATF-2,18093,124,0.85 [0.64-1.15],0.2946007533684566
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ATF4,Cyclic AMP-dependent transcription factor ATF-4,15494,101,0.72 [0.39-1.33],0.2985433617965985
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ATG16L1,Autophagy-related protein 16-1,16000,108,1.17 [0.95-1.46],0.1410552264901867
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ATG4A,Cysteine protease ATG4A,18072,126,0.98 [0.75-1.29],0.9068627709728816
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ATOX1,Copper transport protein ATOX1,18535,130,1.08 [0.87-1.35],0.4837151679518824
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,15526,102,1.13 [0.79-1.62],0.4962793645772885
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,15526,102,1.29 [0.76-2.17],0.3400792259945584
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,15526,102,0.90 [0.54-1.50],0.6930452367543702
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ATP1B4,Protein ATP1B4,15494,101,0.84 [0.51-1.36],0.466475391053215
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ATP2B4,Plasma membrane calcium-transporting ATPase 4,15526,102,0.99 [0.74-1.35],0.9725899289307582
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ATP5F1D,"ATP synthase subunit delta, mitochondrial",15526,102,1.10 [0.79-1.54],0.5551908650628885
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ATP5IF1,"ATPase inhibitor, mitochondrial",18552,130,0.96 [0.83-1.10],0.5228999539094643
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ATP5PO,"ATP synthase subunit O, mitochondrial",18093,124,1.02 [0.69-1.50],0.9329250688383296
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ATP6AP2,Renin receptor,18072,126,1.32 [0.94-1.85],0.1124856081017175
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ATP6V1D,V-type proton ATPase subunit D,18402,129,1.08 [0.59-1.96],0.8014739765935424
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ATP6V1F,V-type proton ATPase subunit F,18065,124,1.16 [0.92-1.47],0.1977670166176071
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ATP6V1G1,V-type proton ATPase subunit G 1,15602,101,1.25 [0.97-1.60],0.0854785228110689
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ATP6V1G2,V-type proton ATPase subunit G 2,15526,102,0.88 [0.71-1.09],0.2477438761169244
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ATRAID,All-trans retinoic acid-induced differentiation factor,16000,108,1.75 [1.22-2.51],0.0023048281585433
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ATRN,"Attractin, Isoform 2",16076,107,1.27 [0.41-3.87],0.6782251596567637
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ATXN10,Ataxin-10,18093,124,1.20 [0.96-1.50],0.1120093761857564
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ATXN2,Ataxin-2,15563,101,1.03 [0.86-1.22],0.7650676754032246
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ATXN2L,Ataxin-2-like protein,16031,108,1.11 [0.78-1.60],0.5560938283015942
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ATXN3,Ataxin-3,16023,107,1.06 [0.79-1.43],0.6839359358262962
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AXIN1,Axin-1,18488,132,1.04 [0.88-1.22],0.6665237028873885
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AXL,Tyrosine-protein kinase receptor UFO,18580,129,1.29 [0.73-2.28],0.3890019608361466
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AZI2,5-azacytidine-induced protein 2,16031,108,1.35 [0.99-1.84],0.0545797453999376
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,AZU1,Azurocidin,17949,124,0.99 [0.80-1.22],0.8905351927546048
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,B2M,Beta-2-microglobulin,16076,107,1.40 [0.98-2.00],0.0606782513314493
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,15526,102,0.61 [0.23-1.60],0.3161131144069609
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",15602,101,1.28 [0.76-2.16],0.3534535912227825
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,B4GALT1,"Beta-1,4-galactosyltransferase 1",18552,130,1.60 [0.91-2.82],0.1034232124748884
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,B4GAT1,"Beta-1,4-glucuronyltransferase 1",18493,131,1.35 [0.72-2.55],0.3463278574973122
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BABAM1,BRISC and BRCA1-A complex member 1,15570,103,0.99 [0.52-1.91],0.9857327246377514
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BACH1,Transcription regulator protein BACH1,18488,132,1.05 [0.85-1.29],0.6673878421224496
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BAG3,BAG family molecular chaperone regulator 3,18303,124,1.04 [0.70-1.57],0.8373186062027107
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BAG4,BAG family molecular chaperone regulator 4,15570,103,1.33 [0.95-1.86],0.0993177613576192
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BAG6,Large proline-rich protein BAG6,18163,124,1.41 [0.92-2.16],0.1152283516072408
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,18072,126,1.03 [0.80-1.32],0.8265096416688293
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BAMBI,BMP and activin membrane-bound inhibitor homolog,18072,126,1.79 [1.07-2.99],0.0265454143338023
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BANK1,B-cell scaffold protein with ankyrin repeats,18488,132,0.99 [0.86-1.15],0.9244219259329732
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BAP18,Chromatin complexes subunit BAP18,16023,107,1.12 [0.89-1.41],0.3489443447633866
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BATF,Basic leucine zipper transcriptional factor ATF-like,15643,104,0.91 [0.71-1.17],0.4683993092789185
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BAX,Apoptosis regulator BAX,18063,124,0.97 [0.81-1.16],0.7458788315405236
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BCAM,Basal cell adhesion molecule,18493,131,1.33 [0.70-2.53],0.3784485785770245
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BCAN,Brevican core protein,18340,127,1.28 [0.81-2.02],0.2987632274089405
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",16050,105,1.62 [0.93-2.80],0.0872834441969073
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",15563,101,0.95 [0.65-1.38],0.7737463794975188
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BCHE,Cholinesterase,15777,107,1.23 [0.60-2.53],0.5651075951182989
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BCL2,Apoptosis regulator Bcl-2,16000,108,1.32 [1.02-1.71],0.0376346661104697
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BCL2L1,Bcl-2-like protein 1,16023,107,1.05 [0.87-1.27],0.5923036995374447
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",18488,132,0.76 [0.54-1.07],0.1196262860425464
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BCL2L15,Bcl-2-like protein 15,15570,103,1.01 [0.73-1.40],0.9402604340913644
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BCL7A,B-cell CLL/lymphoma 7 protein family member A,15494,101,1.05 [0.79-1.40],0.7419830376417484
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BCL7B,B-cell CLL/lymphoma 7 protein family member B,15996,108,0.98 [0.67-1.45],0.934325567423112
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BCR,Breakpoint cluster region protein,18488,132,1.00 [0.85-1.19],0.9748515584204812
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BDNF,Brain-derived neurotrophic factor,16062,108,0.94 [0.76-1.17],0.5995654119679046
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BECN1,Beclin-1,15602,101,1.19 [0.87-1.64],0.2781090334380294
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BEX3,Protein BEX3,15494,101,0.79 [0.49-1.28],0.3326069861302155
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BGLAP,Osteocalcin,16062,108,1.03 [0.82-1.29],0.790987351254739
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BGN,Biglycan,18046,126,0.90 [0.78-1.03],0.1306181393861366
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BHLHE40,Class E basic helix-loop-helix protein 40,15563,101,0.87 [0.65-1.17],0.3722918471694632
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,15526,102,0.71 [0.34-1.46],0.3540452989756105
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BID,BH3-interacting domain death agonist,18488,132,1.14 [0.91-1.42],0.260084299371326
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BIN2,Bridging integrator 2,18493,131,1.08 [0.91-1.28],0.3737774341609354
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BIRC2,Baculoviral IAP repeat-containing protein 2,18072,126,1.04 [0.81-1.34],0.7347754549947783
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BLMH,Bleomycin hydrolase,18719,128,1.29 [0.77-2.15],0.3288880988602903
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BLNK,B-cell linker protein,15570,103,1.62 [1.12-2.35],0.0101913597847385
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,15563,101,1.07 [0.84-1.36],0.5954833096685578
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,16023,107,1.27 [0.82-1.97],0.2750335628586081
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BLVRB,Flavin reductase,18493,131,0.87 [0.68-1.11],0.2518281934639075
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BMP10,Bone morphogenetic protein 10,15698,103,1.08 [0.55-2.11],0.8187886114013253
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BMP4,Bone morphogenetic protein 4,18303,124,1.33 [0.96-1.83],0.0836672509564077
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BMP6,Bone morphogenetic protein 6,18133,124,0.84 [0.56-1.26],0.4024595414025412
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BMPER,BMP-binding endothelial regulator protein,15698,103,1.33 [0.57-3.11],0.5150401023654554
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,16050,105,1.11 [0.65-1.90],0.7084744726822778
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,15570,103,1.41 [0.95-2.10],0.0890687179051299
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BOC,Brother of CDO,18163,124,0.93 [0.46-1.86],0.8273248439145496
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BOLA1,BolA-like protein 1,15563,101,1.28 [0.93-1.76],0.1292689841080258
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BOLA2_BOLA2B,BolA-like protein 2,15602,101,1.05 [0.73-1.52],0.7748391175155285
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BPIFA2,BPI fold-containing family A member 2,15060,99,0.99 [0.83-1.19],0.9475781792861034
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BPIFB1,BPI fold-containing family B member 1,18462,127,0.91 [0.71-1.17],0.4757321536808432
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BPIFB2,BPI fold-containing family B member 2,16021,104,0.79 [0.57-1.10],0.1668002898429663
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BRAP,BRCA1-associated protein,15837,107,1.10 [0.93-1.31],0.2640431768012723
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BRD1,Bromodomain-containing protein 1,15770,101,1.50 [0.88-2.58],0.1398437996156921
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BRD2,Bromodomain-containing protein 2,15563,101,0.81 [0.45-1.46],0.4830974589061344
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BRD3,Bromodomain-containing protein 3,15526,102,0.92 [0.61-1.39],0.6976425210812818
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BRDT,Bromodomain testis-specific protein,15526,102,1.20 [0.73-1.98],0.4764687777220624
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BRK1,Protein BRICK1,18093,124,1.32 [0.94-1.87],0.1101664170119988
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BRME1,Break repair meiotic recombinase recruitment factor 1,15563,101,1.06 [0.66-1.71],0.8137360764976955
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BRSK2,Serine/threonine-protein kinase BRSK2,16031,108,1.05 [0.63-1.75],0.8473459876708319
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BSG,Basigin,18678,129,1.92 [0.88-4.21],0.1026117527781237
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BSND,Barttin,15494,101,0.92 [0.51-1.66],0.7853084040623459
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,18657,131,0.87 [0.65-1.15],0.3288907150999096
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BST2,Bone marrow stromal antigen 2,18657,131,0.83 [0.58-1.18],0.2916388616369687
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BTC,Probetacellulin,18072,126,0.95 [0.77-1.19],0.6679863841948586
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BTD,Biotinidase,16076,107,0.54 [0.22-1.28],0.1605074544616599
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BTLA,B- and T-lymphocyte attenuator,15494,101,0.99 [0.79-1.22],0.9033569114801064
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BTN1A1,Butyrophilin subfamily 1 member A1,15963,108,1.13 [0.73-1.74],0.5965386006451595
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BTN2A1,Butyrophilin subfamily 2 member A1,18552,130,2.35 [1.36-4.04],0.0020621960937872
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BTN3A2,Butyrophilin subfamily 3 member A2,18488,132,0.98 [0.65-1.49],0.9358230877043838
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,BTNL10,Butyrophilin-like protein 10,15494,101,0.99 [0.62-1.60],0.9739918437520768
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,C19orf12,Protein C19orf12,18093,124,0.85 [0.65-1.13],0.2630204424279539
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,C1GALT1C1,C1GALT1-specific chaperone 1,15526,102,1.07 [0.60-1.92],0.8174817119416109
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,C1QA,Complement C1q subcomponent subunit A,18620,129,1.45 [0.72-2.93],0.2935504264662135
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",16031,108,1.01 [0.78-1.30],0.9270789431344216
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,C1QL2,Complement C1q-like protein 2,15570,103,0.72 [0.44-1.15],0.1689611670063497
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,18580,129,1.10 [0.76-1.59],0.6187790805692673
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,15698,103,0.95 [0.56-1.64],0.8662574578556984
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,16031,108,1.20 [0.72-2.02],0.480308272309899
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,15674,103,0.99 [0.67-1.46],0.9500175848296062
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,C1R,Complement C1r subcomponent,16076,107,0.38 [0.12-1.26],0.1141305777084778
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,C1RL,Complement C1r subcomponent-like protein,16041,107,0.79 [0.31-2.00],0.6202223095801072
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,C1S,Complement C1s subcomponent,16076,107,0.69 [0.29-1.67],0.4143422983344672
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,C2,Complement C2,18558,129,0.97 [0.47-1.99],0.9359387058237916
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,C2CD2L,Phospholipid transfer protein C2CD2L,18065,124,1.21 [0.86-1.71],0.2712085260412959
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,C2orf69,UPF0565 protein C2orf69,15643,104,1.28 [1.03-1.59],0.0265065877393443
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,C3,Complement C3,15263,103,0.97 [0.62-1.52],0.8908355018962673
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,C4BPB,C4b-binding protein beta chain,18535,130,1.34 [0.89-2.01],0.1562128205180049
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,C5,Complement C5,16076,107,0.68 [0.19-2.43],0.5504054814323638
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,C7,Complement component C7,15695,105,1.80 [0.97-3.35],0.0618945492289436
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,C7orf50,Uncharacterized protein C7orf50,16023,107,1.05 [0.50-2.21],0.9054775059208792
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,C8B,Complement component C8 beta chain,16076,107,1.00 [0.54-1.86],0.9936279403597144
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,C9,Complement component C9,16073,108,1.21 [0.87-1.69],0.259739551684094
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,C9orf40,Uncharacterized protein C9orf40,16000,108,0.93 [0.74-1.18],0.5667935422527408
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CA1,Carbonic anhydrase 1,18131,128,1.02 [0.78-1.35],0.8614243969250285
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CA11,Carbonic anhydrase-related protein 11,18072,126,0.93 [0.52-1.64],0.7979783836622365
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CA12,Carbonic anhydrase 12,18402,129,0.87 [0.53-1.44],0.596988237863335
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CA13,Carbonic anhydrase 13,18270,130,0.99 [0.86-1.15],0.916660726914175
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CA14,Carbonic anhydrase 14,18664,128,1.17 [0.75-1.81],0.4840099729432617
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CA2,Carbonic anhydrase 2,18435,131,0.94 [0.75-1.18],0.6064856385987081
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CA3,Carbonic anhydrase 3,18694,128,1.39 [1.09-1.77],0.0088948756133497
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CA4,Carbonic anhydrase 4,18719,128,1.19 [0.62-2.27],0.6014181017106563
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CA5A,"Carbonic anhydrase 5A, mitochondrial",18163,124,1.02 [0.85-1.22],0.8500450014661156
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CA6,Carbonic anhydrase 6,18435,131,1.04 [0.81-1.34],0.7645012538939502
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CA7,Carbonic anhydrase 7,15770,101,0.65 [0.34-1.23],0.1824171908866557
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CA8,Carbonic anhydrase-related protein,15570,103,1.22 [0.63-2.36],0.547953188761083
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CA9,Carbonic anhydrase 9,18664,128,1.32 [0.96-1.81],0.0896340832302858
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CABP2,Calcium-binding protein 2,15643,104,1.07 [0.81-1.42],0.6156168154932093
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,15563,101,0.86 [0.46-1.61],0.6397951143490137
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,15526,102,0.91 [0.63-1.32],0.6128503822401066
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,15563,101,1.26 [0.95-1.66],0.1065655398369412
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,16031,108,1.09 [0.88-1.36],0.4169041968564754
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CACYBP,Calcyclin-binding protein,15671,103,1.14 [0.95-1.37],0.1714820256980544
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CADPS,Calcium-dependent secretion activator 1,15643,104,0.90 [0.54-1.50],0.6845699256888094
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CALB1,Calbindin,18402,129,1.31 [0.91-1.87],0.1460991272299504
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CALB2,Calretinin,18093,124,1.49 [0.90-2.50],0.1242729380589358
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CALCA,Calcitonin,18312,127,1.21 [0.97-1.51],0.083723662005512
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CALCB,Calcitonin gene-related peptide 2,16023,107,1.50 [1.08-2.09],0.0164576642531025
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,18610,128,1.08 [0.93-1.26],0.3174439625751578
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,15602,101,1.26 [0.99-1.62],0.0626213021185236
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CALY,Neuron-specific vesicular protein calcyon,15526,102,0.78 [0.44-1.38],0.3933315910904881
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,18072,126,1.09 [0.76-1.55],0.6341285374906336
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,15643,104,0.85 [0.58-1.25],0.4156816766793166
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,16031,108,1.17 [0.98-1.38],0.0787711023517759
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CANT1,Soluble calcium-activated nucleotidase 1,18428,129,1.58 [0.72-3.46],0.2542343119418759
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CAPG,Macrophage-capping protein,18375,125,1.04 [0.79-1.36],0.7937224673050818
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CAPN3,Calpain-3,15996,108,0.83 [0.48-1.41],0.4828692741606168
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CAPS,Calcyphosin,16023,107,1.10 [0.95-1.28],0.2110492458746949
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CARHSP1,Calcium-regulated heat-stable protein 1,18093,124,0.81 [0.59-1.12],0.2092457136676391
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CASC3,Protein CASC3,15643,104,1.08 [0.69-1.69],0.7434430193780551
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CASP1,Caspase-1,18093,124,1.06 [0.85-1.33],0.5847984903728669
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CASP10,Caspase-10,18093,124,0.89 [0.71-1.11],0.3013131732325266
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CASP2,Caspase-2,18488,132,1.01 [0.81-1.27],0.9110166524158522
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CASP3,Caspase-3,18719,128,1.04 [0.87-1.24],0.6945245099256583
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CASP4,Caspase-4,15770,101,1.04 [0.93-1.16],0.4714679948619954
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CASP7,Caspase-7,16023,107,1.08 [0.87-1.35],0.4824091437638053
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CASP8,Caspase-8,18615,128,1.21 [0.96-1.53],0.1121449359488415
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CASP9,Caspase-9,15570,103,0.89 [0.64-1.22],0.4604541975310855
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CASQ2,Calsequestrin-2,15526,102,1.11 [0.78-1.57],0.5708235485170641
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CAT,Catalase,15839,106,0.96 [0.68-1.36],0.8212998353252501
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CBLIF,Cobalamin binding intrinsic factor,18472,130,0.88 [0.73-1.07],0.1991269787069997
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CBLN1,Cerebellin-1,15563,101,0.84 [0.65-1.09],0.2015207251243685
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CBLN4,Cerebellin-4,18664,128,0.71 [0.43-1.17],0.1791183572290318
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CBS,Cystathionine beta-synthase,15602,101,0.73 [0.47-1.12],0.1496407127357746
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CBX2,Chromobox protein homolog 2,15526,102,1.16 [0.76-1.78],0.4845775451108021
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,18340,127,1.03 [0.83-1.28],0.7880658776509893
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCAR2,Cell cycle and apoptosis regulator protein 2,16023,107,1.07 [0.79-1.47],0.6499989465267602
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCDC134,Coiled-coil domain-containing protein 134,15996,108,1.00 [0.68-1.47],0.9906310376769664
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCDC28A,Coiled-coil domain-containing protein 28A,15643,104,0.66 [0.35-1.24],0.1956519677521188
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCDC50,Coiled-coil domain-containing protein 50,16031,108,1.00 [0.78-1.27],0.9724718249508816
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCDC80,Coiled-coil domain-containing protein 80,18492,130,1.82 [1.21-2.72],0.0036845136526988
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,15602,101,1.31 [0.97-1.76],0.0750633679175746
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCL11,Eotaxin,18712,130,0.94 [0.62-1.41],0.7491387826154738
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCL13,C-C motif chemokine 13,18685,130,0.76 [0.61-0.96],0.0228926890161964
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCL14,C-C motif chemokine 14,18467,129,1.57 [1.15-2.17],0.0052011892376369
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCL15,C-C motif chemokine 15,18719,128,1.02 [0.71-1.47],0.912678893455134
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCL16,C-C motif chemokine 16,18719,128,1.28 [0.92-1.78],0.1463753693500692
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCL17,C-C motif chemokine 17,18434,130,0.90 [0.76-1.07],0.2499905388944915
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCL18,C-C motif chemokine 18,18268,129,0.99 [0.79-1.24],0.9341407328102156
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCL19,C-C motif chemokine 19,18657,131,0.77 [0.64-0.92],0.0049286462579142
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCL2,C-C motif chemokine 2,18303,124,0.99 [0.73-1.34],0.9510904750824184
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCL20,C-C motif chemokine 20,18712,130,0.89 [0.73-1.09],0.2515644052001236
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCL21,C-C motif chemokine 21,18552,130,0.79 [0.51-1.21],0.276571710178625
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCL22,C-C motif chemokine 22,18274,129,0.79 [0.58-1.08],0.1343052856505784
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCL23,C-C motif chemokine 23,18552,130,1.54 [1.06-2.23],0.0229847636433849
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCL24,C-C motif chemokine 24,18531,130,0.92 [0.76-1.11],0.3802682763532763
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCL25,C-C motif chemokine 25,18712,130,1.13 [0.82-1.55],0.4461177312739161
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCL26,C-C motif chemokine 26,18488,132,0.94 [0.79-1.12],0.4729652850469906
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCL27,C-C motif chemokine 27,18492,130,0.90 [0.70-1.17],0.4360349855155048
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCL28,C-C motif chemokine 28,18424,131,0.87 [0.66-1.15],0.3266610094504234
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCL3,C-C motif chemokine 3,18488,132,1.19 [0.93-1.53],0.1586489949049955
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCL4,C-C motif chemokine 4,18494,130,1.20 [0.99-1.45],0.0697929692175078
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCL5,C-C motif chemokine 5,18580,129,0.90 [0.77-1.05],0.1862180799550375
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCL7,C-C motif chemokine 7,18488,132,0.89 [0.66-1.18],0.4132373274421226
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCL8,C-C motif chemokine 8,18638,128,1.08 [0.83-1.39],0.5764034354075391
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCN1,CCN family member 1,18376,129,0.99 [0.80-1.23],0.9431022950517822
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCN2,CCN family member 2,18477,129,0.96 [0.73-1.27],0.7744839155330682
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCN3,CCN family member 3,18682,128,1.92 [1.23-2.99],0.0038451364661216
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCN4,CCN family member 4,18664,128,1.68 [1.15-2.46],0.007420838231437
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCN5,CCN family member 5,18493,131,1.30 [0.86-1.96],0.2066084996546502
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCND2,G1/S-specific cyclin-D2,15770,101,1.65 [0.96-2.84],0.0712652475488465
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCNE1,G1/S-specific cyclin-E1,15570,103,1.03 [0.84-1.25],0.7968499351365765
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCS,Copper chaperone for superoxide dismutase,18340,127,0.85 [0.61-1.20],0.362715441444789
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CCT5,T-complex protein 1 subunit epsilon,18072,126,0.88 [0.61-1.28],0.5126578634317885
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD101,Immunoglobulin superfamily member 2,16000,108,0.90 [0.60-1.35],0.6153666729262306
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD109,CD109 antigen,18493,131,1.32 [0.82-2.12],0.2560269966808798
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD14,Monocyte differentiation antigen CD14,18156,129,1.33 [0.91-1.94],0.1470173017080296
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD160,CD160 antigen,18712,130,1.09 [0.78-1.52],0.6092700006515002
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD163,Scavenger receptor cysteine-rich type 1 protein M130,18580,129,0.87 [0.60-1.26],0.4617715545570778
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD164,Sialomucin core protein 24,18493,131,1.57 [1.11-2.24],0.011248897678212
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD164L2,CD164 sialomucin-like 2 protein,15643,104,0.75 [0.44-1.29],0.2967708494106424
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD177,CD177 antigen,18461,131,1.07 [0.94-1.21],0.3046772485594083
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD1C,T-cell surface glycoprotein CD1c,18535,130,1.36 [0.71-2.63],0.3549466806771946
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD2,T-cell surface antigen CD2,15526,102,1.01 [0.62-1.66],0.9548369899481596
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD200,OX-2 membrane glycoprotein,18488,132,1.78 [1.04-3.05],0.0363669093293654
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD200R1,Cell surface glycoprotein CD200 receptor 1,18422,132,1.00 [0.64-1.54],0.9866085636842582
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD207,C-type lectin domain family 4 member K,18060,126,1.50 [0.99-2.25],0.0540735568350488
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD209,CD209 antigen,18538,128,1.18 [0.79-1.77],0.4110085010667781
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD22,B-cell receptor CD22,18712,130,0.80 [0.54-1.17],0.2434288731923975
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD226,CD226 antigen,15570,103,1.05 [0.67-1.65],0.8283592647206639
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD244,Natural killer cell receptor 2B4,18712,130,0.88 [0.50-1.56],0.665705539448422
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD248,Endosialin,16062,108,1.66 [1.05-2.62],0.0285921481097609
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD27,CD27 antigen,18535,130,1.55 [1.07-2.24],0.0216678055526412
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD274,Programmed cell death 1 ligand 1,18340,127,1.22 [0.76-1.95],0.4098294159028021
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD276,CD276 antigen,18462,130,1.39 [0.88-2.19],0.1533777499068907
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD28,T-cell-specific surface glycoprotein CD28,18072,126,1.05 [0.68-1.60],0.8383135236878683
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD2AP,CD2-associated protein,18492,130,1.10 [0.86-1.40],0.4587171928757977
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD300A,CMRF35-like molecule 8,15698,103,1.53 [0.83-2.83],0.1754107411467302
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD300C,CMRF35-like molecule 6,18657,131,1.43 [0.92-2.22],0.1169743664694228
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD300E,CMRF35-like molecule 2,18609,127,1.75 [1.21-2.52],0.0027651357781042
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD300LF,CMRF35-like molecule 1,18664,128,1.09 [0.83-1.44],0.527971664596156
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD300LG,CMRF35-like molecule 9,18493,131,1.75 [1.17-2.63],0.0069096075981891
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD302,CD302 antigen,18402,129,2.33 [1.47-3.67],0.0002870531002229
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD33,Myeloid cell surface antigen CD33,18535,130,0.97 [0.80-1.17],0.720905521873751
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD34,Hematopoietic progenitor cell antigen CD34,18597,131,1.27 [0.67-2.43],0.4609925673674383
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD36,Platelet glycoprotein 4,15570,103,1.05 [0.69-1.60],0.8172541082698439
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,18402,129,1.37 [0.84-2.23],0.2085583636839101
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD3D,T-cell surface glycoprotein CD3 delta chain,15563,101,0.73 [0.38-1.40],0.3503550507793398
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD3E,T-cell surface glycoprotein CD3 epsilon chain,15770,101,1.20 [0.77-1.85],0.4233432146235483
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD3G,T-cell surface glycoprotein CD3 gamma chain,15570,103,0.69 [0.50-0.97],0.0318608156182202
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD4,T-cell surface glycoprotein CD4,18455,131,1.05 [0.62-1.77],0.8557156883024231
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD40,Tumor necrosis factor receptor superfamily member 5,18473,130,1.06 [0.77-1.45],0.7366495743776349
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD40LG,CD40 ligand,18712,130,0.96 [0.80-1.17],0.7130295836932811
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD46,Membrane cofactor protein,18412,128,1.57 [0.93-2.64],0.0920784130843931
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD48,CD48 antigen,18531,130,1.71 [1.02-2.87],0.0437578509344816
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD5,T-cell surface glycoprotein CD5,18638,128,1.57 [1.01-2.45],0.0442147634909234
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD55,Complement decay-accelerating factor,17871,126,2.09 [1.27-3.45],0.0039084621812685
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD58,Lymphocyte function-associated antigen 3,18428,130,1.89 [0.78-4.58],0.1617559812628237
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD59,CD59 glycoprotein,17847,122,2.68 [1.54-4.68],0.000520494831542
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD5L,CD5 antigen-like,16008,107,1.00 [0.67-1.48],0.9837871665977622
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD6,T-cell differentiation antigen CD6,18678,129,0.87 [0.64-1.17],0.3533550660062808
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD63,CD63 antigen,18303,124,0.87 [0.64-1.19],0.3910847486467129
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD69,Early activation antigen CD69,18400,130,0.97 [0.81-1.16],0.7432610861233839
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD7,T-cell antigen CD7,15543,103,1.16 [0.76-1.77],0.4966948439971681
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD70,CD70 antigen,18488,132,1.53 [1.08-2.17],0.0175260493626979
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD72,B-cell differentiation antigen CD72,15698,103,1.08 [0.68-1.72],0.7489412877167145
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD74,HLA class II histocompatibility antigen gamma chain,18657,131,1.71 [1.10-2.66],0.0168093932583489
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD79B,B-cell antigen receptor complex-associated protein beta chain,18712,130,1.39 [0.98-1.97],0.061102510063314
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD80,T-lymphocyte activation antigen CD80,16050,105,1.07 [0.60-1.92],0.8161882265421387
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD82,CD82 antigen,15770,101,1.07 [0.68-1.69],0.7736210620722745
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD83,CD83 antigen,18488,132,1.23 [0.77-1.95],0.3841622306407414
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD84,SLAM family member 5,18488,132,0.89 [0.55-1.45],0.6446983531900496
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD86,T-lymphocyte activation antigen CD86,16000,108,1.71 [0.92-3.17],0.0904545349119514
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD8A,T-cell surface glycoprotein CD8 alpha chain,18657,131,1.00 [0.74-1.35],0.9884312018052188
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD93,Complement component C1q receptor,17823,128,1.91 [1.17-3.12],0.0094207286978262
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD99,CD99 antigen,18493,131,2.66 [1.25-5.65],0.0110685481642487
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CD99L2,CD99 antigen-like protein 2,18493,131,2.02 [1.09-3.73],0.0253716503716017
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDA,Cytidine deaminase,16029,105,1.06 [0.72-1.55],0.7747473896597439
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDAN1,Codanin-1,16023,107,1.03 [0.45-2.35],0.9435126662156578
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDC123,Cell division cycle protein 123 homolog,15494,101,1.08 [0.81-1.44],0.5831622354747564
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDC25A,M-phase inducer phosphatase 1,15494,101,0.97 [0.59-1.61],0.9144806428184844
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDC26,Anaphase-promoting complex subunit CDC26,15962,108,1.27 [0.98-1.64],0.072204982564692
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDC27,Cell division cycle protein 27 homolog,18072,126,1.19 [0.93-1.53],0.1703606300586664
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDC37,Hsp90 co-chaperone Cdc37,18535,130,1.04 [0.87-1.26],0.6608354794557072
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDC42BPB,Serine/threonine-protein kinase MRCK beta,16000,108,1.20 [1.00-1.43],0.0481422309391076
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDCP1,CUB domain-containing protein 1,18340,127,1.06 [0.80-1.41],0.685964305257817
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDH1,Cadherin-1,17893,125,1.35 [0.94-1.92],0.1025448329534775
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDH15,Cadherin-15,18629,131,0.78 [0.61-0.99],0.0399483557423956
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDH17,Cadherin-17,18492,130,0.98 [0.78-1.23],0.8535042924104561
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDH2,Cadherin-2,18492,130,0.67 [0.42-1.05],0.0791084201789384
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDH22,Cadherin-22,15770,101,0.49 [0.23-1.02],0.0561462433867087
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDH23,Cadherin-23,16023,107,1.03 [0.52-2.02],0.9376621879267456
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDH3,Cadherin-3,18657,131,1.35 [0.88-2.07],0.1708813803029968
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDH4,Cadherin-4,15563,101,0.69 [0.43-1.10],0.1169303846945828
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDH5,Cadherin-5,18719,128,1.44 [0.87-2.39],0.1546717015668651
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDH6,Cadherin-6,18492,130,0.95 [0.62-1.43],0.7894595601413147
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDHR1,Cadherin-related family member 1,18093,124,0.95 [0.64-1.42],0.8179091214912902
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDHR2,Cadherin-related family member 2,18402,129,0.90 [0.71-1.15],0.397467179710855
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDHR5,Cadherin-related family member 5,18492,130,0.66 [0.46-0.96],0.0310778458677687
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDK1,Cyclin-dependent kinase 1,15494,101,1.27 [0.75-2.15],0.3826906863050806
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,16031,108,0.96 [0.70-1.32],0.8183221074909678
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDKL5,Cyclin-dependent kinase-like 5,15563,101,1.00 [0.69-1.44],0.992584120238031
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDKN1A,Cyclin-dependent kinase inhibitor 1,18402,129,1.00 [0.86-1.16],0.9861112646757566
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,18402,129,1.01 [0.85-1.19],0.946635130840063
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDNF,Cerebral dopamine neurotrophic factor,18402,129,1.68 [1.21-2.33],0.0020959463018649
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,18492,130,0.55 [0.31-0.94],0.0303255825290621
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CDSN,Corneodesmosin,18661,130,1.62 [1.13-2.31],0.0084994627708643
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,18508,130,1.47 [0.66-3.25],0.3448227780052526
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,16000,108,0.94 [0.75-1.18],0.5899973323912532
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,15770,101,0.87 [0.64-1.20],0.4022128105989909
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,16000,108,1.53 [1.00-2.33],0.0491287390640013
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,15770,101,0.99 [0.63-1.56],0.9659095338094004
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,18488,132,1.12 [0.94-1.34],0.1872687761771858
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,18072,126,0.98 [0.70-1.38],0.921944678924178
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,17834,123,1.09 [0.84-1.42],0.5107048908054523
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,16062,108,0.60 [0.36-0.99],0.0455585331865389
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,18163,124,1.26 [0.92-1.72],0.1431266515315827
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CEBPA,CCAAT/enhancer-binding protein alpha,15570,103,1.13 [0.70-1.82],0.6295693741403178
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CEBPB,CCAAT/enhancer-binding protein beta,18163,124,1.11 [0.73-1.69],0.616044939094925
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CELA2A,Chymotrypsin-like elastase family member 2A,16062,108,1.02 [0.76-1.36],0.9116574865802652
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CELA3A,Chymotrypsin-like elastase family member 3A,18688,128,1.00 [0.77-1.30],0.985844484562344
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,15698,103,1.27 [0.65-2.46],0.4865072430191458
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CEMIP2,Cell surface hyaluronidase,15570,103,0.98 [0.51-1.85],0.9407134667255056
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CEND1,Cell cycle exit and neuronal differentiation protein 1,15563,101,0.84 [0.58-1.23],0.3700895736252527
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CENPF,Centromere protein F,15770,101,1.11 [0.79-1.57],0.5511575366175027
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CENPJ,Centromere protein J,15770,101,0.99 [0.75-1.31],0.9493834964263932
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CEP112,Centrosomal protein of 112 kDa,15526,102,0.88 [0.55-1.40],0.5817992402057607
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CEP152,Centrosomal protein of 152 kDa,15494,101,1.46 [1.04-2.05],0.0286903400140136
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CEP164,Centrosomal protein of 164 kDa,18183,127,1.04 [0.81-1.33],0.7769311641240332
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CEP170,Centrosomal protein of 170 kDa,15602,101,1.33 [1.07-1.64],0.0089888784849816
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CEP20,Centrosomal protein 20,18072,126,0.97 [0.78-1.19],0.7458244479990647
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CEP290,Centrosomal protein of 290 kDa,15770,101,1.12 [0.82-1.53],0.4615508227948515
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CEP350,Centrosome-associated protein 350,15494,101,0.84 [0.49-1.44],0.5223954494445827
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CEP43,Centrosomal protein 43,18022,123,1.06 [0.84-1.34],0.5979008290035199
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CEP85,Centrosomal protein of 85 kDa,18072,126,1.23 [0.97-1.56],0.0881647887001514
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CERT,Ceramide transfer protein,18093,124,1.04 [0.80-1.35],0.7590435352902192
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CES1,Liver carboxylesterase 1,18534,128,0.92 [0.75-1.12],0.380147707454565
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CES2,Cocaine esterase,18402,129,1.23 [0.95-1.60],0.1198765167278352
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CES3,Carboxylesterase 3,18402,129,1.06 [0.85-1.32],0.615403687730745
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CETN2,Centrin-2,18093,124,1.08 [0.86-1.36],0.5200592328599124
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CETN3,Centrin-3,16000,108,1.18 [0.93-1.49],0.1646269536702544
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CFB,Complement factor B,15805,106,0.78 [0.44-1.39],0.4039562616088696
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CFC1,Cryptic protein,18072,126,1.16 [0.84-1.61],0.3698764990643862
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CFD,Complement factor D,16076,107,1.85 [0.91-3.75],0.0896294355900242
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CFH,Complement factor H,15174,103,1.48 [0.66-3.34],0.3458050518424049
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CFHR2,Complement factor H-related protein 2,15962,107,0.99 [0.71-1.37],0.9397136387242132
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CFHR4,Complement factor H-related protein 4,16042,107,1.05 [0.81-1.36],0.7151285770215171
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CFHR5,Complement factor H-related protein 5,15874,107,1.42 [0.88-2.29],0.14635574595929
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CFI,Complement factor I,16076,107,0.56 [0.22-1.46],0.2395253032635244
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CFP,Properdin,16076,107,0.91 [0.39-2.15],0.8297204816054748
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CGA,Glycoprotein hormones alpha chain,18493,131,1.18 [0.93-1.51],0.1696133957094941
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,16073,108,0.98 [0.59-1.61],0.9267978397123532
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CGN,Cingulin,15643,104,0.81 [0.47-1.40],0.4475528719081452
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CGREF1,Cell growth regulator with EF hand domain protein 1,18492,130,1.21 [0.84-1.74],0.300767893383319
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,18072,126,1.02 [0.78-1.34],0.8925374911608986
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CHAD,Chondroadherin,15698,103,1.19 [0.78-1.80],0.4226130944799955
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",16023,107,1.54 [1.04-2.28],0.0294982057823164
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CHCHD6,MICOS complex subunit MIC25,15996,108,1.63 [0.94-2.83],0.0815673665869379
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CHEK2,Serine/threonine-protein kinase Chk2,18163,124,1.06 [0.65-1.74],0.8081151003345384
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CHGA,Chromogranin-A,16062,108,1.10 [0.90-1.34],0.3699310950365392
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CHGB,Secretogranin-1,18606,130,1.04 [0.71-1.52],0.8409607669764351
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CHI3L1,Chitinase-3-like protein 1,18117,128,1.07 [0.89-1.29],0.466656975516125
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CHIT1,Chitotriosidase-1,18577,128,1.10 [0.97-1.24],0.1285859487437311
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CHL1,Neural cell adhesion molecule L1-like protein,18553,129,1.19 [0.71-2.00],0.5024335094213116
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CHM,Rab proteins geranylgeranyltransferase component A 1,15643,104,1.04 [0.77-1.42],0.7878521685702546
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CHMP1A,Charged multivesicular body protein 1a,18340,127,0.93 [0.77-1.14],0.5027228864222768
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CHMP6,Charged multivesicular body protein 6,16050,105,1.17 [0.84-1.61],0.3571763577040746
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CHP1,Calcineurin B homologous protein 1,15563,101,0.90 [0.68-1.19],0.4673337558368107
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CHRDL1,Chordin-like protein 1,18531,130,1.54 [0.95-2.52],0.0818959449973472
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CHRDL2,Chordin-like protein 2,18492,130,1.06 [0.75-1.49],0.7308703975547832
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CHRM1,Muscarinic acetylcholine receptor M1,15643,104,1.24 [0.79-1.95],0.3412078489938576
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CIAPIN1,Anamorsin,18535,130,1.11 [0.86-1.43],0.4234296600633909
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CILP,Cartilage intermediate layer protein 1,16062,108,1.31 [0.92-1.86],0.1363748798233392
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CINP,Cyclin-dependent kinase 2-interacting protein,15770,101,1.07 [0.71-1.62],0.7457721491915865
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CIRBP,Cold-inducible RNA-binding protein,16000,108,1.11 [0.91-1.34],0.2973496460498179
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CIT,Citron Rho-interacting kinase,15643,104,1.27 [0.89-1.81],0.1940783943545337
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CKAP4,Cytoskeleton-associated protein 4,18620,129,1.74 [1.13-2.69],0.0126118017567792
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CKB,Creatine kinase B-type,16062,108,1.47 [1.07-2.04],0.019297077680079
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",18409,130,0.92 [0.73-1.16],0.4808408665190606
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLASP1,CLIP-associating protein 1,15494,101,0.97 [0.75-1.26],0.8088467256440246
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLC,Galectin-10,18462,129,0.97 [0.77-1.23],0.8051633408251645
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLEC10A,C-type lectin domain family 10 member A,18340,127,1.40 [0.91-2.17],0.1283452134329528
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLEC11A,C-type lectin domain family 11 member A,18465,131,1.03 [0.74-1.43],0.853825560852039
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLEC12A,C-type lectin domain family 12 member A,15570,103,1.14 [0.45-2.94],0.7787106543172835
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLEC14A,C-type lectin domain family 14 member A,18493,131,1.89 [1.20-2.98],0.0061780861610133
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLEC1A,C-type lectin domain family 1 member A,18163,124,2.68 [1.75-4.08],4.883077249939034e-06
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLEC1B,C-type lectin domain family 1 member B,18657,131,0.96 [0.82-1.13],0.6379037661806253
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLEC2L,C-type lectin domain family 2 member L,15643,104,1.04 [0.73-1.47],0.8344030850828127
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLEC3B,Tetranectin,15717,106,0.67 [0.27-1.65],0.3862636543385089
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLEC4A,C-type lectin domain family 4 member A,18488,132,0.92 [0.59-1.41],0.6933006185317995
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLEC4C,C-type lectin domain family 4 member C,18488,132,1.05 [0.76-1.44],0.7854252999976179
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLEC4D,C-type lectin domain family 4 member D,18488,132,0.83 [0.64-1.07],0.1548645969313593
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLEC4G,C-type lectin domain family 4 member G,18488,132,1.34 [0.84-2.12],0.2180155430628578
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLEC4M,C-type lectin domain family 4 member M,16040,108,1.07 [0.74-1.56],0.7250260426200694
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLEC5A,C-type lectin domain family 5 member A,18432,130,1.31 [0.78-2.18],0.3073782356617796
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLEC6A,C-type lectin domain family 6 member A,18072,126,1.16 [0.83-1.63],0.3899276242521703
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLEC7A,C-type lectin domain family 7 member A,18712,130,0.89 [0.71-1.10],0.2795507122482836
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLGN,Calmegin,15643,104,1.25 [0.86-1.82],0.2403383443065818
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLIC5,Chloride intracellular channel protein 5,15643,104,1.31 [0.78-2.22],0.3076027848511434
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLINT1,Clathrin interactor 1,15494,101,0.83 [0.53-1.31],0.4185730279303775
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLIP2,CAP-Gly domain-containing linker protein 2,18488,132,1.05 [0.91-1.20],0.4987628160702836
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLMP,CXADR-like membrane protein,18664,128,1.65 [0.80-3.40],0.1750983115355321
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLNS1A,Methylosome subunit pICln,15643,104,1.05 [0.61-1.83],0.856791277807986
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",18312,127,0.85 [0.72-1.00],0.0563767545673264
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLPS,Colipase,18455,131,1.15 [0.93-1.42],0.20261113376085
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLSPN,Claspin,18065,124,1.17 [0.82-1.68],0.385273132335602
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLSTN1,Calsyntenin-1,18093,124,1.09 [0.82-1.46],0.5444077618959805
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLSTN2,Calsyntenin-2,18712,130,1.21 [0.82-1.77],0.3323752304571325
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLSTN3,Calsyntenin-3,16023,107,1.40 [0.78-2.49],0.2568958065726374
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLTA,Clathrin light chain A,18163,124,1.27 [0.92-1.75],0.149345368402029
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLU,Clusterin,16076,107,0.63 [0.24-1.62],0.3370397085249089
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CLUL1,Clusterin-like protein 1,18458,130,1.18 [0.83-1.67],0.361562169075549
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CMC1,COX assembly mitochondrial protein homolog,16050,105,1.14 [0.93-1.40],0.2024180663310281
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CMIP,C-Maf-inducing protein,15996,108,1.12 [0.90-1.40],0.2966058905546062
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CNDP1,Beta-Ala-His dipeptidase,18580,129,0.90 [0.64-1.27],0.5482105939097078
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CNGB3,Cyclic nucleotide-gated cation channel beta-3,15563,101,1.31 [1.02-1.67],0.0311002027349312
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",15574,101,1.20 [0.94-1.52],0.1481118768086337
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CNPY2,Protein canopy homolog 2,18163,124,0.96 [0.73-1.27],0.7792175730353421
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CNPY4,Protein canopy homolog 4,18402,129,1.02 [0.83-1.26],0.8252162188528117
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CNST,Consortin,18492,130,0.98 [0.85-1.13],0.7830060399283478
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CNTF,Ciliary neurotrophic factor,15563,101,1.28 [0.75-2.18],0.3587661469060567
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CNTN1,Contactin-1,18719,128,0.76 [0.43-1.32],0.3264489455599636
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CNTN2,Contactin-2,18664,128,0.91 [0.64-1.30],0.6060428307238952
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CNTN3,Contactin-3,18493,131,0.96 [0.55-1.69],0.8891900988399128
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CNTN4,Contactin-4,18493,131,1.10 [0.57-2.14],0.7753776662559972
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CNTN5,Contactin-5,18542,131,1.07 [0.70-1.64],0.7536157868189196
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CNTNAP2,Contactin-associated protein-like 2,18488,132,1.26 [0.87-1.80],0.2167433250128919
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CNTNAP4,Contactin-associated protein-like 4,15643,104,1.04 [0.88-1.23],0.6320085080965524
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,COCH,Cochlin,16050,105,1.45 [0.98-2.15],0.0636311039344068
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,COL15A1,Collagen alpha-1(XV) chain,16062,108,2.18 [1.11-4.26],0.0228587299744903
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,COL18A1,Collagen alpha-1(XVIII) chain,18564,128,1.57 [0.79-3.10],0.194159422364195
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,COL1A1,Collagen alpha-1(I) chain,18719,128,1.45 [0.76-2.79],0.262079300606536
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,COL24A1,Collagen alpha-1(XXIV) chain,16000,108,0.95 [0.69-1.31],0.7736779684930803
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,COL28A1,Collagen alpha-1(XXVIII) chain,15643,104,1.06 [0.84-1.34],0.6219854940456448
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,COL2A1,Collagen alpha-1(II) chain,15602,101,0.89 [0.69-1.14],0.3470891201780303
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,COL3A1,Collagen alpha-1(III) chain,16062,108,1.11 [0.51-2.42],0.7988570942840596
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,COL4A1,Collagen alpha-1(IV) chain,18492,130,0.96 [0.63-1.45],0.8458417891237328
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,COL4A4,Collagen alpha-4(IV) chain,15741,101,1.03 [0.72-1.47],0.873614521170814
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,COL5A1,Collagen alpha-1(V) chain,15698,103,1.10 [0.68-1.80],0.694362718167642
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,COL6A3,Collagen alpha-3(VI) chain,18719,128,1.92 [1.28-2.89],0.0017157337482582
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,COL9A1,Collagen alpha-1(IX) chain,18488,132,1.01 [0.72-1.43],0.9508064742604284
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,COL9A2,Collagen alpha-2(IX) chain,15770,101,1.26 [0.88-1.80],0.2067988703716455
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,COLEC12,Collectin-12,18462,130,1.91 [1.08-3.39],0.0269626960143189
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,COMMD1,COMM domain-containing protein 1,15602,101,1.43 [1.06-1.93],0.0203773823165819
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,COMMD9,COMM domain-containing protein 9,15996,108,1.22 [0.81-1.84],0.3370500433481587
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,COMP,Cartilage oligomeric matrix protein,18319,128,1.75 [1.09-2.81],0.0209463626971397
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,COMT,Catechol O-methyltransferase,17965,123,1.10 [0.91-1.34],0.3170946044058286
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,COPB2,Coatomer subunit beta',15526,102,1.18 [0.79-1.75],0.4244736399145856
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,COPE,Coatomer subunit epsilon,18093,124,0.55 [0.35-0.86],0.0081613986092698
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",15602,101,1.36 [0.95-1.95],0.0968865354293401
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CORO1A,Coronin-1A,18124,124,1.11 [0.94-1.31],0.2208647143793966
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CORO6,Coronin-6,15563,101,1.03 [0.62-1.73],0.909831360624459
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",18402,129,0.97 [0.77-1.21],0.7712044483378536
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,COX6B1,Cytochrome c oxidase subunit 6B1,16050,105,1.17 [0.67-2.05],0.5872289356400198
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CPA1,Carboxypeptidase A1,18719,128,1.02 [0.80-1.30],0.8634421510860936
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CPA2,Carboxypeptidase A2,18604,131,0.97 [0.76-1.22],0.7667380590617774
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CPA4,Carboxypeptidase A4,15397,102,1.30 [0.82-2.05],0.2640997198570898
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CPB1,Carboxypeptidase B,18719,128,1.09 [0.85-1.40],0.5047121082580968
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CPB2,Carboxypeptidase B2,16051,107,0.47 [0.21-1.06],0.0691863150166308
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CPE,Carboxypeptidase E,18504,128,1.08 [0.72-1.61],0.7170120467191432
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CPLX2,Complexin-2,15494,101,0.49 [0.25-0.96],0.0374978080555749
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CPM,Carboxypeptidase M,18570,130,0.80 [0.50-1.29],0.3607413810892017
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",15570,103,0.98 [0.48-2.01],0.9553415427928376
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CPPED1,Serine/threonine-protein phosphatase CPPED1,18657,131,0.86 [0.68-1.09],0.202859356320728
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CPQ,Carboxypeptidase Q,16035,108,0.73 [0.44-1.21],0.2234873115687899
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CPTP,Ceramide-1-phosphate transfer protein,15526,102,0.82 [0.49-1.37],0.4484395681818608
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CPVL,Probable serine carboxypeptidase CPVL,18628,127,1.19 [0.81-1.76],0.3744355153401874
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CPXM1,Probable carboxypeptidase X1,18535,130,0.94 [0.75-1.18],0.6032229901075769
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CPXM2,Inactive carboxypeptidase-like protein X2,16050,105,1.92 [0.95-3.91],0.0704067556926285
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CR1,Complement receptor type 1,16017,108,1.27 [0.75-2.14],0.3725834674871738
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CR2,Complement receptor type 2,18580,129,0.87 [0.62-1.22],0.4154859873702408
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,18072,126,1.14 [0.96-1.37],0.134367745712298
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CRADD,Death domain-containing protein CRADD,18312,127,1.03 [0.83-1.27],0.7986499116581127
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CREB3,Cyclic AMP-responsive element-binding protein 3,15494,101,0.96 [0.67-1.37],0.8093235750917491
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CREBZF,CREB/ATF bZIP transcription factor,15494,101,1.29 [0.65-2.57],0.4684700656401305
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CREG1,Protein CREG1,18248,128,1.03 [0.70-1.51],0.8891791939307904
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CRELD1,Protein disulfide isomerase CRELD1,15698,103,1.12 [0.66-1.91],0.663387457657588
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CRELD2,Protein disulfide isomerase CRELD2,18531,130,1.21 [0.90-1.62],0.2117971375103091
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CRH,Corticoliberin,18046,126,0.89 [0.74-1.08],0.2477350088333598
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CRHBP,Corticotropin-releasing factor-binding protein,18462,130,1.08 [0.60-1.93],0.7944897221797963
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CRHR1,Corticotropin-releasing factor receptor 1,18163,124,0.94 [0.72-1.24],0.6816926128562991
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CRIM1,Cysteine-rich motor neuron 1 protein,18552,130,2.69 [1.26-5.73],0.0102459515932105
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CRIP2,Cysteine-rich protein 2,18340,127,1.00 [0.65-1.54],0.9975434727451936
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CRISP2,Cysteine-rich secretory protein 2,18664,128,0.80 [0.60-1.05],0.1026413789953815
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CRISP3,Cysteine-rich secretory protein 3,15918,107,1.10 [0.55-2.20],0.7895484981647376
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CRKL,Crk-like protein,18497,130,1.03 [0.89-1.19],0.7303742177036491
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CRLF1,Cytokine receptor-like factor 1,18552,130,2.06 [1.10-3.88],0.0241372516826174
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CRNN,Cornulin,17962,120,0.99 [0.78-1.26],0.9176093237548908
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CRTAC1,Cartilage acidic protein 1,18719,128,1.32 [0.79-2.20],0.2926106299718972
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CRTAM,Cytotoxic and regulatory T-cell molecule,18340,127,1.19 [0.87-1.62],0.2845608325191451
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CRTAP,Cartilage-associated protein,15643,104,1.08 [0.76-1.54],0.6722322776576297
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CRX,Cone-rod homeobox protein,18163,124,1.12 [0.99-1.27],0.0768412240319238
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CRYBB1,Beta-crystallin B1,16050,105,1.30 [0.98-1.72],0.0689948728398687
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CRYBB2,Beta-crystallin B2,16023,107,0.99 [0.77-1.28],0.9477134601216998
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CRYGD,Gamma-crystallin D,16023,107,1.18 [0.98-1.43],0.0803259653810109
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CRYM,Ketimine reductase mu-crystallin,15563,101,1.07 [0.83-1.38],0.5993424469359173
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CRYZL1,Quinone oxidoreductase-like protein 1,15602,101,1.11 [0.90-1.38],0.3427952383610254
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CSDE1,Cold shock domain-containing protein E1,15526,102,1.08 [0.93-1.24],0.3123079019963628
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CSF1,Macrophage colony-stimulating factor 1,18552,130,2.04 [1.15-3.61],0.0145844380422211
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CSF1R,Macrophage colony-stimulating factor 1 receptor,16073,108,1.32 [0.85-2.06],0.2212747422515109
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CSF2,Granulocyte-macrophage colony-stimulating factor,15526,102,0.91 [0.53-1.56],0.7374089846442831
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,18340,127,0.99 [0.77-1.29],0.966069650153521
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CSF2RB,Cytokine receptor common subunit beta,15570,103,1.44 [0.91-2.28],0.1204477887785987
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CSF3,Granulocyte colony-stimulating factor,18183,127,0.76 [0.54-1.07],0.1141545692120107
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CSF3R,Granulocyte colony-stimulating factor receptor,15570,103,0.67 [0.33-1.36],0.2662100889773404
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CSH1,Chorionic somatomammotropin hormone 1,16073,108,1.78 [0.99-3.21],0.053327216456556
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CSNK1D,Casein kinase I isoform delta,15570,103,1.10 [0.83-1.46],0.5181124117737443
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CSNK2A1,Casein kinase II subunit alpha,16031,108,1.17 [0.78-1.76],0.43954211773623
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CSPG4,Chondroitin sulfate proteoglycan 4,16062,108,2.12 [1.22-3.67],0.0075642591073746
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CSPG5,Chondroitin sulfate proteoglycan 5,15563,101,1.01 [0.69-1.49],0.9500944838816572
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CSRP3,Cysteine and glycine-rich protein 3,15526,102,1.16 [0.97-1.38],0.0971320038540616
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CST1,Cystatin-SN,13942,93,1.10 [0.91-1.34],0.3196520835202803
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CST3,Cystatin-C,18545,129,2.14 [1.29-3.56],0.0032528263680966
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CST5,Cystatin-D,18105,122,1.07 [0.80-1.43],0.6616936582599378
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CST6,Cystatin-M,18012,123,1.09 [0.79-1.52],0.5933526660335313
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CST7,Cystatin-F,18494,130,1.19 [1.04-1.35],0.0108393799576103
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CSTB,Cystatin-B,18238,126,1.35 [0.95-1.92],0.0937854718678517
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CTAG1A_CTAG1B,Cancer/testis antigen 1,15743,101,1.05 [0.72-1.54],0.8029023652648075
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CTBS,Di-N-acetylchitobiase,15851,107,1.08 [0.53-2.22],0.8260119556814212
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CTF1,Cardiotrophin-1,18163,124,1.07 [0.89-1.28],0.4990611339117743
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CTHRC1,Collagen triple helix repeat-containing protein 1,16062,108,1.85 [0.98-3.48],0.0585370484618345
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CTLA4,Cytotoxic T-lymphocyte protein 4,16062,108,0.81 [0.44-1.48],0.4883957291251705
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CTNNA1,Catenin alpha-1,15563,101,0.97 [0.54-1.75],0.923699610260322
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CTRB1,Chymotrypsinogen B,18493,131,0.89 [0.68-1.17],0.3999447001498987
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CTRC,Chymotrypsin-C,18461,129,0.86 [0.68-1.09],0.222236866453523
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CTRL,Chymotrypsin-like protease CTRL-1,16023,107,1.04 [0.80-1.35],0.7781689152151727
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CTSB,Cathepsin B,18496,128,1.49 [1.13-1.96],0.0047572691503127
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CTSC,Dipeptidyl peptidase 1,18427,129,1.08 [0.76-1.52],0.67283975334623
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CTSD,Cathepsin D,17307,122,1.33 [0.93-1.90],0.1140455771722556
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CTSE,Cathepsin E,15698,103,0.84 [0.59-1.21],0.3596304998152546
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CTSF,Cathepsin F,18535,130,0.87 [0.59-1.30],0.5025844464957054
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CTSH,Pro-cathepsin H,18101,124,0.89 [0.72-1.11],0.3057308675058764
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CTSL,Cathepsin L1,18492,130,1.61 [0.86-3.03],0.1394667024391623
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CTSO,Cathepsin O,18712,130,1.06 [0.64-1.77],0.8097430884534126
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CTSS,Cathepsin S,14598,105,1.74 [0.79-3.84],0.1669061939753232
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CTSV,Cathepsin L2,18594,127,0.94 [0.63-1.40],0.7664338355102311
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CTSZ,Cathepsin Z,18521,128,1.60 [0.98-2.62],0.0589541301835458
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CUZD1,CUB and zona pellucida-like domain-containing protein 1,15643,104,0.73 [0.42-1.29],0.2782010070541973
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CWC15,Spliceosome-associated protein CWC15 homolog,15909,108,1.25 [0.99-1.57],0.0617673527316054
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CX3CL1,Fractalkine,18340,127,1.74 [1.10-2.75],0.0179254111759917
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CXADR,Coxsackievirus and adenovirus receptor,18488,132,1.13 [0.82-1.56],0.4501255076658634
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CXCL1,Growth-regulated alpha protein,18442,130,0.97 [0.82-1.15],0.7091709255648544
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CXCL10,C-X-C motif chemokine 10,18552,130,1.13 [0.89-1.42],0.3117821641129473
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CXCL11,C-X-C motif chemokine 11,18657,131,1.06 [0.87-1.28],0.5599024994423412
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CXCL12,Stromal cell-derived factor 1,18183,127,0.89 [0.59-1.34],0.5852666001189933
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CXCL13,C-X-C motif chemokine 13,18657,131,0.95 [0.71-1.27],0.7291314282677066
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CXCL14,C-X-C motif chemokine 14,18183,127,1.21 [0.96-1.54],0.1093976014433299
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CXCL16,C-X-C motif chemokine 16,18688,128,2.51 [1.30-4.86],0.0061577395802232
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CXCL17,C-X-C motif chemokine 17,18712,130,0.59 [0.41-0.87],0.0068938032954657
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CXCL3,C-X-C motif chemokine 3,18473,130,0.93 [0.80-1.10],0.4120711018793622
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CXCL5,C-X-C motif chemokine 5,18430,130,0.90 [0.79-1.04],0.1428777626488419
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CXCL6,C-X-C motif chemokine 6,18712,130,0.83 [0.67-1.03],0.0848395558639775
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CXCL8,Interleukin-8,18381,125,0.94 [0.74-1.21],0.6479638028517518
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CXCL9,C-X-C motif chemokine 9,18552,130,1.21 [0.97-1.52],0.0943702674408534
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CYB5A,Cytochrome b5,15494,101,0.93 [0.70-1.23],0.6134653909864449
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CYB5R2,NADH-cytochrome b5 reductase 2,15835,107,1.54 [1.12-2.10],0.0069598738440736
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",15526,102,0.96 [0.76-1.21],0.7403633049967951
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CYTH3,Cytohesin-3,15494,101,0.84 [0.62-1.13],0.2435248709109456
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,CYTL1,Cytokine-like protein 1,16062,108,1.40 [0.67-2.91],0.3693368362332326
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DAAM1,Disheveled-associated activator of morphogenesis 1,15698,103,1.13 [0.90-1.42],0.2890815156237174
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DAB2,Disabled homolog 2,18664,128,1.04 [0.90-1.19],0.6126974289306104
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DAG1,Dystroglycan,18552,130,0.94 [0.67-1.31],0.7018001372728864
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DAND5,DAN domain family member 5,15570,103,1.23 [0.95-1.60],0.1150579445383498
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DAPK2,Death-associated protein kinase 2,15570,103,1.22 [0.92-1.62],0.1595886259805264
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,18488,132,0.99 [0.87-1.12],0.8379717000422017
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DARS1,"Aspartate--tRNA ligase, cytoplasmic",18312,127,1.13 [0.91-1.41],0.2691566081246986
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DBH,Dopamine beta-hydroxylase,16052,108,0.95 [0.81-1.11],0.5222754787051848
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DBI,Acyl-CoA-binding protein,18404,129,1.14 [0.93-1.39],0.211678424183358
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DBN1,Drebrin,15570,103,1.35 [0.95-1.93],0.0934194769229421
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DBNL,Drebrin-like protein,18552,130,1.02 [0.86-1.20],0.8267092418009373
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",18535,130,1.16 [0.75-1.81],0.4985186912611814
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DCC,Netrin receptor DCC,15643,104,0.47 [0.17-1.29],0.1453077459413469
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DCDC2C,Doublecortin domain-containing protein 2C,15494,101,0.93 [0.67-1.29],0.6685970203779532
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DCLRE1C,Protein artemis,15494,101,1.29 [0.72-2.28],0.3905661583554852
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DCN,Decorin,18163,124,2.36 [1.23-4.53],0.010009076481785
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DCTD,Deoxycytidylate deaminase,15698,103,1.10 [0.90-1.34],0.3639258893253289
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DCTN1,Dynactin subunit 1,18664,128,1.03 [0.81-1.32],0.789199244949888
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DCTN2,Dynactin subunit 2,18402,129,1.06 [0.90-1.25],0.4947329389580061
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DCTN6,Dynactin subunit 6,18093,124,0.91 [0.72-1.16],0.4573952037993313
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DCTPP1,dCTP pyrophosphatase 1,18492,130,1.09 [0.66-1.80],0.7366069213184725
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DCUN1D1,DCN1-like protein 1,15563,101,1.02 [0.80-1.31],0.8491868917464064
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DCUN1D2,DCN1-like protein 2,15494,101,1.11 [0.88-1.39],0.3719615576871751
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DCXR,L-xylulose reductase,18535,130,0.74 [0.55-1.01],0.0550548837609807
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DDA1,DET1- and DDB1-associated protein 1,15526,102,0.97 [0.59-1.60],0.9029769788740816
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",18402,129,1.32 [0.94-1.85],0.1081940333008003
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DDC,Aromatic-L-amino-acid decarboxylase,18472,130,1.13 [0.81-1.58],0.455656501279591
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DDHD2,Phospholipase DDHD2,16031,108,1.20 [0.91-1.58],0.203520678504732
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DDI2,Protein DDI1 homolog 2,15698,103,0.79 [0.61-1.03],0.0773497540600603
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DDR1,Epithelial discoidin domain-containing receptor 1,18657,131,1.61 [0.83-3.12],0.1556793134831417
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DDT,D-dopachrome decarboxylase,16062,108,0.92 [0.58-1.45],0.7149192123024251
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DDX1,ATP-dependent RNA helicase DDX1,16000,108,1.18 [0.85-1.64],0.3316322704532804
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DDX25,ATP-dependent RNA helicase DDX25,15643,104,0.82 [0.46-1.47],0.5053132156751662
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DDX39A,ATP-dependent RNA helicase DDX39A,15570,103,1.24 [0.63-2.45],0.5265022237799375
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DDX4,Probable ATP-dependent RNA helicase DDX4,15570,103,0.97 [0.67-1.38],0.8478362232217802
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DDX53,Probable ATP-dependent RNA helicase DDX53,15643,104,1.16 [0.73-1.83],0.5323687708652657
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DDX58,Antiviral innate immune response receptor RIG-I,18072,126,1.11 [0.86-1.44],0.4274671248942356
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",18488,132,0.96 [0.82-1.13],0.6440275441978244
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DEFA1_DEFA1B,Neutrophil defensin 1,18148,128,1.08 [0.81-1.43],0.6070998977645747
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DEFB103A_DEFB103B,Beta-defensin 103,15462,102,0.80 [0.48-1.35],0.4080900171952312
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DEFB104A_DEFB104B,Beta-defensin 104,15563,101,1.03 [0.73-1.45],0.8798002745209874
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DEFB116,Beta-defensin 116,15563,101,1.02 [0.78-1.33],0.8758898236364422
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DEFB118,Beta-defensin 118,15563,101,1.20 [0.91-1.57],0.1933834644014396
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DEFB4A_DEFB4B,Beta-defensin 4A,18207,129,1.07 [0.97-1.19],0.1923885832441577
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DENND2B,DENN domain-containing protein 2B,15526,102,0.69 [0.41-1.15],0.1553737852265665
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DENR,Density-regulated protein,15570,103,0.98 [0.70-1.38],0.9285310625674792
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DFFA,DNA fragmentation factor subunit alpha,18712,130,1.01 [0.80-1.28],0.9295026020177668
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DGCR6,Protein DGCR6,15563,101,0.84 [0.51-1.39],0.4998604306507869
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DGKA,Diacylglycerol kinase alpha,15570,103,1.20 [0.86-1.69],0.2837767539791065
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DGKZ,Diacylglycerol kinase zeta,18183,127,0.83 [0.53-1.30],0.4115588087561003
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DHODH,Dihydroorotate dehydrogenase,15526,102,1.06 [0.71-1.57],0.7728805640046733
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DHPS,Deoxyhypusine synthase,15996,108,1.12 [0.72-1.72],0.6185055703466283
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,16023,107,1.18 [0.82-1.71],0.3749676597846476
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DIABLO,"Diablo homolog, mitochondrial",18432,130,0.97 [0.84-1.11],0.6442997735491566
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DIPK1C,Divergent protein kinase domain 1C,15643,104,0.78 [0.47-1.28],0.3184902027430651
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DIPK2B,Divergent protein kinase domain 2B,15698,103,1.73 [1.03-2.91],0.039503691401073
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DKK1,Dickkopf-related protein 1,18657,131,0.87 [0.67-1.13],0.2835637955821182
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DKK3,Dickkopf-related protein 3,18719,128,1.28 [0.75-2.18],0.3680376482679559
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DKK4,Dickkopf-related protein 4,18305,125,1.31 [0.95-1.81],0.0966124536984036
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DKKL1,Dickkopf-like protein 1,18402,129,1.02 [0.85-1.22],0.8396900771659396
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DLG4,Disks large homolog 4,16023,107,1.23 [0.96-1.57],0.0950075262367955
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DLGAP5,Disks large-associated protein 5,16031,108,0.52 [0.28-0.94],0.0297946070031732
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DLK1,Protein delta homolog 1,18719,128,1.22 [0.93-1.61],0.1541622469724483
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DLL1,Delta-like protein 1,18535,130,2.02 [1.23-3.34],0.0057222073806238
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DLL4,Delta-like protein 4,15602,101,0.98 [0.79-1.21],0.8538348592274743
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DMD,Dystrophin,15602,101,1.44 [1.03-2.00],0.0318563687061334
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DMP1,Dentin matrix acidic phosphoprotein 1,15602,101,0.92 [0.65-1.29],0.6181015428410529
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DNAJA1,DnaJ homolog subfamily A member 1,15494,101,0.98 [0.63-1.53],0.9417727749025994
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DNAJA2,DnaJ homolog subfamily A member 2,18654,130,1.00 [0.83-1.21],0.9954614842263148
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DNAJA4,DnaJ homolog subfamily A member 4,16023,107,0.94 [0.72-1.22],0.6399818255729135
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DNAJB1,DnaJ homolog subfamily B member 1,18402,129,0.92 [0.77-1.11],0.3958265775473399
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DNAJB14,DnaJ homolog subfamily B member 14,16000,108,1.25 [0.96-1.64],0.1002342820716009
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DNAJB2,DnaJ homolog subfamily B member 2,15698,103,1.10 [0.77-1.57],0.6069229181533616
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DNAJB6,DnaJ homolog subfamily B member 6,15555,102,1.18 [0.94-1.48],0.1549180950522828
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DNAJB8,DnaJ homolog subfamily B member 8,18163,124,1.09 [0.83-1.42],0.5399849844251662
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DNAJC21,DnaJ homolog subfamily C member 21,16023,107,1.15 [0.73-1.81],0.5463639754201747
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DNAJC6,Putative tyrosine-protein phosphatase auxilin,15602,101,1.13 [0.90-1.42],0.2753301860783012
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DNAJC9,DnaJ homolog subfamily C member 9,16000,108,1.26 [0.99-1.59],0.0611857834578837
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DNER,Delta and Notch-like epidermal growth factor-related receptor,18432,129,0.82 [0.45-1.51],0.5314557658992226
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DNLZ,DNL-type zinc finger protein,15563,101,0.93 [0.73-1.20],0.5982330070882944
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DNM1,Dynamin-1,16000,108,0.97 [0.83-1.14],0.7278403991185227
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DNM3,Dynamin-3,16031,108,1.46 [1.11-1.93],0.0067971061005554
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DNMBP,Dynamin-binding protein,18340,127,1.12 [0.86-1.44],0.3975705268983631
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DNPEP,Aspartyl aminopeptidase,16023,107,1.23 [0.88-1.73],0.2228500153685947
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,18518,130,0.88 [0.65-1.19],0.4106800745519831
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DOC2B,Double C2-like domain-containing protein beta,15643,104,0.82 [0.45-1.49],0.5109226310787858
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DOCK9,Dedicator of cytokinesis protein 9,15563,101,0.94 [0.78-1.12],0.4859082390447633
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DOK1,Docking protein 1,16023,107,1.06 [0.92-1.21],0.4287134628665749
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DOK2,Docking protein 2,18492,130,1.01 [0.89-1.15],0.8412913537357896
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DPEP1,Dipeptidase 1,18312,127,1.13 [0.80-1.59],0.4984936830242833
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DPEP2,Dipeptidase 2,18402,129,1.38 [0.82-2.31],0.2202018895658107
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DPP10,Inactive dipeptidyl peptidase 10,18488,132,1.01 [0.65-1.57],0.9537436343400048
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DPP4,Dipeptidyl peptidase 4,18172,128,0.66 [0.36-1.19],0.163293552790209
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DPP6,Dipeptidyl aminopeptidase-like protein 6,18402,129,0.97 [0.61-1.54],0.8938470244502383
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DPP7,Dipeptidyl peptidase 2,18352,129,1.19 [0.92-1.52],0.1782482098407409
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DPT,Dermatopontin,18719,128,2.21 [1.14-4.28],0.0193910818106018
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DPY30,Protein dpy-30 homolog,18612,127,1.07 [0.83-1.39],0.586293061806296
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DRAXIN,Draxin,18340,127,1.05 [0.72-1.54],0.7850468389036893
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DRG2,Developmentally-regulated GTP-binding protein 2,18402,129,1.09 [0.83-1.43],0.5397699290452449
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DSC2,Desmocollin-2,18262,129,1.58 [1.01-2.47],0.0440644929176991
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DSCAM,Down syndrome cell adhesion molecule,16031,108,1.73 [1.05-2.87],0.0316994956737274
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DSG2,Desmoglein-2,18493,131,1.52 [0.86-2.68],0.1466065485543953
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DSG3,Desmoglein-3,18604,127,1.62 [1.04-2.54],0.0336606002659061
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DSG4,Desmoglein-4,18336,128,0.80 [0.58-1.11],0.1801171549473347
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DTD1,D-aminoacyl-tRNA deacylase 1,15698,103,1.10 [0.88-1.37],0.3996883052374012
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DTNB,Dystrobrevin beta,15958,108,1.97 [1.41-2.76],7.911610438433381e-05
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DTX2,Probable E3 ubiquitin-protein ligase DTX2,15643,104,0.87 [0.61-1.24],0.4431444179062697
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DTX3,Probable E3 ubiquitin-protein ligase DTX3,18402,129,1.73 [0.93-3.23],0.0849180547950204
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DTYMK,Thymidylate kinase,16050,105,1.24 [0.94-1.63],0.1214937243790388
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DUOX2,Dual oxidase 2,18163,124,0.97 [0.77-1.22],0.767248809192044
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DUSP13,Dual specificity protein phosphatase 13 isoform A,15996,108,0.96 [0.62-1.50],0.867625791060185
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DUSP29,Dual specificity phosphatase 29,15643,104,1.18 [0.92-1.51],0.2018678083963337
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DUSP3,Dual specificity protein phosphatase 3,18093,124,0.91 [0.75-1.12],0.3771861270170106
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",16000,108,1.00 [0.84-1.20],0.998617376288222
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DXO,Decapping and exoribonuclease protein,16023,107,1.23 [0.83-1.83],0.3028248494408357
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,15996,108,0.93 [0.61-1.40],0.7182447863560808
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DYNLT1,Dynein light chain Tctex-type 1,15643,104,1.00 [0.79-1.27],0.9981276177182832
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,DYNLT3,Dynein light chain Tctex-type 3,15996,108,1.13 [0.75-1.72],0.5559145442236185
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,18340,127,1.03 [0.87-1.21],0.7664541509004248
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EBI3_IL27,Interleukin-27,18641,128,1.48 [0.88-2.49],0.1357261475119304
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ECE1,Endothelin-converting enzyme 1,18093,124,0.93 [0.59-1.46],0.7490114976438305
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",16050,105,0.90 [0.68-1.18],0.4285666339644952
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ECHS1,"Enoyl-CoA hydratase, mitochondrial",15602,101,0.95 [0.77-1.17],0.631018489888139
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ECI2,Enoyl-CoA delta isomerase 2,15526,102,1.13 [0.84-1.52],0.4064647116568231
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ECM1,Extracellular matrix protein 1,15653,104,0.83 [0.51-1.35],0.4481188366032751
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ECSCR,Endothelial cell-specific chemotaxis regulator,15563,101,0.86 [0.57-1.31],0.488100091726268
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EDA2R,Tumor necrosis factor receptor superfamily member 27,18664,128,1.74 [1.16-2.61],0.0070587748885317
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EDAR,Tumor necrosis factor receptor superfamily member EDAR,18488,132,0.93 [0.78-1.10],0.3842257591653364
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EDDM3B,Epididymal secretory protein E3-beta,15996,108,1.09 [0.81-1.48],0.5545568346981584
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,15526,102,1.05 [0.65-1.72],0.8319094268413975
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EDF1,Endothelial differentiation-related factor 1,16031,108,1.10 [0.86-1.41],0.4463695602090958
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,18163,124,1.08 [0.68-1.71],0.7543576152760656
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EDN1,Endothelin-1,15602,101,1.39 [0.71-2.70],0.3378651454867588
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EDNRB,Endothelin receptor type B,15570,103,1.20 [0.83-1.73],0.3323398380603223
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EEF1D,Elongation factor 1-delta,16050,105,1.23 [1.01-1.50],0.0393897215908234
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EFCAB14,EF-hand calcium-binding domain-containing protein 14,16000,108,1.71 [1.18-2.49],0.0048190376678406
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EFCAB2,Dynein regulatory complex protein 8,15770,101,0.98 [0.56-1.70],0.9346259201488104
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,18550,129,2.04 [1.26-3.31],0.0036581047541506
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EFHD1,EF-hand domain-containing protein D1,16031,108,1.06 [0.63-1.79],0.8242283260225421
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EFNA1,Ephrin-A1,18460,129,2.30 [1.40-3.75],0.0009100432502919
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EFNA4,Ephrin-A4,18303,124,2.16 [1.36-3.45],0.0011832482442356
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EFNB2,Ephrin-B2,15643,104,1.07 [0.78-1.48],0.6656149422309271
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EGF,Pro-epidermal growth factor,18441,129,0.95 [0.82-1.11],0.5226731727210239
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EGFL7,Epidermal growth factor-like protein 7,18072,126,0.91 [0.59-1.39],0.6517139512862635
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EGFLAM,Pikachurin,16000,108,1.51 [0.87-2.64],0.1429093132083776
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EGFR,Epidermal growth factor receptor,18719,128,1.25 [0.47-3.35],0.6589975744518719
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EGLN1,Egl nine homolog 1,18488,132,0.99 [0.75-1.31],0.9428690830295928
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EHBP1,EH domain-binding protein 1,16050,105,1.21 [0.95-1.55],0.1243647721007414
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EHD3,EH domain-containing protein 3,15602,101,1.02 [0.86-1.20],0.8527223064925542
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",16023,107,0.95 [0.68-1.33],0.7807941592768994
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",15944,108,1.12 [0.95-1.32],0.1682986991370498
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,15526,102,1.29 [0.99-1.69],0.0590097004194468
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,15602,101,1.19 [0.79-1.79],0.3994135609607203
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EIF4B,Eukaryotic translation initiation factor 4B,18340,127,1.08 [0.81-1.43],0.5994389653750609
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EIF4E,Eukaryotic translation initiation factor 4E,15570,103,1.05 [0.84-1.30],0.6871193468749652
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,18492,130,0.96 [0.75-1.23],0.7349780159059348
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,18712,130,1.07 [0.91-1.25],0.4007568310060099
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,16031,108,1.26 [0.96-1.64],0.0934033371440508
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EIF5,Eukaryotic translation initiation factor 5,15526,102,0.90 [0.57-1.44],0.6664008364366105
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EIF5A,Eukaryotic translation initiation factor 5A-1,18183,127,1.27 [0.82-1.96],0.2817480044724634
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ELAC1,Zinc phosphodiesterase ELAC protein 1,16031,108,1.04 [0.84-1.30],0.6932875831921969
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ELAVL4,ELAV-like protein 4,15563,101,0.86 [0.67-1.11],0.2398746793429781
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ELN,Elastin,16050,105,2.38 [1.39-4.07],0.0015450340216758
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ELOA,Elongin-A,18402,129,1.13 [0.88-1.46],0.3317656260182248
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ELOB,Elongin-B,15526,102,1.04 [0.63-1.71],0.8702821262181877
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ENAH,Protein enabled homolog,18183,127,1.25 [0.91-1.72],0.1643893923581139
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ENDOU,Poly(U)-specific endoribonuclease,14813,102,1.31 [0.94-1.82],0.1162204053159005
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ENG,Endoglin,18719,128,1.40 [0.57-3.46],0.4679211605050224
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ENO1,Alpha-enolase,18478,131,0.99 [0.82-1.21],0.956845566119996
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ENO2,Gamma-enolase,18657,131,0.99 [0.78-1.25],0.9065853929230268
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ENO3,Beta-enolase,15602,101,0.97 [0.70-1.34],0.835297147455312
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ENOPH1,Enolase-phosphatase E1,15996,108,0.85 [0.58-1.25],0.4055652418225285
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,15526,102,1.39 [0.74-2.58],0.3043270745856707
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ENPEP,Glutamyl aminopeptidase,15526,102,1.24 [0.86-1.79],0.2451001026299619
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,18719,128,0.86 [0.44-1.66],0.6467359495201517
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,18552,130,1.09 [0.75-1.58],0.6538795357464875
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,15602,101,0.87 [0.51-1.49],0.607114523246377
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,17909,127,1.00 [0.82-1.21],0.972129800296444
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ENSA,Alpha-endosulfine,15996,108,1.36 [1.01-1.83],0.0454737289046816
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,18072,126,1.14 [0.78-1.66],0.5098987207192514
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,18163,124,1.62 [0.77-3.40],0.2017254327795292
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,18163,124,0.90 [0.52-1.57],0.7130692410132817
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ENTR1,Endosome-associated-trafficking regulator 1,15602,101,1.20 [0.89-1.61],0.2332950459713142
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EP300,Histone acetyltransferase p300,15570,103,1.40 [0.83-2.37],0.2102930399042013
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EPB41L5,Band 4.1-like protein 5,15643,104,1.08 [0.82-1.43],0.5907713785386947
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EPCAM,Epithelial cell adhesion molecule,18457,130,1.12 [0.96-1.32],0.1532983258330632
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EPGN,Epigen,15996,108,0.48 [0.24-0.96],0.0379248820595903
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EPHA1,Ephrin type-A receptor 1,18518,130,1.39 [0.84-2.30],0.2063481217054908
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EPHA10,Ephrin type-A receptor 10,18093,124,1.13 [0.91-1.40],0.266427657844171
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EPHA2,Ephrin type-A receptor 2,17846,125,1.56 [0.95-2.59],0.0815134837783745
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EPHA4,Ephrin type-A receptor 4,15698,103,1.62 [0.84-3.12],0.1495276324928258
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EPHB4,Ephrin type-B receptor 4,18719,128,2.77 [1.58-4.83],0.0003508234091608
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EPHB6,Ephrin type-B receptor 6,18312,127,1.73 [1.06-2.82],0.0289323534766665
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EPHX2,Bifunctional epoxide hydrolase 2,18163,124,1.00 [0.77-1.30],0.9983690360091336
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EPN1,Epsin-1,15770,101,0.78 [0.47-1.28],0.3228059159736568
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EPO,Erythropoietin,18488,132,1.11 [0.90-1.37],0.3110806533716327
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EPPK1,Epiplakin,15602,101,1.13 [0.87-1.47],0.3608420522720119
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,18635,127,1.38 [0.82-2.31],0.2206664599868084
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ERBB2,Receptor tyrosine-protein kinase erbB-2,18535,130,0.95 [0.49-1.82],0.8725976827534605
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ERBB3,Receptor tyrosine-protein kinase erbB-3,18400,130,1.18 [0.54-2.56],0.6806635015166975
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ERBB4,Receptor tyrosine-protein kinase erbB-4,18535,130,0.93 [0.48-1.81],0.8266973671306391
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ERBIN,Erbin,18402,129,0.98 [0.85-1.15],0.8355813659442086
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ERC2,ERC protein 2,15643,104,0.97 [0.75-1.25],0.7885081999547866
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ERCC1,DNA excision repair protein ERCC-1,15494,101,0.85 [0.46-1.55],0.5852621660818395
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EREG,Proepiregulin,18312,127,0.93 [0.76-1.14],0.4598456021089283
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ERI1,3'-5' exoribonuclease 1,15770,101,1.44 [0.87-2.37],0.1517593532069018
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ERMAP,Erythroid membrane-associated protein,15570,103,1.20 [0.78-1.84],0.4066703003576769
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,15996,108,1.44 [0.92-2.27],0.1123078745212008
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ERP29,Endoplasmic reticulum resident protein 29,15698,103,1.09 [0.93-1.28],0.298863626581541
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ERP44,Endoplasmic reticulum resident protein 44,18376,129,1.17 [0.64-2.14],0.6092086037925133
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ERVV-1,Endogenous retrovirus group V member 1 Env polyprotein,15526,102,0.85 [0.53-1.37],0.5015606951337542
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ESAM,Endothelial cell-selective adhesion molecule,18719,128,1.62 [1.01-2.58],0.0442602437394331
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ESM1,Endothelial cell-specific molecule 1,18462,130,0.95 [0.60-1.50],0.8135606604189385
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ESPL1,Separin,15494,101,1.08 [0.79-1.48],0.639237987272147
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ESR1,Estrogen receptor,15570,103,0.80 [0.54-1.20],0.2842464668344472
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ESYT2,Extended synaptotagmin-2,16023,107,1.13 [0.91-1.41],0.268786679722272
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EVI2B,Protein EVI2B,15494,101,0.81 [0.47-1.40],0.4533728441155024
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EVI5,Ecotropic viral integration site 5 protein homolog,15570,103,1.17 [0.95-1.44],0.1374817908299254
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EVPL,Envoplakin,15770,101,1.05 [0.58-1.91],0.8664027714837554
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EXOSC10,Exosome component 10,15526,102,0.98 [0.69-1.39],0.919501791190964
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EXTL1,Exostosin-like 1,15526,102,0.73 [0.45-1.18],0.2007852014124329
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,EZR,Ezrin,18657,131,0.98 [0.51-1.88],0.959434220004785
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,F10,Coagulation factor X,16073,108,1.46 [0.88-2.43],0.1428928405807951
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,F11,Coagulation factor XI,15851,107,1.11 [0.64-1.92],0.7169422769837135
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,F11R,Junctional adhesion molecule A,18493,131,1.16 [0.88-1.52],0.294183156809929
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,F12,Coagulation factor XII,16076,107,1.06 [0.67-1.67],0.8183562649878465
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,F13B,Coagulation factor XIII B chain,16008,107,0.76 [0.36-1.58],0.4620485643809638
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,F2,Prothrombin,16076,107,0.98 [0.29-3.34],0.9767424844377336
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,F2R,Proteinase-activated receptor 1,18531,130,1.03 [0.79-1.36],0.8212025338009545
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,F3,Tissue factor,18543,127,1.94 [1.06-3.54],0.0320976491998943
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,F7,Coagulation factor VII,18551,129,1.03 [0.62-1.70],0.921336000595906
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,F9,Coagulation factor IX,18558,129,1.03 [0.43-2.43],0.9516936930476456
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FABP1,"Fatty acid-binding protein, liver",18462,130,1.10 [0.93-1.29],0.2557438111511074
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FABP2,"Fatty acid-binding protein, intestinal",18492,130,1.10 [0.91-1.33],0.3033371894251894
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FABP3,"Fatty acid-binding protein, heart",16050,105,1.48 [1.08-2.03],0.0160624969877185
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FABP4,"Fatty acid-binding protein, adipocyte",18719,128,1.26 [0.91-1.74],0.1570863888149322
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FABP5,Fatty acid-binding protein 5,18597,131,1.07 [0.85-1.35],0.5540603065404832
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FABP6,Gastrotropin,18133,124,1.39 [1.09-1.78],0.0071917629563194
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FABP9,Fatty acid-binding protein 9,18488,132,1.10 [0.84-1.44],0.4925037301926113
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FADD,FAS-associated death domain protein,18492,130,1.01 [0.82-1.24],0.9288490435469916
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FAM13A,Protein FAM13A,16000,108,1.29 [0.99-1.67],0.0574371048315921
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FAM171A2,Protein FAM171A2,16031,108,0.94 [0.82-1.07],0.3191058417868803
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FAM171B,Protein FAM171B,15996,108,1.48 [0.91-2.43],0.1160353614425827
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FAM172A,Cotranscriptional regulator FAM172A,15602,101,1.25 [0.92-1.71],0.1540211204415628
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FAM20A,Pseudokinase FAM20A,16050,105,0.99 [0.50-1.94],0.9688101978244628
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FAM3B,Protein FAM3B,18402,129,1.23 [0.77-1.97],0.3794357156411817
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FAM3C,Protein FAM3C,18472,130,1.88 [1.13-3.12],0.0154784321945332
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FAM3D,Protein FAM3D,16000,108,1.09 [0.89-1.35],0.4076717229967388
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FAP,Prolyl endopeptidase FAP,18719,128,1.01 [0.56-1.82],0.9688367101115872
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FARSA,Phenylalanine--tRNA ligase alpha subunit,15643,104,1.13 [0.88-1.46],0.3264334507665387
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FAS,Tumor necrosis factor receptor superfamily member 6,18659,128,0.98 [0.61-1.58],0.9273310254858822
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FASLG,Tumor necrosis factor ligand superfamily member 6,18712,130,1.35 [0.88-2.07],0.1633000394395638
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FBLN2,Fibulin-2,16062,108,2.38 [1.31-4.32],0.0042526398485113
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FBN2,Fibrillin-2,15643,104,1.12 [0.81-1.54],0.5032532816542339
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FBP1,"Fructose-1,6-bisphosphatase 1",18492,130,0.99 [0.80-1.23],0.9413458712792298
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,16050,105,0.98 [0.75-1.28],0.8867132144685047
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FCAR,Immunoglobulin alpha Fc receptor,18488,132,1.13 [0.82-1.56],0.4470670754078224
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,16031,108,1.81 [0.90-3.66],0.0979464183180843
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FCER2,Low affinity immunoglobulin epsilon Fc receptor,18493,131,1.34 [1.00-1.79],0.0474064571329017
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,18435,129,1.05 [0.80-1.38],0.7235179579863498
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,18072,126,1.08 [0.82-1.42],0.5862061567712111
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,18524,129,1.10 [0.80-1.52],0.5569930058022878
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FCN1,Ficolin-1,16052,108,1.44 [0.99-2.10],0.0545599996057205
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FCN2,Ficolin-2,18431,128,0.99 [0.67-1.47],0.9740338384204972
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FCRL1,Fc receptor-like protein 1,18492,130,0.88 [0.61-1.26],0.4765222750138399
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FCRL2,Fc receptor-like protein 2,18626,128,1.09 [0.79-1.50],0.6043752624605899
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FCRL3,Fc receptor-like protein 3,18183,127,1.26 [0.94-1.68],0.1204100733156507
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FCRL5,Fc receptor-like protein 5,18493,131,0.90 [0.69-1.18],0.4609928940815445
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FCRL6,Fc receptor-like protein 6,18488,132,1.26 [1.00-1.58],0.0480864155111367
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FCRLB,Fc receptor-like B,18072,126,0.85 [0.64-1.13],0.2696687377528733
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FDX1,"Adrenodoxin, mitochondrial",15526,102,1.11 [0.84-1.46],0.4584340432779742
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FDX2,"Ferredoxin-2, mitochondrial",15526,102,0.86 [0.59-1.24],0.4108372331500746
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FEN1,Flap endonuclease 1,18072,126,1.08 [0.87-1.33],0.5068502223147526
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FES,Tyrosine-protein kinase Fes/Fps,18072,126,1.39 [1.10-1.75],0.0058055889758925
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FETUB,Fetuin-B,18558,129,1.31 [0.79-2.18],0.2946009280775788
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FGA,Fibrinogen alpha chain,15710,105,1.01 [0.55-1.89],0.9640495679067862
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",16031,108,1.14 [0.91-1.43],0.2544119116733102
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FGF12,Fibroblast growth factor 12,15570,103,0.95 [0.62-1.47],0.8249068351529101
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FGF16,Fibroblast growth factor 16,15570,103,1.22 [0.83-1.78],0.3058660978808608
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FGF19,Fibroblast growth factor 19,18552,130,1.08 [0.88-1.31],0.4589859639359211
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FGF2,Fibroblast growth factor 2,18488,132,0.99 [0.79-1.24],0.9422471309215854
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FGF20,Fibroblast growth factor 20,15570,103,0.77 [0.46-1.27],0.3061204267359142
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FGF21,Fibroblast growth factor 21,18641,128,1.07 [0.94-1.22],0.307370542676156
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FGF23,Fibroblast growth factor 23,18634,128,1.44 [1.13-1.83],0.0033641657791804
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FGF3,Fibroblast growth factor 3,15570,103,0.56 [0.26-1.22],0.1453074115853906
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FGF5,Fibroblast growth factor 5,18183,127,1.26 [0.79-2.01],0.3373545233185551
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FGF6,Fibroblast growth factor 6,15570,103,1.18 [0.76-1.83],0.4522626784467991
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FGF7,Fibroblast growth factor 7,15494,101,0.97 [0.75-1.25],0.7938640967456653
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FGF9,Fibroblast growth factor 9,15467,101,0.82 [0.51-1.30],0.3986647247145021
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FGFBP1,Fibroblast growth factor-binding protein 1,18535,130,0.96 [0.60-1.55],0.8729266551872722
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FGFBP2,Fibroblast growth factor-binding protein 2,16062,108,0.98 [0.68-1.41],0.9050746636060432
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FGFBP3,Fibroblast growth factor-binding protein 3,16023,107,1.02 [0.61-1.69],0.943778723341032
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FGFR2,Fibroblast growth factor receptor 2,18535,130,2.41 [1.23-4.72],0.0106841589664888
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FGFR4,Fibroblast growth factor receptor 4,15698,103,1.09 [0.75-1.57],0.6621822972608095
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FGL1,Fibrinogen-like protein 1,16073,108,1.19 [0.89-1.58],0.2386250275240431
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FGR,Tyrosine-protein kinase Fgr,18093,124,1.12 [0.89-1.41],0.3358202887771088
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FH,"Fumarate hydratase, mitochondrial",15563,101,0.97 [0.76-1.23],0.7753832525495624
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FHIP2A,FHF complex subunit HOOK interacting protein 2A,15526,102,1.06 [0.72-1.56],0.7669046326797087
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FHIT,Bis(5'-adenosyl)-triphosphatase,18093,124,1.03 [0.82-1.28],0.824344311289934
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FIS1,Mitochondrial fission 1 protein,18460,130,1.02 [0.83-1.25],0.88376891370179
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,16031,108,1.11 [0.92-1.33],0.2698642737229276
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,18560,129,0.99 [0.86-1.14],0.9127142909253748
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,18340,127,1.11 [0.76-1.61],0.5881988778396756
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,18340,127,1.07 [0.91-1.27],0.4115244165652486
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,18065,124,1.00 [0.71-1.41],0.994588322279378
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FKBPL,FK506-binding protein-like,16000,108,1.20 [0.88-1.63],0.2423972088444184
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FLI1,Friend leukemia integration 1 transcription factor,18072,126,1.01 [0.88-1.17],0.8791883984087012
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,18340,127,1.54 [0.88-2.67],0.1285346678727705
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FLT1,Vascular endothelial growth factor receptor 1,18365,129,2.09 [1.06-4.10],0.0328905046342559
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FLT3,Receptor-type tyrosine-protein kinase FLT3,18072,126,1.15 [0.69-1.89],0.5971593408077613
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FLT3LG,Fms-related tyrosine kinase 3 ligand,18712,130,0.90 [0.58-1.41],0.6554730197517153
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FLT4,Vascular endothelial growth factor receptor 3,18535,130,1.27 [0.80-2.03],0.3119140843030813
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FMNL1,Formin-like protein 1,18093,124,1.06 [0.85-1.33],0.6080070031583431
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FMR1,Synaptic functional regulator FMR1,18072,126,1.05 [0.67-1.65],0.8324339298073854
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FN1,Fibronectin,16076,107,0.78 [0.39-1.55],0.4772935672931829
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FNDC1,Fibronectin type III domain-containing protein 1,16023,107,1.13 [0.76-1.68],0.5453439821113697
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,15996,108,1.06 [0.63-1.79],0.826254218532801
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FOLH1,Glutamate carboxypeptidase 2,15570,103,1.00 [0.83-1.20],0.9795897921551792
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FOLR1,Folate receptor alpha,18452,129,1.50 [0.88-2.57],0.133516728946937
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FOLR2,Folate receptor beta,18657,131,1.88 [1.12-3.18],0.0176856435181321
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FOLR3,Folate receptor gamma,18479,130,1.12 [1.05-1.19],0.0009326640395809
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FOS,Proto-oncogene c-Fos,15467,101,1.00 [0.58-1.71],0.9940301024067428
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FOSB,Protein fosB,18093,124,1.10 [0.75-1.62],0.6343964450881081
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FOXJ3,Forkhead box protein J3,15570,103,1.35 [0.94-1.93],0.101444180607057
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FOXO1,Forkhead box protein O1,18488,132,1.03 [0.86-1.23],0.7584022107970693
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FOXO3,Forkhead box protein O3,18072,126,1.04 [0.88-1.22],0.6556820101644988
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FRMD4B,FERM domain-containing protein 4B,15526,102,1.40 [1.09-1.79],0.0091246778440798
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FRMD7,FERM domain-containing protein 7,15643,104,1.02 [0.59-1.78],0.9362202773160444
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FRZB,Secreted frizzled-related protein 3,18280,123,1.03 [0.53-2.02],0.923949236833332
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FSHB,Follitropin subunit beta,15602,101,1.18 [0.78-1.78],0.436229244134084
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FST,Follistatin,18531,130,1.12 [0.81-1.54],0.5049861459656737
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FSTL1,Follistatin-related protein 1,15602,101,1.85 [0.79-4.34],0.1550952235386626
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FSTL3,Follistatin-related protein 3,18432,130,2.24 [1.41-3.55],0.0006350771390452
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FTCD,Formimidoyltransferase-cyclodeaminase,15985,107,0.88 [0.70-1.10],0.2570887593486866
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FUCA1,Tissue alpha-L-fucosidase,18590,128,1.08 [0.89-1.31],0.4500271696451143
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FUOM,Fucose mutarotase,15698,103,0.87 [0.63-1.19],0.3788178023463778
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FURIN,Furin,18535,130,1.08 [0.67-1.75],0.7564785810918044
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FUS,RNA-binding protein FUS,18042,126,1.25 [0.85-1.83],0.2491305410946568
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",15743,101,1.05 [0.77-1.42],0.7740441504980216
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,18657,131,0.94 [0.67-1.31],0.7087836293684195
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FUT8,"Alpha-(1,6)-fucosyltransferase",18340,127,0.78 [0.59-1.03],0.0834622735294173
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FXN,"Frataxin, mitochondrial",18664,128,1.01 [0.82-1.25],0.9112185771536234
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FXYD5,FXYD domain-containing ion transport regulator 5,18183,127,0.97 [0.75-1.24],0.7808866296426102
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FYB1,FYN-binding protein 1,18455,131,1.05 [0.89-1.24],0.5882159641722309
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FZD10,Frizzled-10,15643,104,0.92 [0.65-1.30],0.6334284049468515
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,FZD8,Frizzled-8,15563,101,0.99 [0.63-1.55],0.9711548559871728
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GABARAP,Gamma-aminobutyric acid receptor-associated protein,15996,108,1.18 [0.82-1.69],0.3634068869771846
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,15770,101,1.15 [0.90-1.48],0.2564157253519886
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,15563,101,1.06 [0.79-1.43],0.6779623553082378
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GAD1,Glutamate decarboxylase 1,15494,101,1.05 [0.50-2.18],0.9008555038116044
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GAD2,Glutamate decarboxylase 2,15570,103,0.90 [0.58-1.40],0.6524411578687648
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,15770,101,1.09 [0.76-1.55],0.6364518641545002
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,15602,101,1.00 [0.69-1.44],0.9991137401068916
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GAGE2A,G antigen 2A,15494,101,1.02 [0.77-1.35],0.8919190447799021
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GAL,Galanin peptides,18552,130,1.09 [0.86-1.37],0.4960772787027065
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,18402,129,0.99 [0.56-1.74],0.9599065623682308
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,18664,128,1.26 [0.70-2.27],0.4361757105353869
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,18183,127,1.28 [0.89-1.83],0.1761296057423696
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,16050,105,1.35 [0.71-2.56],0.3582327599476462
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GALNT7,N-acetylgalactosaminyltransferase 7,18402,129,1.32 [0.62-2.81],0.4753464467036471
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GAMT,Guanidinoacetate N-methyltransferase,15526,102,1.10 [0.64-1.89],0.7401326948061937
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,15353,100,0.69 [0.39-1.22],0.2055827843554187
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GART,Trifunctional purine biosynthetic protein adenosine-3,16031,108,1.01 [0.50-2.03],0.9881166729841064
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GAS2,Growth arrest-specific protein 2,15770,101,1.04 [0.72-1.49],0.8439397816631935
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GAS6,Growth arrest-specific protein 6,18599,127,1.35 [0.71-2.55],0.3608805739454942
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GASK1A,Golgi-associated kinase 1A,15526,102,0.94 [0.59-1.47],0.7715270390872013
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GAST,Gastrin,16023,107,1.01 [0.88-1.16],0.8427094615026226
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,15494,101,0.82 [0.39-1.71],0.5945662678368171
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",15602,101,1.04 [0.81-1.35],0.7339066968465212
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GBA,Lysosomal acid glucosylceramidase,15643,104,1.03 [0.73-1.46],0.8593324930825748
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GBP1,Guanylate-binding protein 1,15995,107,1.04 [0.78-1.38],0.8096633453651159
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GBP2,Guanylate-binding protein 2,18183,127,0.98 [0.75-1.28],0.9022788273293062
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GBP4,Guanylate-binding protein 4,18093,124,1.11 [0.80-1.52],0.5414648803428905
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GBP6,Guanylate-binding protein 6,15526,102,0.94 [0.60-1.48],0.7990944508509109
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GC,Vitamin D-binding protein,16076,107,0.86 [0.42-1.77],0.6837511829410621
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GCC1,GRIP and coiled-coil domain-containing protein 1,16023,107,1.10 [0.92-1.30],0.2991755743625028
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GCG,Pro-glucagon,18072,126,0.97 [0.86-1.10],0.6569968001276589
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,15323,102,0.96 [0.64-1.43],0.8363244940387293
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GCLM,Glutamate--cysteine ligase regulatory subunit,15526,102,1.19 [0.81-1.74],0.36610527035695
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",18402,129,1.06 [0.67-1.68],0.7894816414676256
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GDF15,Growth/differentiation factor 15,18719,128,1.52 [1.11-2.09],0.0092950448614466
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GDF2,Growth/differentiation factor 2,18492,130,0.70 [0.45-1.09],0.1103022911746601
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GDNF,Glial cell line-derived neurotrophic factor,18093,124,1.52 [1.03-2.24],0.0347717553579306
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GET3,ATPase GET3,16050,105,0.73 [0.49-1.10],0.1288884714248495
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GFAP,Glial fibrillary acidic protein,18042,126,1.02 [0.73-1.44],0.8873717280371773
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GFER,FAD-linked sulfhydryl oxidase ALR,18072,126,1.12 [0.87-1.44],0.372127823938823
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,18072,126,0.99 [0.87-1.13],0.9281696907449642
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GFRA1,GDNF family receptor alpha-1,18641,128,1.97 [1.15-3.38],0.0132709310859081
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GFRA2,GDNF family receptor alpha-2,18402,129,1.67 [0.78-3.56],0.1851881130704133
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GFRA3,GDNF family receptor alpha-3,18284,127,1.25 [0.71-2.21],0.4368058472978775
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GFRAL,GDNF family receptor alpha-like,15562,106,1.07 [0.79-1.45],0.6677563654054862
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GGA1,ADP-ribosylation factor-binding protein GGA1,18093,124,1.01 [0.80-1.28],0.9232488346161056
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GGACT,Gamma-glutamylaminecyclotransferase,16050,105,1.09 [0.84-1.42],0.5316482502926633
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GGCT,Gamma-glutamylcyclotransferase,16023,105,1.21 [0.84-1.77],0.3087825803489124
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GGH,Gamma-glutamyl hydrolase,18198,128,1.19 [0.76-1.87],0.440489586896316
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GGT1,Glutathione hydrolase 1 proenzyme,18460,129,0.74 [0.53-1.05],0.0891244395542761
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GGT5,Glutathione hydrolase 5 proenzyme,18340,127,2.16 [1.17-3.97],0.0133047626046475
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GH1,Somatotropin,18472,130,1.05 [0.96-1.14],0.299719476046116
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GH2,Growth hormone variant,18072,126,0.90 [0.80-1.01],0.0747588927048953
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GHR,Growth hormone receptor,15698,103,0.71 [0.36-1.41],0.3330330991800573
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GHRHR,Growth hormone-releasing hormone receptor,18093,124,0.90 [0.65-1.25],0.5405536550468911
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GHRL,Appetite-regulating hormone,18492,130,1.11 [0.92-1.34],0.2627519029496206
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GID8,Glucose-induced degradation protein 8 homolog,16031,108,0.52 [0.25-1.07],0.0749302294397309
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GIGYF2,GRB10-interacting GYF protein 2,16031,108,1.21 [0.95-1.53],0.1174135359307826
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GIMAP7,GTPase IMAP family member 7,15698,103,1.08 [0.60-1.95],0.8031695276468069
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GIMAP8,GTPase IMAP family member 8,15494,101,1.34 [0.97-1.85],0.0805249514046935
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GIP,Gastric inhibitory polypeptide,15602,101,1.16 [0.83-1.63],0.3822821753150598
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GIPC2,PDZ domain-containing protein GIPC2,16023,107,2.00 [1.18-3.38],0.0100056605281401
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GIPC3,PDZ domain-containing protein GIPC3,16000,108,1.09 [0.90-1.31],0.3981350901120589
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GIPR,Gastric inhibitory polypeptide receptor,15570,103,0.75 [0.46-1.22],0.2476142452426218
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GIT1,ARF GTPase-activating protein GIT1,15570,103,1.17 [0.96-1.42],0.1237374936704305
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GJA8,Gap junction alpha-8 protein,15494,101,0.93 [0.68-1.29],0.6839708281701278
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GKN1,Gastrokine-1,17752,124,1.38 [0.79-2.41],0.2648666023939945
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GLA,Alpha-galactosidase A,15671,103,0.84 [0.51-1.38],0.4872724110728865
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GLB1,Beta-galactosidase,18340,127,1.01 [0.70-1.46],0.9607121269289872
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GLI2,Zinc finger protein GLI2,15570,103,1.07 [0.60-1.89],0.8241805003745064
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GLO1,Lactoylglutathione lyase,18163,124,0.98 [0.74-1.29],0.8641839468823768
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GLOD4,Glyoxalase domain-containing protein 4,18439,130,1.09 [0.70-1.72],0.6982713667436232
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GLP1R,Glucagon-like peptide 1 receptor,15563,101,1.06 [0.65-1.75],0.8108171856576142
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GLRX,Glutaredoxin-1,18371,129,1.00 [0.76-1.32],0.9945122345017084
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",15698,103,1.05 [0.85-1.30],0.667259098373933
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,18093,124,0.74 [0.48-1.14],0.1756658531281247
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GLYR1,Putative oxidoreductase GLYR1,15996,108,1.09 [0.81-1.47],0.556449730298825
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GM2A,Ganglioside GM2 activator,15674,106,1.46 [0.94-2.28],0.0920810491799346
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GMFG,Glia maturation factor gamma,16050,105,1.18 [0.91-1.54],0.204833866432506
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GMPR,GMP reductase 1,18712,130,1.04 [0.75-1.44],0.8193729976621731
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GMPR2,GMP reductase 2,15698,103,1.13 [0.85-1.51],0.3940454142496276
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GNAS,Neuroendocrine secretory protein 55,16031,108,1.02 [0.82-1.27],0.8721865088452805
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,18072,126,1.04 [0.82-1.33],0.7264071772980931
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,15643,104,1.19 [0.85-1.66],0.3195670370368796
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GNLY,Granulysin,18493,131,1.09 [0.82-1.45],0.5456670439407451
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GNPDA1,Glucosamine-6-phosphate isomerase 1,15602,101,0.74 [0.37-1.45],0.3773877755776893
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GNPDA2,Glucosamine-6-phosphate isomerase 2,15698,103,0.96 [0.57-1.62],0.867238267507514
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GOLGA3,Golgin subfamily A member 3,16031,108,1.07 [0.84-1.35],0.5849481613778119
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GOLM2,Protein GOLM2,18657,131,1.20 [0.60-2.39],0.6041853826727859
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,18488,132,0.97 [0.84-1.13],0.7347724204847257
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GORASP2,Golgi reassembly-stacking protein 2,16000,108,1.36 [0.94-1.97],0.1036544106204236
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GOT1,"Aspartate aminotransferase, cytoplasmic",16062,108,0.88 [0.56-1.39],0.5952316722270583
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GP1BA,Platelet glycoprotein Ib alpha chain,18439,128,1.35 [0.86-2.14],0.1960902217169754
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GP1BB,Platelet glycoprotein Ib beta chain,15526,102,0.99 [0.75-1.32],0.9701835670689302
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,17929,121,1.25 [1.05-1.49],0.0115737960159829
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GP5,Platelet glycoprotein V,15698,103,1.04 [0.61-1.75],0.893877034896281
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GP6,Platelet glycoprotein VI,18455,131,1.00 [0.84-1.19],0.9986647009436308
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GPA33,Cell surface A33 antigen,18402,129,1.07 [0.95-1.20],0.2568739201396314
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GPC1,Glypican-1,18664,128,1.74 [1.02-2.98],0.0423356462026574
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GPC5,Glypican-5,18340,127,0.88 [0.66-1.16],0.3553860688698431
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GPD1,Glycerol-3-phosphate dehydrogenase,15996,108,0.90 [0.62-1.31],0.5821874135427066
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GPHA2,Glycoprotein hormone alpha-2,16000,108,1.09 [0.73-1.63],0.6814052428391095
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GPI,Glucose-6-phosphate isomerase,16073,108,1.19 [0.81-1.73],0.3816919261185524
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,16000,108,1.26 [0.95-1.67],0.1088538750061973
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GPKOW,G-patch domain and KOW motifs-containing protein,18093,124,1.28 [0.83-1.97],0.2587233039765502
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GPNMB,Transmembrane glycoprotein NMB,18002,127,0.83 [0.48-1.44],0.5028809248730781
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GPR101,Probable G-protein coupled receptor 101,15563,101,1.03 [0.73-1.45],0.8636680316822712
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GPR158,Probable G-protein coupled receptor 158,16031,108,1.39 [0.88-2.20],0.1570219077854463
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GPR15L,Protein GPR15L,16000,108,1.36 [1.02-1.82],0.0390923486011807
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GPR37,Prosaposin receptor GPR37,18163,124,1.17 [0.90-1.50],0.2345094030970982
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GPRC5C,G-protein coupled receptor family C group 5 member C,15996,108,1.11 [0.81-1.53],0.5040171845973254
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GRAP2,GRB2-related adapter protein 2,18492,130,1.03 [0.91-1.16],0.6791901437311731
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,16050,105,1.12 [0.83-1.50],0.4723501555839943
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GRIK2,"Glutamate receptor ionotropic, kainate 2",16031,108,0.96 [0.63-1.46],0.8376130978833468
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",15563,101,1.06 [0.76-1.48],0.720616842775742
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GRK5,G protein-coupled receptor kinase 5,18163,124,1.23 [0.94-1.61],0.1378605795081889
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GRN,Progranulin,18392,129,2.53 [1.40-4.58],0.0021923885756727
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GRP,Gastrin-releasing peptide,15602,101,1.07 [0.74-1.54],0.7186686098720496
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GRPEL1,"GrpE protein homolog 1, mitochondrial",18402,129,0.97 [0.73-1.28],0.8105589616262225
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GRSF1,G-rich sequence factor 1,15406,100,1.09 [0.87-1.37],0.4577690065177401
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GSAP,Gamma-secretase-activating protein,18072,126,1.05 [0.88-1.25],0.601506332820026
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GSN,Gelsolin,16004,107,2.83 [1.18-6.83],0.0203831751190858
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GSR,"Glutathione reductase, mitochondrial",15989,108,1.62 [0.70-3.73],0.2576038006386112
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GSTA1,Glutathione S-transferase A1,18462,129,0.92 [0.76-1.12],0.4064121715602784
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GSTA3,Glutathione S-transferase A3,18072,126,0.88 [0.71-1.10],0.2662470515333147
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GSTM4,Glutathione S-transferase Mu 4,15526,102,1.05 [0.82-1.34],0.7134833660244967
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GSTP1,Glutathione S-transferase P,17979,123,1.11 [0.89-1.38],0.3638901843900162
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GSTT2B,Glutathione S-transferase theta-2B,16023,107,1.06 [0.98-1.15],0.1417643579923914
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,15770,101,0.93 [0.69-1.27],0.661884761019653
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GTPBP2,GTP-binding protein 2,15643,104,1.12 [0.89-1.41],0.3522183224593185
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GUCA2A,Guanylin,18389,128,1.87 [1.20-2.91],0.0056598934069545
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GUCY2C,Heat-stable enterotoxin receptor,15770,101,0.85 [0.64-1.13],0.2635069329929103
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GUK1,Guanylate kinase,15526,102,1.14 [0.74-1.76],0.5479591330565854
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GUSB,Beta-glucuronidase,18567,128,1.11 [0.86-1.44],0.4015173790752709
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GYS1,"Glycogen [starch] synthase, muscle",18163,124,1.04 [0.88-1.24],0.6528880193320462
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GZMA,Granzyme A,18712,130,1.31 [0.83-2.04],0.2425634350497692
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GZMB,Granzyme B,18488,132,1.02 [0.81-1.28],0.8892266829638641
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,GZMH,Granzyme H,18163,124,1.20 [1.01-1.42],0.0353224649679937
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,H2AP,Huntingtin-interacting protein M,15494,101,0.91 [0.60-1.39],0.6750334278783134
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",15526,102,0.93 [0.68-1.28],0.6710980944678955
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",18615,128,1.05 [0.84-1.30],0.6780724199538207
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HAO1,Hydroxyacid oxidase 1,18664,128,0.88 [0.77-1.01],0.0666377875075263
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HARS1,"Histidine--tRNA ligase, cytoplasmic",18493,131,1.06 [0.86-1.29],0.5912191084227476
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HAVCR1,Hepatitis A virus cellular receptor 1,18638,128,1.15 [0.89-1.48],0.2847844391782812
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HAVCR2,Hepatitis A virus cellular receptor 2,18493,131,1.93 [1.28-2.91],0.0017049273327421
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HBEGF,Proheparin-binding EGF-like growth factor,18615,128,0.80 [0.65-1.00],0.0471473534259184
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HBQ1,Hemoglobin subunit theta-1,18664,128,0.96 [0.75-1.24],0.7796816889279594
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HBZ,Hemoglobin subunit zeta,16050,105,1.10 [0.93-1.31],0.2610681465013075
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HCG22,Protein PBMUCL2,15526,102,0.77 [0.48-1.24],0.2839872135854955
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HCLS1,Hematopoietic lineage cell-specific protein,18712,130,1.05 [0.79-1.39],0.7451840676792149
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HDAC8,Histone deacetylase 8,15570,103,0.87 [0.60-1.24],0.4375995878593716
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HDAC9,Histone deacetylase 9,15563,101,1.16 [0.92-1.46],0.2015658007555072
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HDDC2,5'-deoxynucleotidase HDDC2,16000,108,1.24 [0.82-1.87],0.3160440232857287
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HDGF,Hepatoma-derived growth factor,18629,128,0.96 [0.81-1.14],0.6592755882306038
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HDGFL2,Hepatoma-derived growth factor-related protein 2,16023,107,1.27 [0.99-1.64],0.0650540217543849
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HEBP1,Heme-binding protein 1,18163,124,1.20 [0.91-1.57],0.19038656001242
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HEG1,Protein HEG homolog 1,15698,103,0.85 [0.42-1.73],0.6532196020298692
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HEPACAM2,HEPACAM family member 2,16023,107,0.89 [0.58-1.36],0.5788750355220864
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HEPH,Hephaestin,16050,105,1.16 [0.58-2.32],0.6658330784295613
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HEXIM1,Protein HEXIM1,18488,132,1.04 [0.86-1.26],0.6946734275272654
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HGF,Hepatocyte growth factor,18712,130,1.19 [0.76-1.88],0.4496979972232858
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HGFAC,Hepatocyte growth factor activator,15933,108,0.57 [0.29-1.10],0.0917721098308882
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,18072,126,1.07 [0.88-1.32],0.4958370167365896
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HHEX,Hematopoietically-expressed homeobox protein HHEX,16023,107,1.09 [0.85-1.38],0.5013361410723627
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HIF1A,Hypoxia-inducible factor 1-alpha,15570,103,0.99 [0.72-1.36],0.956532837453953
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HIP1,Huntingtin-interacting protein 1,15526,102,1.09 [0.64-1.84],0.7569671880467264
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HIP1R,Huntingtin-interacting protein 1-related protein,15987,106,1.17 [0.83-1.66],0.3698250620382178
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HJV,Hemojuvelin,16031,108,0.95 [0.61-1.48],0.813348501597976
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HK2,Hexokinase-2,18163,124,1.09 [0.61-1.96],0.763365863296421
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HLA-A,"HLA class I histocompatibility antigen, A alpha chain",16031,108,1.25 [0.71-2.18],0.4389618607305012
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",18426,132,0.88 [0.57-1.35],0.5540689813281552
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HLA-E,"HLA class I histocompatibility antigen, alpha chain E",18488,132,1.76 [1.08-2.87],0.0222066992287022
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HMBS,Porphobilinogen deaminase,18664,128,0.81 [0.56-1.19],0.2884650640121983
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HMCN2,Hemicentin-2,15668,103,0.97 [0.69-1.34],0.8351924264458602
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",15602,101,1.11 [0.76-1.64],0.5811366314047568
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",15526,102,1.13 [0.75-1.69],0.5587132689452999
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HMMR,Hyaluronan mediated motility receptor,15456,101,1.27 [0.93-1.73],0.132994606908787
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HMOX1,Heme oxygenase 1,18295,130,1.25 [0.91-1.70],0.1675671060396323
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HMOX2,Heme oxygenase 2,18093,124,1.01 [0.71-1.43],0.9540918336724864
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HNF1A,Hepatocyte nuclear factor 1-alpha,15643,104,1.02 [0.78-1.32],0.9092382031176768
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HNMT,Histamine N-methyltransferase,18253,124,1.18 [0.84-1.66],0.3454155098448338
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,18098,124,1.07 [0.87-1.32],0.4961390121784466
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,16031,108,1.27 [0.93-1.73],0.1270363331464483
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HPCAL1,Hippocalcin-like protein 1,18712,130,0.98 [0.80-1.21],0.8729115333988008
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HPGDS,Hematopoietic prostaglandin D synthase,18072,126,0.91 [0.59-1.39],0.6571490789229261
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HPSE,Heparanase,15867,107,1.06 [0.87-1.30],0.5581988159024864
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HRAS,GTPase Hras,15741,101,0.94 [0.75-1.17],0.5547002727806407
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,15602,101,1.62 [0.96-2.73],0.0713366762126807
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HRG,Histidine-rich glycoprotein,16008,107,0.76 [0.42-1.36],0.3574134765705111
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HS1BP3,HCLS1-binding protein 3,15602,101,1.17 [0.95-1.45],0.1414111379574001
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,18402,129,0.68 [0.45-1.04],0.0741162812721498
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,18664,128,1.49 [1.08-2.05],0.015822771073091
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,15570,103,1.42 [0.87-2.33],0.1607605224156058
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HSBP1,Heat shock factor-binding protein 1,15602,101,1.16 [0.95-1.41],0.1491211475663166
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,18488,132,1.18 [0.80-1.74],0.4134155298026168
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,16023,107,1.13 [0.83-1.52],0.4415766518220098
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HSD17B3,Testosterone 17-beta-dehydrogenase 3,15526,102,1.15 [0.80-1.63],0.4478755050230731
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,15602,101,1.17 [0.79-1.74],0.4281444288749596
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HSP90B1,Endoplasmin,18009,123,0.92 [0.70-1.21],0.5591495796024011
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HSPA1A,Heat shock 70 kDa protein 1A,18518,130,1.02 [0.82-1.27],0.8522693409127076
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HSPA2,Heat shock-related 70 kDa protein 2,15996,108,1.37 [0.87-2.14],0.1752295066273497
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HSPB1,Heat shock protein beta-1,18201,128,1.15 [0.91-1.46],0.2264695858453828
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HSPB6,Heat shock protein beta-6,18664,128,1.84 [1.29-2.62],0.000775324356724
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,18379,128,2.66 [1.63-4.36],9.350214706885964e-05
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HTR1A,5-hydroxytryptamine receptor 1A,15563,101,1.09 [0.85-1.40],0.4960943881534907
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HTR1B,5-hydroxytryptamine receptor 1B,15563,101,0.92 [0.59-1.43],0.704050776045547
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HTRA2,"Serine protease HTRA2, mitochondrial",18535,130,1.06 [0.82-1.37],0.6534553872594212
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HYAL1,Hyaluronidase-1,18418,129,0.68 [0.34-1.36],0.274130742757028
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,HYOU1,Hypoxia up-regulated protein 1,18719,128,3.86 [2.00-7.43],5.543485898800426e-05
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ICA1,Islet cell autoantigen 1,18183,127,1.09 [0.90-1.33],0.383142235319336
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ICAM1,Intercellular adhesion molecule 1,18434,128,1.18 [0.67-2.06],0.5698923322339261
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ICAM2,Intercellular adhesion molecule 2,18719,128,1.44 [0.89-2.33],0.1422367817866475
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ICAM3,Intercellular adhesion molecule 3,18719,128,1.05 [0.58-1.93],0.864114092004932
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ICAM4,Intercellular adhesion molecule 4,18488,132,1.18 [0.88-1.59],0.2632813542856922
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ICAM5,Intercellular adhesion molecule 5,18492,130,0.80 [0.57-1.12],0.1957533041739091
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ICOSLG,ICOS ligand,18402,129,2.15 [0.94-4.92],0.0681947458780403
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ID4,DNA-binding protein inhibitor ID-4,15770,101,1.20 [0.83-1.75],0.3310121360247335
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IDI2,Isopentenyl-diphosphate delta-isomerase 2,18093,124,1.27 [0.95-1.72],0.1096289992292666
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IDO1,"Indoleamine 2,3-dioxygenase 1",15602,101,1.16 [0.85-1.57],0.3462664241458553
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IDS,Iduronate 2-sulfatase,18712,130,0.65 [0.12-3.43],0.6071057321356905
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IDUA,Alpha-L-iduronidase,18664,128,0.69 [0.50-0.95],0.0251382710764564
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,15634,104,1.13 [0.69-1.85],0.618249283958874
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,15770,101,1.03 [0.71-1.49],0.8767056043574374
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,15770,101,1.27 [0.79-2.03],0.3197946125619116
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IFNAR1,Interferon alpha/beta receptor 1,16000,108,1.77 [0.95-3.29],0.0729173386499547
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IFNG,Interferon gamma,18183,127,1.05 [0.91-1.22],0.4689857955524072
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IFNGR1,Interferon gamma receptor 1,18552,130,2.56 [1.50-4.39],0.0005947660906003
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IFNGR2,Interferon gamma receptor 2,18340,127,0.80 [0.58-1.11],0.1788296609852251
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IFNL1,Interferon lambda-1,18093,124,1.08 [0.76-1.55],0.6660670613910606
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IFNL2,Interferon lambda-2,15563,101,0.89 [0.62-1.27],0.5263334863160072
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IFNLR1,Interferon lambda receptor 1,18488,132,1.38 [0.94-2.02],0.1008566438371261
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IFNW1,Interferon omega-1,15526,102,0.73 [0.39-1.39],0.3384994996554801
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IFT20,Intraflagellar transport protein 20 homolog,15643,104,1.24 [0.84-1.84],0.2829935484999044
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IGBP1,Immunoglobulin-binding protein 1,16031,108,1.11 [0.82-1.50],0.5120462020908743
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,15563,101,1.42 [1.10-1.83],0.0070946427221446
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,16062,108,1.11 [0.56-2.20],0.7608426029567814
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IGF1R,Insulin-like growth factor 1 receptor,18402,129,1.46 [0.71-2.99],0.306918048716941
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,15526,102,1.07 [0.73-1.59],0.7234822038718141
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IGF2R,Cation-independent mannose-6-phosphate receptor,18493,131,2.21 [1.16-4.22],0.0163004868985157
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IGFBP1,Insulin-like growth factor-binding protein 1,18694,128,1.08 [0.95-1.23],0.2218672636350454
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IGFBP2,Insulin-like growth factor-binding protein 2,18689,128,1.43 [1.09-1.87],0.0104533602495406
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IGFBP3,Insulin-like growth factor-binding protein 3,18580,129,1.18 [0.72-1.95],0.5105827495677517
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IGFBP4,Insulin-like growth factor-binding protein 4,18270,131,1.74 [1.27-2.38],0.0004962386313612
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IGFBP6,Insulin-like growth factor-binding protein 6,18432,129,2.02 [1.30-3.14],0.0016545384915038
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IGFBP7,Insulin-like growth factor-binding protein 7,18719,128,1.54 [1.00-2.37],0.0511552222487295
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IGFBPL1,Insulin-like growth factor-binding protein-like 1,18492,130,1.76 [1.13-2.76],0.0131902644613391
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IGFL4,Insulin growth factor-like family member 4,15570,103,1.06 [0.83-1.35],0.6319981853047674
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IGHMBP2,DNA-binding protein SMUBP-2,15526,102,1.06 [0.77-1.47],0.7279862047260106
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IGLC2,Immunoglobulin lambda constant 2,16054,107,1.29 [0.72-2.31],0.3888569555931777
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IGLON5,IgLON family member 5,15494,101,1.25 [1.09-1.45],0.0017890464244317
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IGSF21,Immunoglobulin superfamily member 21,15602,101,1.25 [0.82-1.92],0.3010144510787262
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IGSF3,Immunoglobulin superfamily member 3,18402,129,2.03 [1.43-2.90],8.938132256661223e-05
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IGSF8,Immunoglobulin superfamily member 8,18492,130,1.18 [0.72-1.95],0.5049574063817226
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IGSF9,Protein turtle homolog A,16050,105,1.01 [0.80-1.26],0.9628977231525956
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IKBKG,NF-kappa-B essential modulator,18488,132,1.03 [0.87-1.23],0.6945733295339451
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IKZF2,Zinc finger protein Helios,18072,126,0.96 [0.80-1.16],0.6862054339478456
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL10,Interleukin-10,18183,127,1.03 [0.85-1.26],0.747589446084955
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL10RA,Interleukin-10 receptor subunit alpha,18183,127,0.93 [0.69-1.25],0.6184639023960454
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL10RB,Interleukin-10 receptor subunit beta,18552,130,1.65 [1.02-2.67],0.0432884303028016
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL11,Interleukin-11,18183,127,0.85 [0.64-1.13],0.2669678462391801
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL12A_IL12B,Interleukin-12,18402,129,1.17 [0.96-1.44],0.1277364174619282
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL12B,Interleukin-12 subunit beta,18712,130,1.24 [0.93-1.65],0.1495336083534443
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL12RB1,Interleukin-12 receptor subunit beta-1,18183,127,0.84 [0.55-1.30],0.4419056222404628
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL12RB2,Interleukin-12 receptor subunit beta-2,15570,103,1.26 [0.82-1.94],0.2912527286031887
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL13,Interleukin-13,18183,127,1.00 [0.73-1.37],0.983216908473258
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL13RA1,Interleukin-13 receptor subunit alpha-1,18249,128,1.55 [0.80-3.00],0.1980196765785496
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL13RA2,Interleukin-13 receptor subunit alpha-2,15563,101,0.91 [0.47-1.74],0.7714149334498315
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL15,Interleukin-15,18488,132,1.39 [0.88-2.18],0.1585640391111889
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL15RA,Interleukin-15 receptor subunit alpha,18183,127,1.19 [0.75-1.88],0.4580068439875735
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL16,Pro-interleukin-16,18712,130,1.17 [0.83-1.64],0.3742242314108337
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL17A,Interleukin-17A,18143,127,1.13 [0.80-1.59],0.4978758903379952
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL17C,Interleukin-17C,18183,127,1.22 [1.01-1.49],0.0429463693818455
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL17D,Interleukin-17D,18183,127,1.21 [0.86-1.72],0.2782908554742815
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL17F,Interleukin-17F,18183,127,1.09 [0.90-1.33],0.3805273452047573
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL17RA,Interleukin-17 receptor A,18493,131,1.05 [0.74-1.49],0.7991430167721948
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL17RB,Interleukin-17 receptor B,18262,129,1.05 [0.78-1.40],0.7622763715995236
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL18,Interleukin-18,18399,130,1.00 [0.70-1.43],0.99565866734217
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL18BP,Interleukin-18-binding protein,18580,129,1.91 [1.18-3.09],0.0087051154904363
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL18R1,Interleukin-18 receptor 1,18712,130,1.13 [0.70-1.83],0.6151285250319927
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL18RAP,Interleukin-18 receptor accessory protein,18224,124,0.93 [0.84-1.03],0.1442609083781885
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL19,Interleukin-19,18028,127,1.19 [0.97-1.46],0.1022553410446351
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL1A,Interleukin-1 alpha,18183,127,0.83 [0.62-1.11],0.2161383705372909
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL1B,Interleukin-1 beta,18097,126,0.92 [0.69-1.24],0.5980836632826105
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL1R1,Interleukin-1 receptor type 1,18460,129,1.51 [0.77-2.96],0.2355257997970228
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL1R2,Interleukin-1 receptor type 2,18433,130,0.74 [0.34-1.62],0.4514393822921115
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL1RAP,Interleukin-1 receptor accessory protein,18493,131,1.23 [0.89-1.71],0.2075110479534796
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL1RL1,Interleukin-1 receptor-like 1,18659,128,1.19 [0.85-1.68],0.3112002624294063
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL1RL2,Interleukin-1 receptor-like 2,18183,127,1.23 [0.80-1.89],0.3488873999688703
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL1RN,Interleukin-1 receptor antagonist protein,18431,130,1.08 [0.81-1.45],0.5971985173819853
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL2,Interleukin-2,18183,127,0.63 [0.39-1.03],0.0671187780248632
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL20,Interleukin-20,18183,127,0.91 [0.64-1.29],0.5802794565174456
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL20RA,Interleukin-20 receptor subunit alpha,18183,127,0.91 [0.62-1.34],0.6444662656569435
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL20RB,Interleukin-20 receptor subunit beta,15570,103,1.02 [0.65-1.61],0.923867629113156
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL21R,Interleukin-21 receptor,15570,103,0.74 [0.48-1.16],0.1903799256700591
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL22,Interleukin-22,15996,108,0.97 [0.74-1.28],0.8537044897831916
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL22RA1,Interleukin-22 receptor subunit alpha-1,18183,127,1.15 [0.86-1.55],0.345106401558818
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL24,Interleukin-24,18183,127,0.99 [0.72-1.37],0.970796768641256
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL25,Interleukin-25,15436,101,1.55 [0.88-2.74],0.1315812330960952
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL2RA,Interleukin-2 receptor subunit alpha,18371,125,1.13 [0.75-1.68],0.5621237799374982
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL2RB,Interleukin-2 receptor subunit beta,18183,127,0.85 [0.55-1.34],0.4907980961338327
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL2RG,Cytokine receptor common subunit gamma,15996,108,1.17 [0.73-1.87],0.5158649750519795
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL3,Interleukin-3,15494,101,0.97 [0.72-1.30],0.8404240887922778
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL31,Interleukin-31,15570,103,1.05 [0.76-1.45],0.7728685712598024
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL31RA,Interleukin-31 receptor subunit alpha,15513,102,1.18 [0.71-1.98],0.518610328474114
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL32,Interleukin-32,18488,132,0.88 [0.60-1.28],0.5063559400808927
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL33,Interleukin-33,18183,127,1.16 [0.78-1.73],0.4675859563978364
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL34,Interleukin-34,18063,124,0.88 [0.57-1.37],0.5803430949356461
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL36A,Interleukin-36 alpha,15570,103,0.79 [0.53-1.17],0.244127214893191
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL36G,Interleukin-36 gamma,15525,103,1.04 [0.79-1.36],0.7879720892137295
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL3RA,Interleukin-3 receptor subunit alpha,18183,127,1.37 [0.84-2.23],0.2047490858903241
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL4,Interleukin-4,18183,127,1.09 [0.91-1.32],0.3463055041219158
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL4R,Interleukin-4 receptor subunit alpha,18488,132,1.39 [0.91-2.13],0.1282929738613771
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL5,Interleukin-5,18183,127,1.09 [0.98-1.20],0.0975944896387949
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL5RA,Interleukin-5 receptor subunit alpha,18488,132,0.80 [0.61-1.07],0.1297536650844407
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL6,Interleukin-6,18402,129,1.12 [0.92-1.35],0.2492295027270774
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL6R,Interleukin-6 receptor subunit alpha,18409,128,1.62 [1.03-2.55],0.0381976921464421
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL6ST,Interleukin-6 receptor subunit beta,18492,130,1.47 [0.60-3.58],0.3989644334727101
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL7,Interleukin-7,18488,132,0.94 [0.74-1.20],0.6253381380875954
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL7R,Interleukin-7 receptor subunit alpha,18493,131,1.11 [0.82-1.49],0.5130640442273469
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IL9,Interleukin-9,15770,101,0.84 [0.56-1.26],0.403844251366426
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,18062,124,1.09 [0.83-1.42],0.5438137067416146
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IMMT,MICOS complex subunit MIC60,15996,108,1.36 [0.96-1.92],0.0838772407503181
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IMPA1,Inositol monophosphatase 1,18340,127,1.10 [0.85-1.42],0.4726812886158531
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IMPACT,Protein IMPACT,16023,107,1.09 [0.78-1.53],0.6149250070244077
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IMPG1,Interphotoreceptor matrix proteoglycan 1,15563,101,0.58 [0.28-1.19],0.1351326216790606
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ING1,Inhibitor of growth protein 1,18065,124,1.10 [0.80-1.50],0.5581298274186736
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,INHBB,Inhibin beta B chain,15698,103,1.45 [1.02-2.07],0.0377210052771497
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,INHBC,Inhibin beta C chain,18493,131,1.14 [0.77-1.70],0.5177510221085349
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,INPP1,Inositol polyphosphate 1-phosphatase,18402,129,1.38 [1.05-1.82],0.021759074665065
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",15602,101,1.42 [1.03-1.97],0.0326086524240745
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",16031,108,0.74 [0.45-1.22],0.2406545544272732
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",18402,129,1.01 [0.86-1.19],0.9129533501653908
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,INSL3,Insulin-like 3,16023,107,1.00 [0.81-1.22],0.9734595971491128
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,INSL4,Early placenta insulin-like peptide,15996,108,1.14 [0.81-1.61],0.4614489412031948
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,INSL5,Insulin-like peptide INSL5,16000,108,1.05 [0.87-1.26],0.6263788225648239
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,INSR,Insulin receptor,15570,103,2.55 [0.83-7.79],0.1007427191099087
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IPCEF1,Interactor protein for cytohesin exchange factors 1,18303,124,0.96 [0.80-1.14],0.6368239708974226
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IQGAP2,Ras GTPase-activating-like protein IQGAP2,18402,129,1.10 [0.83-1.46],0.5061183453289756
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",18163,124,1.18 [1.01-1.39],0.0420244583220296
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IRAK1,Interleukin-1 receptor-associated kinase 1,18183,127,1.01 [0.80-1.27],0.9247825394532558
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IRAK4,Interleukin-1 receptor-associated kinase 4,18488,132,0.99 [0.86-1.15],0.9409459982758088
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,17819,124,1.08 [0.71-1.63],0.7342753517554648
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ISM1,Isthmin-1,18488,132,1.16 [0.78-1.75],0.4645672642056496
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ISM2,Isthmin-2,16062,108,0.71 [0.45-1.13],0.1484081520168009
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IST1,IST1 homolog,15874,108,1.09 [0.90-1.31],0.3936098076872102
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ITGA11,Integrin alpha-11,18488,132,0.89 [0.56-1.42],0.6380149216059365
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ITGA2,Integrin alpha-2,15698,103,1.04 [0.60-1.82],0.8883035930789647
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ITGA5,Integrin alpha-5,18493,131,1.46 [0.77-2.76],0.2434773225350354
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ITGA6,Integrin alpha-6,18488,132,1.05 [0.78-1.41],0.7440346956659217
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ITGAL,Integrin alpha-L,15570,103,1.37 [0.86-2.16],0.1860196157785437
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ITGAM,Integrin alpha-M,18493,131,1.26 [0.78-2.05],0.346273558286072
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ITGAV,Integrin alpha-V,18664,128,1.47 [0.56-3.85],0.4373915139763602
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ITGAX,Integrin alpha-X,15770,101,1.45 [1.12-1.88],0.0050769883245207
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ITGB1,Integrin beta-1,18495,129,1.73 [0.84-3.54],0.1376391582766851
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ITGB1BP1,Integrin beta-1-binding protein 1,18072,126,0.93 [0.62-1.38],0.7085585368521627
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ITGB1BP2,Integrin beta-1-binding protein 2,18163,124,1.08 [0.94-1.25],0.2884581621073551
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ITGB2,Integrin beta-2,18400,127,1.19 [0.68-2.10],0.5360961751805587
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ITGB5,Integrin beta-5,18535,130,0.95 [0.62-1.44],0.8051283037523165
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ITGB6,Integrin beta-6,18183,127,0.92 [0.55-1.55],0.7532382072357148
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ITGB7,Integrin beta-7,18664,128,1.14 [0.82-1.59],0.4389860358940732
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ITGBL1,Integrin beta-like protein 1,16062,108,1.44 [0.90-2.33],0.1321654142143451
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,16076,107,0.77 [0.28-2.07],0.602880152135365
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,18580,129,1.28 [0.85-1.94],0.2419541509711585
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,16076,107,0.81 [0.36-1.78],0.5933115286899211
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,15996,108,1.40 [1.03-1.90],0.0326686296229853
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ITM2A,Integral membrane protein 2A,18488,132,1.09 [0.86-1.40],0.4722207942733282
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ITPA,Inosine triphosphate pyrophosphatase,15526,102,1.00 [0.75-1.34],0.9903948749182078
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",15602,101,1.16 [0.90-1.50],0.2594902737661158
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",15563,101,1.06 [0.70-1.59],0.7794758050886852
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",18093,124,0.99 [0.72-1.36],0.9653225154610896
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,IZUMO1,Izumo sperm-egg fusion protein 1,15494,101,0.98 [0.65-1.49],0.9418763287674102
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,JAM2,Junctional adhesion molecule B,18657,131,2.11 [1.23-3.63],0.0070485812721486
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,JAM3,Junctional adhesion molecule C,15698,103,1.04 [0.71-1.53],0.8306230182962603
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,JCHAIN,Immunoglobulin J chain,18183,127,0.97 [0.75-1.25],0.8041941970790203
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,15494,101,1.18 [0.88-1.59],0.2725704692041152
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,JPT2,Jupiter microtubule associated homolog 2,16000,108,1.15 [0.93-1.42],0.2122769838200805
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,JUN,Transcription factor AP-1,18183,127,1.13 [0.85-1.50],0.4043673358521478
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,18402,129,1.11 [0.78-1.58],0.5677291833763998
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KAZN,Kazrin,16000,108,1.19 [1.00-1.42],0.0562955718195905
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KCNC4,Potassium voltage-gated channel subfamily C member 4,15563,101,1.24 [0.93-1.66],0.1371578612623434
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KCNH2,Potassium voltage-gated channel subfamily H member 2,15643,104,0.90 [0.68-1.18],0.4374450385235366
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KCNIP4,Kv channel-interacting protein 4,18093,124,0.71 [0.48-1.04],0.0806880115707613
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KCTD5,BTB/POZ domain-containing protein KCTD5,15708,106,1.24 [0.86-1.78],0.2476153161930968
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KDM3A,Lysine-specific demethylase 3A,15570,103,0.95 [0.76-1.20],0.6644152080733421
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KDR,Vascular endothelial growth factor receptor 2,18535,130,1.40 [0.75-2.59],0.2899170536569181
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KEL,Kell blood group glycoprotein,18093,124,0.92 [0.59-1.44],0.7289926396361399
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KHDC3L,KH domain-containing protein 3,15494,101,0.97 [0.73-1.29],0.845208508814221
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KHK,Ketohexokinase,15602,101,0.96 [0.70-1.31],0.7920395238578384
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KIAA0319,Dyslexia-associated protein KIAA0319,16023,107,1.40 [0.84-2.31],0.1949367365118555
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KIAA1549,UPF0606 protein KIAA1549,15770,101,0.85 [0.65-1.11],0.2255516030593187
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KIAA1549L,UPF0606 protein KIAA1549L,15770,101,1.09 [0.57-2.11],0.7912983500210715
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KIAA2013,Uncharacterized protein KIAA2013,15996,108,1.16 [0.87-1.55],0.3209438372671435
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KIF1C,Kinesin-like protein KIF1C,15526,102,1.13 [0.66-1.94],0.6476419074844668
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KIF20B,Kinesin-like protein KIF20B,15563,101,1.19 [0.95-1.48],0.1289882212896594
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KIF22,Kinesin-like protein KIF22,15526,102,1.02 [0.87-1.19],0.7961634209759667
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KIFBP,KIF-binding protein,18402,129,1.00 [0.83-1.21],0.9802863120648648
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,15996,108,1.07 [0.88-1.32],0.4981033305857004
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,18072,126,1.08 [0.89-1.32],0.4379342227157997
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,16000,108,0.96 [0.86-1.07],0.4763501242891335
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,18072,126,1.02 [0.90-1.15],0.7793075291792433
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,15494,101,1.07 [0.87-1.30],0.5269409209499415
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KIRREL1,Kin of IRRE-like protein 1,15563,101,0.91 [0.63-1.33],0.6373771057524182
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KIRREL2,Kin of IRRE-like protein 2,18093,124,1.54 [1.09-2.16],0.0139867044291969
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KIT,Mast/stem cell growth factor receptor Kit,18558,129,1.07 [0.63-1.83],0.7903247592609883
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KITLG,Kit ligand,18492,130,1.05 [0.68-1.60],0.8378466878169559
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KLB,Beta-klotho,18093,124,0.97 [0.78-1.20],0.7518961272323377
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KLF4,Krueppel-like factor 4,15563,101,1.07 [0.69-1.66],0.7534222789738816
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KLHL41,Kelch-like protein 41,16031,108,1.15 [0.82-1.63],0.4142037143127184
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KLK1,Kallikrein-1,18316,127,1.00 [0.89-1.13],0.9921722669763228
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KLK10,Kallikrein-10,18481,129,1.34 [0.94-1.90],0.1029857085689664
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KLK11,Kallikrein-11,18348,127,1.48 [1.01-2.17],0.0447900036467787
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KLK12,Kallikrein-12,18072,126,1.04 [0.92-1.17],0.5600096773692932
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KLK13,Kallikrein-13,18063,127,1.18 [0.83-1.67],0.3659669718302774
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KLK14,Kallikrein-14,18664,128,1.06 [0.76-1.49],0.7157720550801099
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KLK15,Kallikrein-15,15965,108,1.20 [0.84-1.71],0.3189308238239645
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KLK3,Prostate-specific antigen,16062,108,1.34 [1.15-1.56],0.0002235279037542
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KLK4,Kallikrein-4,18664,128,1.11 [0.87-1.42],0.4052655036799529
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KLK6,Kallikrein-6,18498,130,1.69 [1.02-2.80],0.043035844145047
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KLK7,Kallikrein-7,15317,102,1.13 [0.69-1.85],0.6336561743198552
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KLK8,Kallikrein-8,17857,117,1.92 [1.27-2.89],0.0018763735104171
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KLKB1,Plasma kallikrein,15759,105,0.69 [0.32-1.49],0.3422045481952216
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KLRB1,Killer cell lectin-like receptor subfamily B member 1,18712,130,1.41 [0.94-2.11],0.0924726967651679
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,15563,101,1.15 [0.87-1.52],0.3169279313345258
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KLRD1,Natural killer cells antigen CD94,18712,130,1.17 [0.84-1.62],0.3531921863530483
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KLRF1,Killer cell lectin-like receptor subfamily F member 1,15570,103,0.98 [0.63-1.52],0.9229569729731186
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KLRK1,NKG2-D type II integral membrane protein,16023,107,1.18 [0.81-1.73],0.3924879686237515
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KRT14,"Keratin, type I cytoskeletal 14",17541,122,1.08 [0.64-1.83],0.7601062783981832
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KRT17,"Keratin, type I cytoskeletal 17",15526,102,0.81 [0.48-1.35],0.4147445831992189
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KRT18,"Keratin, type I cytoskeletal 18",18402,129,1.05 [0.87-1.27],0.6150352493104826
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KRT19,"Keratin, type I cytoskeletal 19",18457,132,1.10 [0.88-1.39],0.4042293558169841
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KRT5,"Keratin, type II cytoskeletal 5",18093,124,1.51 [1.16-1.98],0.0025342202790164
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KRT6C,"Keratin, type II cytoskeletal 6C",15526,102,0.94 [0.54-1.61],0.8111590315781887
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KRT8,"Keratin, type II cytoskeletal 8",15563,101,0.93 [0.71-1.21],0.5882859814831224
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KYAT1,Kynurenine--oxoglutarate transaminase 1,18461,130,1.13 [0.86-1.49],0.365317675089254
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,KYNU,Kynureninase,18712,130,0.93 [0.65-1.33],0.6765231247319365
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,L1CAM,Neural cell adhesion molecule L1,18535,130,1.27 [0.75-2.15],0.3798896709961128
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,16050,105,0.99 [0.80-1.22],0.9177801315011372
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LACRT,Extracellular glycoprotein lacritin,15962,108,1.18 [0.84-1.66],0.3435603944912607
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LACTB2,Endoribonuclease LACTB2,18492,130,1.02 [0.81-1.30],0.8548801437441628
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LAG3,Lymphocyte activation gene 3 protein,18402,129,1.54 [1.09-2.18],0.0144796717980802
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,18462,130,1.37 [0.90-2.07],0.141037730825253
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,18340,127,1.07 [0.92-1.25],0.3668416139587007
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LAMA1,Laminin subunit alpha-1,15526,102,1.23 [0.91-1.65],0.1822700984971269
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LAMA4,Laminin subunit alpha-4,18552,130,1.26 [0.80-1.98],0.3112988035475682
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LAMB1,Laminin subunit beta-1,15602,101,0.82 [0.44-1.53],0.5356736234409951
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LAMP1,Lysosome-associated membrane glycoprotein 1,15629,105,1.10 [0.54-2.23],0.7951102786560831
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LAMP2,Lysosome-associated membrane glycoprotein 2,17928,121,0.74 [0.35-1.59],0.4430480895864316
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LAMP3,Lysosome-associated membrane glycoprotein 3,18678,129,1.00 [0.74-1.35],0.991566171230866
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LAMTOR5,Ragulator complex protein LAMTOR5,15996,108,1.57 [1.08-2.28],0.0189530126346181
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LAP3,Cytosol aminopeptidase,18183,127,1.17 [0.85-1.61],0.3242707030738594
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LARP1,La-related protein 1,15996,108,1.18 [0.91-1.53],0.2122375474882461
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LAT,Linker for activation of T-cells family member 1,18712,130,0.92 [0.75-1.12],0.3967513186425937
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LAT2,Linker for activation of T-cells family member 2,18402,129,1.04 [0.92-1.18],0.5137653412944423
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LATS1,Serine/threonine-protein kinase LATS1,15570,103,1.21 [0.97-1.51],0.0881192329528809
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LAYN,Layilin,18312,127,1.99 [1.32-3.00],0.0010178127722199
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LBP,Lipopolysaccharide-binding protein,18580,129,1.04 [0.80-1.36],0.7589258509051949
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LBR,Delta(14)-sterol reductase LBR,18657,131,0.99 [0.79-1.24],0.9537231374976476
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LCAT,Phosphatidylcholine-sterol acyltransferase,16073,108,1.46 [0.62-3.43],0.3886921004829863
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LCN15,Lipocalin-15,16031,108,1.17 [0.90-1.52],0.2290889905363212
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LCN2,Neutrophil gelatinase-associated lipocalin,17964,126,1.38 [0.95-2.02],0.0937737388933669
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LCP1,Plastin-2,16062,108,0.94 [0.63-1.40],0.7618211728816935
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LDLR,Low-density lipoprotein receptor,18537,128,0.95 [0.69-1.30],0.7549123642749566
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LDLRAP1,Low density lipoprotein receptor adapter protein 1,16031,108,1.04 [0.86-1.25],0.7003288829825045
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LECT2,Leukocyte cell-derived chemotaxin-2,16050,105,1.43 [1.09-1.88],0.0104904304130716
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LEFTY2,Left-right determination factor 2,18641,128,1.10 [0.81-1.50],0.5343165909391399
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LEG1,Protein LEG1 homolog,15157,101,1.04 [0.78-1.38],0.7873408970657716
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LELP1,Late cornified envelope-like proline-rich protein 1,15563,101,0.89 [0.66-1.19],0.4293424937275978
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LEO1,RNA polymerase-associated protein LEO1,16031,108,1.36 [0.89-2.08],0.1587221706221559
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LEP,Leptin,18492,130,0.93 [0.74-1.17],0.5483441242506248
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LEPR,Leptin receptor,18492,130,0.77 [0.47-1.29],0.3261140461454058
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LETM1,Mitochondrial proton/calcium exchanger protein,16031,108,1.25 [0.91-1.70],0.1641034129105231
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LGALS1,Galectin-1,18492,130,1.35 [0.87-2.08],0.1823160094389198
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LGALS3,Galectin-3,18544,127,1.32 [0.78-2.24],0.305978531103749
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LGALS3BP,Galectin-3-binding protein,16076,107,1.01 [0.55-1.85],0.97377786061218
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LGALS4,Galectin-4,18462,130,1.16 [0.88-1.52],0.2940239068381297
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LGALS7_LGALS7B,Galectin-7,18458,125,1.46 [1.04-2.04],0.0276839239918374
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LGALS8,Galectin-8,18657,131,1.14 [0.88-1.46],0.3189237733413784
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LGALS9,Galectin-9,18473,130,1.75 [1.06-2.90],0.0301448296702063
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LGMN,Legumain,18552,130,1.13 [0.74-1.74],0.5680517753464186
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LHB,Lutropin subunit beta,18072,126,0.94 [0.78-1.13],0.5209005672506202
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,18489,130,0.96 [0.74-1.25],0.7741900144025711
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LIF,Leukemia inhibitory factor,18093,124,0.85 [0.60-1.20],0.3504999001598882
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LIFR,Leukemia inhibitory factor receptor,18488,132,1.30 [0.67-2.50],0.4359119893812729
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,18493,131,1.40 [0.89-2.20],0.1459571610725795
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,16062,108,1.15 [0.97-1.36],0.1160991409268891
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,15526,102,0.82 [0.54-1.25],0.3654454988201224
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,18472,130,1.26 [0.77-2.04],0.3543504897359373
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,16050,105,0.92 [0.72-1.18],0.5150977760101348
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,18719,128,1.12 [0.63-1.99],0.7041444121247677
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,18629,128,1.44 [0.90-2.30],0.1296607445662497
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,18183,127,1.17 [0.82-1.69],0.3850290447179867
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,18719,128,1.04 [0.83-1.30],0.7329957852554618
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LIPF,Gastric triacylglycerol lipase,15602,101,0.90 [0.66-1.22],0.4927494631622471
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LMNB1,Lamin-B1,15973,108,1.04 [0.79-1.39],0.7700030421646652
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LMNB2,Lamin-B2,16023,107,1.69 [0.93-3.06],0.0859295211761784
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LMOD1,Leiomodin-1,16031,108,1.06 [0.61-1.85],0.8280096524605547
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LMOD2,Leiomodin-2,15563,101,0.92 [0.66-1.29],0.6255421279765605
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LONP1,"Lon protease homolog, mitochondrial",15602,101,1.04 [0.84-1.30],0.7081602431736713
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LPA,Apolipoprotein(a),15722,105,1.01 [0.91-1.12],0.8010931767689029
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LPCAT2,Lysophosphatidylcholine acyltransferase 2,18402,129,1.14 [0.85-1.53],0.3931781370424768
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LPL,Lipoprotein lipase,18492,130,0.93 [0.68-1.29],0.6749153403797559
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LPO,Lactoperoxidase,17843,121,0.91 [0.69-1.20],0.5007648648410934
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LPP,Lipoma-preferred partner,15526,102,1.23 [0.92-1.65],0.1602247254297449
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,15526,102,1.14 [0.87-1.50],0.3427393799807212
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,15643,104,0.88 [0.55-1.41],0.6013238128647979
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LRG1,Leucine-rich alpha-2-glycoprotein,16076,107,0.87 [0.43-1.76],0.6982751581937443
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,18615,128,1.09 [0.70-1.70],0.705765284128832
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,15522,103,0.84 [0.40-1.74],0.6304669843743038
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LRP1,Prolow-density lipoprotein receptor-related protein 1,18402,129,1.03 [0.58-1.86],0.9106860158023454
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LRP11,Low-density lipoprotein receptor-related protein 11,18492,130,1.48 [0.97-2.25],0.0691928184791407
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LRP2,Low-density lipoprotein receptor-related protein 2,15643,104,0.78 [0.44-1.37],0.3840982894560488
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LRP2BP,LRP2-binding protein,15643,104,0.92 [0.71-1.20],0.5430502282137478
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,18657,131,0.93 [0.69-1.24],0.6094666687778554
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LRRC25,Leucine-rich repeat-containing protein 25,18402,129,1.26 [0.85-1.87],0.2503399555827616
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LRRC37A2,Leucine-rich repeat-containing protein 37A2,16000,108,1.51 [1.00-2.29],0.0508978999592567
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LRRC38,Leucine-rich repeat-containing protein 38,15643,104,0.67 [0.43-1.02],0.0625562351818632
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LRRC59,Leucine-rich repeat-containing protein 59,16050,105,1.31 [0.92-1.88],0.1377305929919481
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,15996,108,1.60 [1.14-2.23],0.0060896863685171
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LRRN1,Leucine-rich repeat neuronal protein 1,18183,127,1.05 [0.70-1.57],0.8134164940181894
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,15643,104,0.74 [0.44-1.25],0.2620435252642445
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,16031,108,1.18 [0.58-2.39],0.6464821547642745
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LSM1,U6 snRNA-associated Sm-like protein LSm1,18072,126,1.09 [0.82-1.43],0.5587236256955165
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LSM8,U6 snRNA-associated Sm-like protein LSm8,15770,101,1.02 [0.81-1.29],0.8511369723136987
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LSP1,Lymphocyte-specific protein 1,18488,132,0.91 [0.62-1.34],0.6443373282621119
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LTA,Lymphotoxin-alpha,18488,132,1.37 [0.94-2.01],0.1017991879558743
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LTA4H,Leukotriene A-4 hydrolase,18664,128,1.16 [0.90-1.49],0.2644312206754308
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LTB,Lymphotoxin-beta,15996,108,1.29 [0.85-1.98],0.2357518880116149
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LTBP2,Latent-transforming growth factor beta-binding protein 2,18719,128,1.70 [1.02-2.85],0.0420004351622988
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LTBP3,Latent-transforming growth factor beta-binding protein 3,18072,126,1.35 [1.05-1.75],0.0207624826883464
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LTBR,Tumor necrosis factor receptor superfamily member 3,18370,130,2.07 [1.26-3.39],0.0038298106209237
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LTO1,Protein LTO1 homolog,18183,127,1.19 [0.84-1.69],0.3227342204187016
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LUZP2,Leucine zipper protein 2,15996,108,1.42 [1.00-2.02],0.0520415101154232
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LXN,Latexin,18257,127,1.08 [0.87-1.34],0.501645492724235
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LY6D,Lymphocyte antigen 6D,18375,129,1.66 [1.15-2.39],0.0067834806526451
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LY75,Lymphocyte antigen 75,18488,132,1.30 [0.86-1.96],0.2119542523945076
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LY9,T-lymphocyte surface antigen Ly-9,18260,126,1.43 [0.83-2.47],0.1985126503559558
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LY96,Lymphocyte antigen 96,18340,127,1.11 [0.72-1.70],0.632953837847507
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LYAR,Cell growth-regulating nucleolar protein,18072,126,1.20 [0.96-1.49],0.1134800195572128
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LYN,Tyrosine-protein kinase Lyn,18402,129,1.03 [0.86-1.24],0.7245069613724622
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LYPD1,Ly6/PLAUR domain-containing protein 1,18093,124,0.94 [0.72-1.23],0.6589128014064334
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LYPD3,Ly6/PLAUR domain-containing protein 3,18391,126,0.84 [0.52-1.35],0.4694530108904957
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LYPD8,Ly6/PLAUR domain-containing protein 8,18072,126,0.80 [0.57-1.12],0.192454798473879
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LYPLA2,Acyl-protein thioesterase 2,15563,101,0.99 [0.83-1.19],0.9350010265218966
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,15643,104,1.15 [0.99-1.34],0.0610091158024411
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,16076,107,1.08 [0.42-2.82],0.8704183722417437
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LYZL2,Lysozyme-like protein 2,15494,101,1.14 [0.70-1.87],0.5885667296936433
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,LZTFL1,Leucine zipper transcription factor-like protein 1,15698,103,1.05 [0.81-1.38],0.6964862566781462
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,M6PR,Cation-dependent mannose-6-phosphate receptor,15602,101,0.86 [0.50-1.49],0.6014994187265881
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,18282,126,1.17 [0.90-1.53],0.2479276736707882
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MAEA,E3 ubiquitin-protein transferase MAEA,18072,126,1.35 [0.94-1.94],0.1005544811536644
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MAG,Myelin-associated glycoprotein,15643,104,1.43 [1.00-2.03],0.0481592000718258
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MAGEA3,Melanoma-associated antigen 3,15770,101,0.90 [0.73-1.10],0.29056175515379
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MAGED1,Melanoma-associated antigen D1,18072,126,0.96 [0.68-1.35],0.8125401051232182
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MAMDC2,MAM domain-containing protein 2,16050,105,2.41 [1.48-3.92],0.0003825323235666
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MAMDC4,Apical endosomal glycoprotein,15996,108,0.90 [0.64-1.26],0.5467122664816559
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",15602,101,1.70 [0.79-3.66],0.1739804751716518
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MAN2B2,Epididymis-specific alpha-mannosidase,16050,105,1.11 [0.81-1.52],0.499922117576593
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",15494,101,1.15 [0.80-1.65],0.4529405155243696
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MANF,Mesencephalic astrocyte-derived neurotrophic factor,18552,130,1.00 [0.88-1.13],0.9403644884494023
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MANSC1,MANSC domain-containing protein 1,18535,130,1.59 [0.92-2.75],0.0957646980950359
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MANSC4,MANSC domain-containing protein 4,15526,102,0.98 [0.74-1.29],0.873752956671096
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,15563,101,0.71 [0.39-1.29],0.260516478744587
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,15526,102,1.14 [0.90-1.45],0.2598872737628598
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MAP2,Microtubule-associated protein 2,16023,107,1.55 [1.12-2.15],0.0080419641064047
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,16000,108,1.35 [1.02-1.79],0.038659672810929
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,18488,132,1.00 [0.86-1.17],0.9530944274829366
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,18072,126,1.07 [0.91-1.25],0.4407399715987691
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,18312,127,1.04 [0.90-1.20],0.5982431176133394
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MAPK13,Mitogen-activated protein kinase 13,15494,101,1.32 [0.92-1.91],0.135875461713608
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MAPK9,Mitogen-activated protein kinase 9,18488,132,1.17 [0.82-1.68],0.3876911974748992
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MAPKAPK2,MAP kinase-activated protein kinase 2,15770,101,1.18 [0.91-1.52],0.2163087398672415
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MAPRE3,Microtubule-associated protein RP/EB family member 3,15494,101,0.99 [0.87-1.13],0.9403860438438152
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MAPT,Microtubule-associated protein tau,18093,124,0.93 [0.69-1.26],0.6523120736073881
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MARCO,Macrophage receptor MARCO,18492,130,0.70 [0.38-1.29],0.2517361544333211
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MARS1,"Methionine--tRNA ligase, cytoplasmic",15671,103,1.18 [0.95-1.47],0.1431196641702952
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MASP1,Mannan-binding lectin serine protease 1,18312,127,2.00 [1.00-4.00],0.051034480174856
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MATN2,Matrilin-2,18492,130,1.44 [0.84-2.46],0.1867678970072666
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MATN3,Matrilin-3,18303,124,1.28 [0.80-2.04],0.3000770246554629
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MAVS,Mitochondrial antiviral-signaling protein,18072,126,1.08 [0.90-1.28],0.4123968966971199
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MAX,Protein max,18093,124,1.01 [0.86-1.17],0.940929069616112
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MB,Myoglobin,18719,128,1.53 [1.20-1.95],0.0005810887679919
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MBL2,Mannose-binding protein C,15861,106,1.07 [0.90-1.27],0.472514067897138
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MCAM,Cell surface glycoprotein MUC18,18580,129,1.70 [1.07-2.70],0.0257050134528777
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",16031,108,1.55 [1.13-2.12],0.0058618246830461
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MCEMP1,Mast cell-expressed membrane protein 1,15570,103,0.94 [0.76-1.18],0.6094547028410071
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MCFD2,Multiple coagulation factor deficiency protein 2,18394,129,1.18 [0.83-1.67],0.3557074352709356
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MCTS1,Malignant T-cell-amplified sequence 1,16000,108,0.92 [0.44-1.92],0.8325180688020946
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,18340,127,0.95 [0.75-1.19],0.63611189862451
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MDH1,"Malate dehydrogenase, cytoplasmic",15991,108,1.36 [0.88-2.11],0.1654438937534221
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MDK,Midkine,18471,129,1.24 [0.94-1.65],0.1314520419793187
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MDM1,Nuclear protein MDM1,15643,104,0.75 [0.40-1.42],0.3791286072022832
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",15602,101,1.01 [0.82-1.25],0.8909581392576665
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MED18,Mediator of RNA polymerase II transcription subunit 18,18072,126,1.03 [0.83-1.26],0.8008766720037752
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MED21,Mediator of RNA polymerase II transcription subunit 21,15526,102,0.92 [0.61-1.38],0.6750489587899022
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MEGF10,Multiple epidermal growth factor-like domains protein 10,18462,130,1.34 [0.91-1.98],0.1383531383242396
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MEGF11,Multiple epidermal growth factor-like domains protein 11,15526,102,0.42 [0.20-0.88],0.0215683052256881
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MEGF9,Multiple epidermal growth factor-like domains protein 9,18659,128,1.96 [0.93-4.15],0.0779166642713726
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MELTF,Melanotransferrin,16050,105,1.56 [0.85-2.84],0.1485818209681879
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MENT,Protein MENT,15698,103,0.92 [0.41-2.07],0.842389553368771
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MEP1A,Meprin A subunit alpha,16000,108,1.09 [0.85-1.40],0.4920616874544666
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MEP1B,Meprin A subunit beta,18492,130,0.92 [0.80-1.04],0.1893363799093233
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MEPE,Matrix extracellular phosphoglycoprotein,18462,130,0.82 [0.43-1.58],0.5605725438924378
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MERTK,Tyrosine-protein kinase Mer,18712,130,1.32 [0.70-2.51],0.3881543542918003
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MESD,LRP chaperone MESD,18493,131,1.01 [0.89-1.15],0.8424631428453186
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MET,Hepatocyte growth factor receptor,18536,128,1.46 [0.65-3.29],0.3599723206013859
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,METAP1,Methionine aminopeptidase 1,18093,124,0.96 [0.55-1.66],0.8740494709188581
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",18488,132,0.97 [0.80-1.17],0.7528435031592264
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,METAP2,Methionine aminopeptidase 2,18641,128,0.97 [0.73-1.28],0.8101526179413958
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MFAP3,Microfibril-associated glycoprotein 3,18163,124,0.98 [0.69-1.37],0.8854165640299734
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MFAP3L,Microfibrillar-associated protein 3-like,15643,104,0.99 [0.74-1.32],0.9514542060148294
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MFAP4,Microfibril-associated glycoprotein 4,15698,103,1.34 [0.74-2.44],0.3300349863754274
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MFAP5,Microfibrillar-associated protein 5,18719,128,1.25 [0.84-1.86],0.2651092523442121
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MFGE8,Lactadherin,18493,131,1.18 [0.83-1.67],0.3655080640898587
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MGLL,Monoglyceride lipase,18531,130,0.95 [0.80-1.13],0.5404633269183561
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MGMT,Methylated-DNA--protein-cysteine methyltransferase,18488,132,0.98 [0.86-1.11],0.7399707990841402
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MIA,Melanoma-derived growth regulatory protein,18535,130,1.42 [0.95-2.13],0.0838527171532594
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MICALL2,MICAL-like protein 2,15643,104,1.14 [0.88-1.48],0.3351105867946213
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,18488,132,1.02 [0.92-1.14],0.674162841682721
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MIF,Macrophage migration inhibitory factor,18457,130,1.01 [0.80-1.27],0.9551617280462488
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MILR1,Allergin-1,18183,127,1.00 [0.73-1.37],0.9846404933498636
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,15996,108,1.15 [0.96-1.36],0.1208201133211755
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MINK1,Misshapen-like kinase 1,16023,107,1.10 [0.90-1.35],0.347128221115892
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MITD1,MIT domain-containing protein 1,18340,127,1.01 [0.86-1.19],0.8942385925467597
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MKI67,Proliferation marker protein Ki-67,15570,103,1.16 [0.76-1.77],0.4856709866230895
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MLLT1,Protein ENL,15494,101,0.91 [0.66-1.25],0.5471215714955425
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MLN,Promotilin,18488,132,1.21 [1.01-1.45],0.0336601579247459
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MME,Neprilysin,18402,129,0.87 [0.70-1.08],0.1972631192148525
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MMP1,Interstitial collagenase,17875,124,1.14 [0.95-1.37],0.1527070344152291
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MMP10,Stromelysin-2,18438,129,0.96 [0.73-1.26],0.7749214499793238
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MMP12,Macrophage metalloelastase,18533,127,1.06 [0.80-1.42],0.6788155778746059
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MMP13,Collagenase 3,18093,124,1.40 [0.85-2.31],0.1924607333251028
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MMP15,Matrix metalloproteinase-15,16050,105,1.00 [0.67-1.49],0.987874218481778
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MMP3,Stromelysin-1,18493,131,1.57 [1.17-2.10],0.0028387776828263
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MMP7,Matrilysin,18139,124,1.36 [0.96-1.91],0.0815988059048608
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MMP8,Neutrophil collagenase,18627,131,1.11 [0.90-1.36],0.3480565268479074
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MMP9,Matrix metalloproteinase-9,18473,131,1.00 [0.78-1.30],0.9835120114150012
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",15526,102,1.27 [0.90-1.78],0.169246396854206
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MN1,Transcriptional activator MN1,15643,104,0.97 [0.69-1.35],0.8473653735149582
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MNAT1,CDK-activating kinase assembly factor MAT1,15770,101,1.08 [0.72-1.63],0.7028031780900732
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MNDA,Myeloid cell nuclear differentiation antigen,18462,129,1.01 [0.87-1.17],0.9091608712232212
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MOCS2,Molybdopterin synthase catalytic subunit,15698,103,1.15 [0.86-1.54],0.3304394416334371
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MOG,Myelin-oligodendrocyte glycoprotein,18664,128,1.75 [1.10-2.78],0.0179525800581206
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MORC3,MORC family CW-type zinc finger protein 3,16023,107,1.44 [0.82-2.53],0.2030155281899836
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MORF4L1,Mortality factor 4-like protein 1,15770,101,0.96 [0.58-1.58],0.8735190672324757
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MORF4L2,Mortality factor 4-like protein 2,15494,101,1.36 [0.89-2.06],0.1540758814467588
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MORN4,MORN repeat-containing protein 4,15494,101,0.94 [0.72-1.22],0.6159648253143291
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MPHOSPH8,M-phase phosphoprotein 8,18163,124,1.08 [0.87-1.32],0.4921579268679632
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MPI,Mannose-6-phosphate isomerase,18402,129,1.04 [0.87-1.25],0.6820848914259705
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,18531,130,0.97 [0.79-1.18],0.7256067285066405
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MPO,Myeloperoxidase,18493,131,0.90 [0.64-1.26],0.5317144065892158
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MPRIP,Myosin phosphatase Rho-interacting protein,15969,108,0.81 [0.52-1.24],0.327351289049515
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MRC1,Macrophage mannose receptor 1,16073,108,1.42 [0.74-2.75],0.2925824671487856
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MRI1,Methylthioribose-1-phosphate isomerase,15643,104,0.92 [0.70-1.23],0.5796916054723356
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MRPL24,"39S ribosomal protein L24, mitochondrial",15526,102,0.95 [0.57-1.58],0.8335128157692409
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MRPL28,"39S ribosomal protein L28, mitochondrial",16031,108,1.02 [0.63-1.64],0.9393825254740442
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MRPL46,"39S ribosomal protein L46, mitochondrial",18093,124,1.02 [0.57-1.81],0.9483069046159076
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MRPL52,"39S ribosomal protein L52, mitochondrial",15456,101,0.97 [0.48-1.99],0.9414030258393146
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",16031,108,1.03 [0.80-1.33],0.8088378706106002
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MRPS16,"28S ribosomal protein S16, mitochondrial",15570,103,0.77 [0.36-1.62],0.4835697000933353
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MSLN,Mesothelin,18372,129,1.13 [0.87-1.46],0.3602691032917554
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MSLNL,Mesothelin-like protein,15643,104,0.79 [0.46-1.35],0.3848861125765783
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MSMB,Beta-microseminoprotein,18471,127,1.44 [1.15-1.80],0.0015685818878472
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MSR1,Macrophage scavenger receptor types I and II,18657,131,1.07 [0.76-1.50],0.7070004290571319
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MSRA,Mitochondrial peptide methionine sulfoxide reductase,18535,130,0.99 [0.80-1.23],0.9630855933256092
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MST1,Hepatocyte growth factor-like protein,15844,106,0.88 [0.71-1.09],0.2401453746871867
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MSTN,Growth/differentiation factor 8,18163,124,1.35 [1.01-1.82],0.0449136618793527
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MTDH,Protein LYRIC,15570,103,1.05 [0.85-1.28],0.6704152195877954
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",16023,107,1.06 [0.52-2.19],0.8677443833305588
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,15770,101,1.10 [0.93-1.30],0.2669459301440915
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MTIF3,"Translation initiation factor IF-3, mitochondrial",16000,108,0.99 [0.80-1.22],0.92655867408772
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MTPN,Myotrophin,18163,124,1.05 [0.65-1.70],0.8420500599544838
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MTR,Methionine synthase,15526,102,0.89 [0.65-1.22],0.4714098097481546
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MTSS1,Protein MTSS 1,16000,108,1.20 [1.02-1.41],0.0289592995438469
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MTSS2,Protein MTSS 2,15996,108,1.09 [0.91-1.32],0.3365809512134266
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MTUS1,Microtubule-associated tumor suppressor 1,15770,101,1.32 [0.99-1.78],0.0617319902996363
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MUC13,Mucin-13,18093,124,1.24 [0.91-1.68],0.1777832503601922
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MUC16,Mucin-16,18402,129,0.96 [0.88-1.03],0.2657057906018502
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MUC2,Mucin-2,16062,108,0.97 [0.79-1.18],0.7419135041425446
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MUCL3,Mucin-like protein 3,15494,101,1.00 [0.64-1.57],0.9935254150639352
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MVK,Mevalonate kinase,18183,127,0.91 [0.74-1.11],0.3496761206706872
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MXRA8,Matrix remodeling-associated protein 8,15698,103,1.18 [0.63-2.19],0.6045653467902199
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MYBPC1,"Myosin-binding protein C, slow-type",16050,105,1.30 [1.04-1.63],0.0227106331218006
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MYBPC2,"Myosin-binding protein C, fast-type",15602,101,1.12 [0.91-1.37],0.2892233190049995
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,16031,108,1.13 [0.86-1.47],0.3806660881109136
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MYDGF,Myeloid-derived growth factor,16050,105,1.13 [0.93-1.36],0.2115259144624954
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MYH4,Myosin-4,15526,102,0.76 [0.47-1.25],0.2790710647022592
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MYH7B,Myosin-7B,15494,101,1.08 [0.72-1.63],0.7086014048015938
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MYH9,Myosin-9,16062,108,1.16 [0.99-1.36],0.0692352837145323
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",15526,102,1.47 [1.01-2.15],0.0443932936977165
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MYL3,Myosin light chain 3,15602,101,1.26 [0.98-1.61],0.0696478810339864
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MYL4,Myosin light chain 4,15602,101,0.96 [0.66-1.39],0.8243158943936113
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MYL6B,Myosin light chain 6B,15643,104,1.02 [0.84-1.24],0.8525842773893366
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",15643,104,1.18 [0.85-1.62],0.3195177903142456
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MYO6,Unconventional myosin-VI,16031,108,1.54 [1.12-2.12],0.0082479440542076
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MYO9B,Unconventional myosin-IXb,18183,127,1.03 [0.81-1.30],0.8216979100469164
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MYOC,Myocilin,18493,131,1.55 [1.09-2.21],0.0148870151369426
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MYOM1,Myomesin-1,15563,101,1.51 [1.20-1.92],0.0005298768043842
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MYOM2,Myomesin-2,15526,102,0.95 [0.66-1.38],0.8034752739274059
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MYOM3,Myomesin-3,15698,103,1.18 [0.97-1.44],0.1058025221446295
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MZB1,Marginal zone B- and B1-cell-specific protein,18513,130,1.12 [0.82-1.51],0.4761722038427255
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,MZT1,Mitotic-spindle organizing protein 1,18072,126,1.26 [0.95-1.68],0.1060606440256401
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NAA10,N-alpha-acetyltransferase 10,15526,102,1.15 [0.79-1.68],0.4686630227866085
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NAA80,N-alpha-acetyltransferase 80,15643,104,1.09 [0.93-1.27],0.2708294830821823
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NAAA,N-acylethanolamine-hydrolyzing acid amidase,18259,126,0.91 [0.70-1.19],0.4940315564332039
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NACC1,Nucleus accumbens-associated protein 1,15996,108,1.18 [0.87-1.60],0.2755072601765652
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NADK,NAD kinase,18492,130,0.96 [0.72-1.27],0.7718480101122831
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NAGA,Alpha-N-acetylgalactosaminidase,15543,103,1.04 [0.75-1.44],0.809887630428969
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NAGK,N-acetyl-D-glucosamine kinase,15574,101,1.37 [0.99-1.90],0.0567856690667113
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,15698,103,0.99 [0.41-2.42],0.98508874299676
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NAMPT,Nicotinamide phosphoribosyltransferase,18072,126,1.07 [0.81-1.41],0.624588442636326
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NAP1L4,Nucleosome assembly protein 1-like 4,15962,108,1.15 [0.73-1.81],0.545497992844916
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NAPRT,Nicotinate phosphoribosyltransferase,16023,107,0.85 [0.48-1.51],0.5807570403677973
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NARS1,"Asparagine--tRNA ligase, cytoplasmic",16031,108,1.16 [0.78-1.71],0.4691779975006547
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NBL1,Neuroblastoma suppressor of tumorigenicity 1,18535,130,1.94 [1.10-3.42],0.021267387138273
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NBN,Nibrin,18183,127,1.12 [0.86-1.45],0.3941887611669795
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NCAM1,Neural cell adhesion molecule 1,18580,129,1.25 [0.78-2.01],0.3435482315963611
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NCAM2,Neural cell adhesion molecule 2,18493,131,0.93 [0.53-1.65],0.8130515678730622
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NCAN,Neurocan core protein,18657,131,0.98 [0.65-1.48],0.9249926760803834
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NCF2,Neutrophil cytosol factor 2,18449,132,0.96 [0.80-1.16],0.6755793491907706
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NCK2,Cytoplasmic protein NCK2,18552,130,0.99 [0.86-1.15],0.9333467338941798
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NCLN,Nicalin,18183,127,1.06 [0.79-1.42],0.6940495571908805
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NCR1,Natural cytotoxicity triggering receptor 1,18462,131,1.01 [0.66-1.53],0.971755445038989
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,16000,108,1.57 [0.93-2.64],0.0907138396579002
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NCS1,Neuronal calcium sensor 1,18664,128,1.12 [0.64-1.96],0.6892244594283143
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NDRG1,Protein NDRG1,18093,124,0.86 [0.64-1.15],0.30014359436769
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,15996,108,0.91 [0.66-1.27],0.5831442083570785
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,15541,103,1.74 [1.07-2.83],0.0268992502703653
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,16000,108,1.05 [0.86-1.30],0.6185993142175383
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",18072,126,0.99 [0.80-1.21],0.8968494699638555
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NEB,Nebulin,15526,102,1.22 [0.78-1.90],0.3825849801496412
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NECAP2,Adaptin ear-binding coat-associated protein 2,15526,102,1.11 [0.84-1.46],0.4784131960132396
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NECTIN1,Nectin-1,15570,103,1.00 [0.57-1.76],0.9938064974196136
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NECTIN2,Nectin-2,18472,130,1.71 [1.05-2.79],0.0301755354874152
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NECTIN4,Nectin-4,18535,130,1.77 [1.13-2.77],0.0120357003992055
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,15570,103,0.96 [0.65-1.42],0.8369843159156838
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NEDD9,Enhancer of filamentation 1,15570,103,0.91 [0.52-1.60],0.7500243953272252
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NEFL,Neurofilament light polypeptide,18041,124,1.30 [0.94-1.81],0.1129295983649866
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NEK7,Serine/threonine-protein kinase Nek7,15770,101,0.92 [0.69-1.21],0.5461475642666409
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NELL1,Protein kinase C-binding protein NELL1,18535,130,0.87 [0.59-1.26],0.4582824703850516
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NELL2,Protein kinase C-binding protein NELL2,18552,130,0.90 [0.53-1.56],0.7165209059552882
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NENF,Neudesin,15996,108,1.05 [0.90-1.21],0.5594463241538765
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NEO1,Neogenin,16031,108,1.78 [0.96-3.29],0.0650596875946791
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NEXN,Nexilin,16073,108,1.39 [1.09-1.78],0.0086638363481193
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NFASC,Neurofascin,18712,130,0.70 [0.40-1.23],0.217411269275956
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NFAT5,Nuclear factor of activated T-cells 5,15570,103,1.25 [1.01-1.53],0.0375687484142183
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",18488,132,1.03 [0.88-1.20],0.753829699131441
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",18183,127,0.98 [0.75-1.27],0.8604710826242661
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NFE2,Transcription factor NF-E2 45 kDa subunit,15602,101,1.35 [1.05-1.74],0.0204759101364365
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NFIC,Nuclear factor 1 C-type,16031,108,1.05 [0.72-1.53],0.7941366305384655
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NFKB1,Nuclear factor NF-kappa-B p105 subunit,15526,102,1.12 [0.86-1.45],0.3957644119198212
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NFKB2,Nuclear factor NF-kappa-B p100 subunit,15770,101,1.09 [0.80-1.49],0.5683624415581358
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NFKBIE,NF-kappa-B inhibitor epsilon,18072,126,1.18 [0.86-1.63],0.3135953406040942
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",16000,108,1.07 [0.90-1.28],0.4314495834451002
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NFX1,Transcriptional repressor NF-X1,15526,102,1.05 [0.79-1.39],0.7203069927043243
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NFYA,Nuclear transcription factor Y subunit alpha,15526,102,1.13 [0.74-1.75],0.5659407644629839
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NGF,Beta-nerve growth factor,18340,127,1.09 [0.31-3.82],0.8917489298471972
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NGFR,Tumor necrosis factor receptor superfamily member 16,16050,105,1.69 [1.09-2.63],0.0195463564649525
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NGRN,Neugrin,16023,107,0.99 [0.43-2.28],0.972473696565184
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NHLRC3,NHL repeat-containing protein 3,15331,101,1.33 [0.71-2.51],0.3714581192905035
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NID1,Nidogen-1,18526,129,0.95 [0.62-1.47],0.815217249472147
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NID2,Nidogen-2,18493,131,0.89 [0.72-1.10],0.272716604376391
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NINJ1,Ninjurin-1,18072,126,1.05 [0.79-1.40],0.7209576518638154
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NIT1,Deaminated glutathione amidase,15602,101,1.09 [0.70-1.68],0.7041550643796858
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NIT2,Omega-amidase NIT2,15990,105,1.10 [0.85-1.42],0.4736119443392366
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NLGN1,Neuroligin-1,15643,104,0.79 [0.55-1.13],0.1923123904499781
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NLGN2,Neuroligin-2,15563,101,1.02 [0.68-1.53],0.93100754264939
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NME1,Nucleoside diphosphate kinase A,15570,103,1.77 [0.78-4.00],0.1731081201098995
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NME3,Nucleoside diphosphate kinase 3,18492,130,1.06 [0.55-2.07],0.8583049465564846
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NMI,N-myc-interactor,15930,108,1.11 [0.86-1.42],0.432839256971545
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,18340,127,1.07 [0.88-1.30],0.515395465968393
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NMRK2,Nicotinamide riboside kinase 2,15494,101,0.75 [0.42-1.34],0.3369365326895585
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,16031,108,1.00 [0.75-1.32],0.9910115896064398
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NOMO1,Nodal modulator 1,18493,131,0.93 [0.47-1.83],0.8285506446579024
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NOP56,Nucleolar protein 56,15526,102,0.99 [0.83-1.18],0.8886025280571852
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NOS1,"Nitric oxide synthase, brain",18093,124,1.38 [1.07-1.78],0.0139252817959656
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NOS2,"Nitric oxide synthase, inducible",15526,102,1.19 [0.76-1.87],0.4429498371146421
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NOS3,"Nitric oxide synthase, endothelial",18093,124,1.04 [0.76-1.43],0.7984836662604744
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NOTCH1,Neurogenic locus notch homolog protein 1,18719,128,2.18 [0.82-5.83],0.1200103117456291
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NOTCH2,Neurogenic locus notch homolog protein 2,16062,108,1.40 [0.59-3.34],0.4474896451562358
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NOTCH3,Neurogenic locus notch homolog protein 3,18719,128,1.74 [1.08-2.80],0.0220676384545975
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NPC2,NPC intracellular cholesterol transporter 2,15800,107,1.74 [1.00-3.03],0.0519010961704833
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NPDC1,Neural proliferation differentiation and control protein 1,18492,130,1.70 [1.10-2.63],0.0167250609940018
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NPHS1,Nephrin,15570,103,0.78 [0.43-1.41],0.4082504142332958
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NPHS2,Podocin,15570,103,1.13 [0.96-1.33],0.1295859602320359
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NPL,N-acetylneuraminate lyase,16050,105,1.07 [0.71-1.62],0.7518319931276707
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NPPB,Natriuretic peptides B,18163,124,1.06 [0.95-1.19],0.3019270424710043
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NPPC,C-type natriuretic peptide,18488,132,1.04 [0.77-1.41],0.7873141690663146
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NPR1,Atrial natriuretic peptide receptor 1,15526,102,1.11 [0.71-1.73],0.6368128829883526
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NPTN,Neuroplastin,18072,126,1.07 [0.89-1.30],0.4632807667372037
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NPTX1,Neuronal pentraxin-1,18493,131,0.83 [0.56-1.22],0.3470678055376074
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NPTX2,Neuronal pentraxin-2,16062,108,0.94 [0.54-1.63],0.8178333862857923
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NPTXR,Neuronal pentraxin receptor,18492,130,1.45 [0.94-2.24],0.0943424651057386
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NPY,Pro-neuropeptide Y,18664,128,0.96 [0.75-1.22],0.7190494793517959
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NRCAM,Neuronal cell adhesion molecule,18492,130,0.97 [0.55-1.69],0.9007346641167282
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NRGN,Neurogranin,16073,108,1.08 [0.88-1.32],0.4536333791399352
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NRN1,Neuritin,16031,108,1.11 [0.70-1.76],0.6615202224703823
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NRP1,Neuropilin-1,18613,129,0.80 [0.44-1.43],0.4429263122192162
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NRP2,Neuropilin-2,18493,131,1.58 [0.93-2.68],0.0911145621116867
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NRTN,Neurturin,18183,127,0.90 [0.65-1.25],0.521520394858684
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NRXN3,Neurexin-3,15643,104,0.74 [0.40-1.37],0.3443267760978653
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NSFL1C,NSFL1 cofactor p47,18657,131,0.98 [0.77-1.25],0.8808930189962527
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",16050,105,1.16 [0.89-1.49],0.2720553416039309
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NT5C1A,Cytosolic 5'-nucleotidase 1A,16023,107,1.93 [1.33-2.81],0.0005596686337327
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NT5C3A,Cytosolic 5'-nucleotidase 3A,18451,132,0.98 [0.82-1.17],0.8147600361429068
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NT5E,5'-nucleotidase,18535,130,0.81 [0.59-1.10],0.1806325910895201
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NTF3,Neurotrophin-3,18488,132,1.06 [0.68-1.66],0.7884648336001362
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NTF4,Neurotrophin-4,18072,126,1.19 [0.81-1.74],0.3837336262480543
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NTRK2,BDNF/NT-3 growth factors receptor,18492,130,0.56 [0.30-1.05],0.0688386409484647
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NTRK3,NT-3 growth factor receptor,18657,131,1.79 [0.86-3.73],0.1196211108726962
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NTproBNP,N-terminal prohormone of brain natriuretic peptide,18492,130,1.20 [1.06-1.36],0.0046005959958386
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NUB1,NEDD8 ultimate buster 1,18488,132,1.02 [0.85-1.23],0.8329483881054154
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,15996,108,1.02 [0.85-1.22],0.8299450192153356
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NUCB2,Nucleobindin-2,18636,128,1.17 [0.77-1.78],0.4698745972081405
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NUDC,Nuclear migration protein nudC,18712,130,1.08 [0.84-1.37],0.5583203943447582
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,15602,101,1.07 [0.50-2.29],0.8568456535602345
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,15526,102,0.84 [0.55-1.28],0.415710508852905
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NUDT16,U8 snoRNA-decapping enzyme,15974,107,1.04 [0.84-1.28],0.7484568764472713
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],18402,129,1.10 [0.84-1.43],0.4803844933384766
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NUDT5,ADP-sugar pyrophosphatase,18493,131,1.20 [0.88-1.63],0.2500190813553428
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NUMB,Protein numb homolog,15570,103,1.10 [0.88-1.39],0.4040447443097389
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NUP50,Nuclear pore complex protein Nup50,15526,102,1.54 [1.04-2.30],0.0323165605243673
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NXPE4,NXPE family member 4,15526,102,1.18 [0.67-2.08],0.5722872895010638
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NXPH1,Neurexophilin-1,18093,124,1.29 [0.91-1.84],0.1493170164785758
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,NXPH3,Neurexophilin-3,15570,103,1.08 [0.57-2.05],0.8056968007416323
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,OBP2B,Odorant-binding protein 2b,18279,124,0.97 [0.74-1.29],0.8563609227721617
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,OCLN,Occludin,16031,108,1.25 [0.83-1.87],0.2827788221329499
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ODAM,Odontogenic ameloblast-associated protein,18063,124,0.99 [0.73-1.33],0.9217707115125332
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,OFD1,Oral-facial-digital syndrome 1 protein,15770,101,0.91 [0.66-1.26],0.5623527713130376
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,OGA,Protein O-GlcNAcase,16000,108,1.19 [0.91-1.54],0.1974063611524679
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,OGFR,Opioid growth factor receptor,18402,129,1.12 [0.68-1.83],0.6636433175453786
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,OGN,Mimecan,18493,131,1.61 [1.13-2.30],0.0083960425296522
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,15770,101,0.84 [0.59-1.17],0.3008368372528286
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,OLFM4,Olfactomedin-4,15105,97,1.01 [0.86-1.18],0.929148535244071
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,OLR1,Oxidized low-density lipoprotein receptor 1,18309,129,1.07 [0.83-1.38],0.6271645263052821
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,OMD,Osteomodulin,18552,130,1.34 [0.90-2.00],0.1455089036391854
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,OMG,Oligodendrocyte-myelin glycoprotein,18402,129,1.23 [0.98-1.54],0.0718402938350029
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,OMP,Olfactory marker protein,15563,101,0.93 [0.61-1.40],0.7117537609388229
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,OPHN1,Oligophrenin-1,16023,107,1.09 [0.92-1.30],0.3140329765207845
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,OPLAH,5-oxoprolinase,15602,101,1.24 [0.95-1.62],0.1132042312272918
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,OPTC,Opticin,18402,129,1.10 [0.79-1.54],0.5809591191918608
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ORM1,Alpha-1-acid glycoprotein 1,16015,107,2.33 [0.97-5.60],0.0591445968646848
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,OSBPL2,Oxysterol-binding protein-related protein 2,16023,107,1.26 [0.85-1.85],0.2519887697904373
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,OSCAR,Osteoclast-associated immunoglobulin-like receptor,18492,130,1.40 [0.89-2.21],0.1495029946254918
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,OSM,Oncostatin-M,18394,131,0.99 [0.79-1.24],0.9409522018697154
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,OSMR,Oncostatin-M-specific receptor subunit beta,18613,129,1.25 [0.55-2.82],0.5948841646653595
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,OSTN,Osteocrin,15643,104,1.28 [0.87-1.87],0.2070578041160413
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,OTOA,Otoancorin,15563,101,1.40 [1.08-1.82],0.0119838531485579
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,OTUD6B,Deubiquitinase OTUD6B,16000,108,1.23 [0.90-1.68],0.2005831983177655
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,OTUD7B,OTU domain-containing protein 7B,16031,108,1.10 [0.82-1.47],0.530151578066782
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",15602,101,1.29 [0.99-1.69],0.0575395022529291
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,OXT,Oxytocin-neurophysin 1,18657,131,1.11 [1.00-1.24],0.0497140235864888
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,P4HB,Protein disulfide-isomerase,18391,128,1.36 [0.91-2.03],0.1294377878811153
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PACS2,Phosphofurin acidic cluster sorting protein 2,15526,102,1.27 [0.94-1.70],0.1171898316599482
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PADI2,Protein-arginine deiminase type-2,18183,127,1.16 [0.93-1.43],0.1845844061243261
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PADI4,Protein-arginine deiminase type-4,18063,124,1.07 [0.88-1.30],0.516780955276521
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PAEP,Glycodelin,18340,127,0.93 [0.80-1.09],0.3713584093685418
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,16031,108,1.02 [0.88-1.18],0.813431806880311
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",15770,101,1.23 [0.87-1.73],0.2410069951307601
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,18163,124,1.02 [0.76-1.35],0.9103730016457748
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PAGR1,PAXIP1-associated glutamate-rich protein 1,15602,101,1.32 [0.87-1.99],0.1878111071063748
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,15467,101,0.97 [0.67-1.40],0.8697659230817935
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PAK4,Serine/threonine-protein kinase PAK 4,18093,124,1.00 [0.77-1.29],0.9728484968690122
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PALLD,Palladin,15570,103,0.89 [0.52-1.52],0.6674077503173208
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PALM,Paralemmin-1,15903,108,1.58 [0.91-2.75],0.1038601170743121
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PALM2,Paralemmin-2,16023,107,1.45 [0.90-2.32],0.1261886217256304
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PALM3,Paralemmin-3,15526,102,1.01 [0.79-1.29],0.9539600503749556
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PAM,Peptidyl-glycine alpha-amidating monooxygenase,18638,128,1.80 [1.00-3.23],0.0481144620710889
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PAMR1,Inactive serine protease PAMR1,18493,131,0.82 [0.45-1.47],0.4986960593318914
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PAPPA,Pappalysin-1,18183,127,0.89 [0.63-1.24],0.4801220340528982
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PARD3,Partitioning defective 3 homolog,15770,101,1.00 [0.78-1.29],0.9877150518277916
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PARK7,Parkinson disease protein 7,18493,131,1.05 [0.77-1.42],0.7758522897215013
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PARP1,Poly [ADP-ribose] polymerase 1,18488,132,1.11 [0.87-1.41],0.4088064674524114
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PAXX,Protein PAXX,15698,103,1.11 [0.73-1.69],0.6156580249838939
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PBK,Lymphokine-activated killer T-cell-originated protein kinase,15494,101,0.90 [0.49-1.66],0.7314163118523174
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PBLD,Phenazine biosynthesis-like domain-containing protein,18093,124,1.12 [0.82-1.53],0.4857027968752141
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,16000,108,1.76 [1.07-2.89],0.0250131395411715
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PCARE,Photoreceptor cilium actin regulator,15563,101,1.09 [0.89-1.33],0.4124228163970518
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,15663,103,1.04 [0.69-1.58],0.8520147990732394
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PCBP2,Poly(rC)-binding protein 2,16031,108,1.12 [0.87-1.44],0.3903493949138087
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PCDH1,Protocadherin-1,18646,129,1.72 [0.89-3.32],0.1052006567112151
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PCDH12,Protocadherin-12,16031,108,1.39 [0.68-2.85],0.3666130556388279
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PCDH17,Protocadherin-17,18492,130,1.57 [1.04-2.36],0.0328211207234978
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PCDH7,Protocadherin-7,16000,108,1.52 [1.04-2.21],0.0300604421352053
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PCDH9,Protocadherin-9,16000,108,1.50 [0.86-2.60],0.150156600333946
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PCDHB15,Protocadherin beta-15,15996,108,1.16 [0.75-1.81],0.5000296409769859
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PCNA,Proliferating cell nuclear antigen,15494,101,0.93 [0.67-1.27],0.633929464288071
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PCSK7,Proprotein convertase subtilisin/kexin type 7,15996,108,0.97 [0.65-1.45],0.8739716914750977
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PCSK9,Proprotein convertase subtilisin/kexin type 9,18719,128,0.69 [0.47-1.03],0.0682130295879643
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PCYT2,Ethanolamine-phosphate cytidylyltransferase,16000,108,1.09 [0.85-1.39],0.4977706005093187
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDAP1,28 kDa heat- and acid-stable phosphoprotein,16050,105,1.09 [0.90-1.32],0.3717341804026546
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDCD1,Programmed cell death protein 1,18632,128,1.04 [0.70-1.54],0.8528105252288002
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDCD1LG2,Programmed cell death 1 ligand 2,18402,129,1.23 [0.75-2.01],0.4159868507324736
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDCD5,Programmed cell death protein 5,18657,131,0.97 [0.75-1.27],0.8524076456769853
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDCD6,Programmed cell death protein 6,18492,130,1.07 [0.85-1.34],0.5757314473948439
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDCL2,Phosducin-like protein 2,15494,101,1.06 [0.73-1.52],0.763764848753733
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",15494,101,1.02 [0.71-1.47],0.9141655424214664
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",15526,102,1.03 [0.75-1.41],0.859074316540137
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",15698,103,1.10 [0.91-1.32],0.3367827990165929
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDGFA,Platelet-derived growth factor subunit A,18719,128,0.87 [0.71-1.08],0.2179552747724965
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDGFB,Platelet-derived growth factor subunit B,18552,130,0.89 [0.75-1.06],0.200040358570599
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDGFC,Platelet-derived growth factor C,18072,126,0.96 [0.53-1.73],0.8936477918850244
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDGFRA,Platelet-derived growth factor receptor alpha,18492,130,0.91 [0.52-1.61],0.7575857738994545
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDGFRB,Platelet-derived growth factor receptor beta,18719,128,1.23 [0.78-1.94],0.3760902565281409
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDIA2,Protein disulfide-isomerase A2,15494,101,1.03 [0.66-1.63],0.8913523010872131
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDIA3,Protein disulfide-isomerase A3,15698,103,0.72 [0.32-1.63],0.4343273655115862
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDIA4,Protein disulfide-isomerase A4,16062,108,1.16 [0.86-1.56],0.3278905139426333
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDIA5,Protein disulfide-isomerase A5,15494,101,1.08 [0.79-1.46],0.6302969693808458
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDLIM5,PDZ and LIM domain protein 5,16031,108,1.11 [0.95-1.30],0.2016401641192735
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDLIM7,PDZ and LIM domain protein 7,18552,130,1.03 [0.91-1.17],0.6288097754863622
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",18072,126,1.14 [0.85-1.52],0.3887969346216391
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDRG1,p53 and DNA damage-regulated protein 1,15643,104,0.99 [0.70-1.42],0.9691709286755316
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,15494,101,1.03 [0.71-1.50],0.8832058038841075
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDZD2,PDZ domain-containing protein 2,15526,102,1.44 [1.09-1.90],0.0094637184295931
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,15570,103,1.16 [0.76-1.76],0.4964625062522323
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PEAR1,Platelet endothelial aggregation receptor 1,18719,128,1.43 [0.72-2.83],0.303522012169631
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PEBP1,Phosphatidylethanolamine-binding protein 1,18493,131,1.04 [0.79-1.36],0.794661526072409
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PECAM1,Platelet endothelial cell adhesion molecule,18493,131,1.46 [0.89-2.42],0.1358510268927859
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PECR,Peroxisomal trans-2-enoyl-CoA reductase,15602,101,1.30 [0.67-2.49],0.4380065655623114
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PENK,Proenkephalin-A,15698,103,1.50 [0.87-2.56],0.1441502022880569
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PEPD,Xaa-Pro dipeptidase,16073,108,1.16 [0.57-2.37],0.6897822894971831
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PER3,Period circadian protein homolog 3,15570,103,1.05 [0.90-1.22],0.5311834533883248
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PF4,Platelet factor 4,15952,106,0.92 [0.76-1.12],0.4027655150455028
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PFDN2,Prefoldin subunit 2,18093,124,1.08 [0.81-1.45],0.5789172905862505
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PFDN4,Prefoldin subunit 4,15494,101,1.10 [0.77-1.56],0.6165992368834974
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PFDN6,Prefoldin subunit 6,15643,104,0.92 [0.67-1.26],0.5855222987402989
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",18376,129,0.92 [0.75-1.13],0.4343766590364435
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PGA4,Pepsin A-4,16073,108,0.97 [0.77-1.22],0.7694138573415755
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",16050,105,1.23 [0.88-1.74],0.2297582001834395
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PGF,Placenta growth factor,18712,130,1.88 [1.09-3.25],0.022737348973445
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PGLYRP1,Peptidoglycan recognition protein 1,18629,128,1.27 [0.89-1.80],0.1865674278659402
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,15880,107,1.28 [0.67-2.44],0.458333499520168
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PGLYRP4,Peptidoglycan recognition protein 4,15526,102,1.16 [0.87-1.54],0.3125008581325864
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PGM2,Phosphoglucomutase-2,15643,104,0.78 [0.52-1.16],0.2208739675375654
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PGR,Progesterone receptor,15570,103,0.99 [0.82-1.20],0.9329617907227202
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PHACTR2,Phosphatase and actin regulator 2,16031,108,1.07 [0.91-1.25],0.4420757502558651
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PHLDB1,Pleckstrin homology-like domain family B member 1,16000,108,1.79 [1.27-2.50],0.0007441383011612
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PHLDB2,Pleckstrin homology-like domain family B member 2,15494,101,0.88 [0.70-1.12],0.296709322013983
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,18340,127,2.23 [1.31-3.78],0.0030058937846284
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,15698,103,1.36 [0.85-2.16],0.1948050009942498
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PI16,Peptidase inhibitor 16,16073,108,0.99 [0.46-2.12],0.974015798501054
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PI3,Elafin,18251,127,1.33 [1.03-1.73],0.0305318345554034
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",16031,108,1.24 [1.00-1.56],0.0551628815455011
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PIGR,Polymeric immunoglobulin receptor,18266,130,0.88 [0.57-1.37],0.583429795052621
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,18488,132,0.90 [0.69-1.16],0.4031960042376172
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,18493,131,2.49 [1.56-3.99],0.0001358991009118
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,15570,103,1.16 [0.84-1.59],0.365064904143857
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PILRA,Paired immunoglobulin-like type 2 receptor alpha,18493,131,1.82 [1.25-2.66],0.0019203864318337
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PILRB,Paired immunoglobulin-like type 2 receptor beta,18492,130,1.53 [1.14-2.05],0.0051158224614102
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,15698,103,0.85 [0.66-1.11],0.2287937951166778
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PITHD1,PITH domain-containing protein 1,15467,101,1.15 [0.92-1.44],0.226616468504337
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PKD1,Polycystin-1,16050,105,1.53 [0.74-3.14],0.2474235482502479
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PKD2,Polycystin-2,15526,102,1.40 [1.07-1.83],0.0142818496283218
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PKLR,Pyruvate kinase PKLR,18497,130,0.94 [0.74-1.20],0.607923155630953
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PKN3,Serine/threonine-protein kinase N3,15770,101,1.10 [0.86-1.41],0.4419845441851758
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PLA2G10,Group 10 secretory phospholipase A2,18340,127,0.69 [0.53-0.90],0.0069097288696575
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PLA2G15,Phospholipase A2 group XV,18535,130,1.73 [0.99-3.02],0.0544280632838505
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PLA2G1B,Phospholipase A2,18693,127,1.02 [0.71-1.46],0.9065959861445584
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PLA2G2A,"Phospholipase A2, membrane associated",18473,126,1.13 [0.85-1.51],0.3921863878395081
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PLA2G4A,Cytosolic phospholipase A2,18552,130,0.98 [0.83-1.17],0.8628824859059498
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PLA2G7,Platelet-activating factor acetylhydrolase,18493,131,1.52 [0.93-2.49],0.0928300181972521
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PLAT,Tissue-type plasminogen activator,18659,128,0.88 [0.64-1.19],0.4036856107953037
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PLAU,Urokinase-type plasminogen activator,18493,131,1.23 [0.76-1.99],0.3915821944782944
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PLAUR,Urokinase plasminogen activator surface receptor,18349,130,1.70 [0.98-2.94],0.0599014192746486
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PLB1,"Phospholipase B1, membrane-associated",16023,107,1.00 [0.73-1.37],0.9990531355865891
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",15570,103,0.96 [0.60-1.53],0.8513584799481771
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",16023,107,1.09 [0.91-1.32],0.3540624333296356
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PLEKHO1,Pleckstrin homology domain-containing family O member 1,16023,107,1.25 [0.96-1.62],0.0957466794450623
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PLG,Plasminogen,15682,106,0.76 [0.32-1.83],0.5464223864399155
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PLIN1,Perilipin-1,18093,124,1.29 [0.84-1.97],0.2459436130415468
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PLIN3,Perilipin-3,18492,130,1.16 [0.81-1.66],0.4124884017172534
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PLPBP,Pyridoxal phosphate homeostasis protein,18492,130,1.04 [0.83-1.31],0.737562945620633
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PLSCR3,Phospholipid scramblase 3,15995,107,1.43 [1.04-1.97],0.0269011175253749
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PLTP,Phospholipid transfer protein,18661,128,1.17 [0.76-1.80],0.467621452915788
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PLXDC1,Plexin domain-containing protein 1,18072,126,1.20 [0.79-1.81],0.3895318098817523
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PLXDC2,Plexin domain-containing protein 2,16023,107,1.00 [0.51-1.95],0.9935225829936296
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PLXNA4,Plexin-A4,18488,132,1.01 [0.83-1.22],0.9573136394180504
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PLXNB2,Plexin-B2,18636,128,1.27 [0.66-2.44],0.4793073225543321
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PLXNB3,Plexin-B3,18430,129,0.94 [0.68-1.31],0.7348443649051091
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,18416,130,1.07 [0.98-1.17],0.1399175913718933
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PMCH,Pro-MCH,15526,102,0.92 [0.70-1.21],0.5490896213178169
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PMM2,Phosphomannomutase 2,15526,102,1.09 [0.79-1.51],0.5821306938292963
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PMS1,PMS1 protein homolog 1,15643,104,0.96 [0.66-1.39],0.821904147851199
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PMVK,Phosphomevalonate kinase,18065,124,1.03 [0.89-1.20],0.6571741097653976
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PNLIP,Pancreatic triacylglycerol lipase,16073,108,1.00 [0.75-1.33],0.998705525195961
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PNLIPRP1,Inactive pancreatic lipase-related protein 1,16023,107,0.98 [0.78-1.24],0.8861868470277994
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PNLIPRP2,Pancreatic lipase-related protein 2,18462,130,1.04 [0.99-1.11],0.1292995546539336
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PNMA1,Paraneoplastic antigen Ma1,15602,101,1.13 [0.82-1.55],0.465192361926713
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PNMA2,Paraneoplastic antigen Ma2,15563,101,1.26 [0.87-1.83],0.2235946253109829
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",18183,127,0.97 [0.85-1.12],0.7196993157893778
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PODXL,Podocalyxin,18402,129,0.80 [0.29-2.23],0.6727896951493862
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PODXL2,Podocalyxin-like protein 2,18535,130,2.11 [1.23-3.61],0.0067420366510595
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,POF1B,Protein POF1B,15570,103,1.28 [0.89-1.84],0.1908102872237046
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,POLR2A,DNA-directed RNA polymerase II subunit RPB1,15570,103,0.62 [0.31-1.24],0.1784087678775746
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",18402,129,1.21 [0.82-1.79],0.3394547407548403
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,POMC,Pro-opiomelanocortin,15602,101,1.04 [0.79-1.36],0.796166869336058
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PON1,Serum paraoxonase/arylesterase 1,16073,108,1.41 [0.70-2.86],0.3337868189793171
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PON2,Serum paraoxonase/arylesterase 2,18163,124,0.86 [0.55-1.36],0.5208015365357896
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PON3,Serum paraoxonase/lactonase 3,18552,130,0.82 [0.48-1.38],0.4463518579032092
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,POSTN,Periostin,16062,108,0.97 [0.59-1.59],0.8977221416961176
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PPBP,Platelet basic protein,15951,106,0.94 [0.76-1.17],0.6054514145066743
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PPCDC,Phosphopantothenoylcysteine decarboxylase,18657,131,1.03 [0.73-1.43],0.8794309095280184
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PPIB,Peptidyl-prolyl cis-trans isomerase B,18502,128,1.00 [0.85-1.18],0.9964278419472408
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PPIE,Peptidyl-prolyl cis-trans isomerase E,15770,101,1.16 [0.89-1.50],0.2764779309496015
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",16062,108,1.02 [0.77-1.36],0.8947769354566083
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PPL,Periplakin,15570,103,1.52 [0.98-2.35],0.0617587388788946
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PPM1A,Protein phosphatase 1A,18072,126,0.93 [0.56-1.56],0.7843165037319075
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PPM1B,Protein phosphatase 1B,15570,103,1.03 [0.76-1.39],0.8583678603024564
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PPM1F,Protein phosphatase 1F,16050,105,1.23 [0.86-1.74],0.2507803856420719
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PPME1,Protein phosphatase methylesterase 1,18402,129,0.95 [0.73-1.24],0.7312814830146093
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,15996,108,1.18 [0.95-1.46],0.134212330694136
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,18535,130,1.06 [0.90-1.24],0.5055836520581587
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,15770,101,0.85 [0.62-1.16],0.3156783512455715
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,16031,108,1.21 [0.99-1.49],0.0657073256751131
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,16031,108,1.02 [0.65-1.62],0.927068177196842
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PPP1R2,Protein phosphatase inhibitor 2,18492,130,1.03 [0.85-1.26],0.730388557101084
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PPP1R9B,Neurabin-2,18712,130,1.05 [0.89-1.23],0.581844468703879
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,16000,108,1.11 [0.96-1.30],0.1567259826073219
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PPP3R1,Calcineurin subunit B type 1,18340,127,1.33 [0.90-1.94],0.1492767315209927
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PPT1,Palmitoyl-protein thioesterase 1,15643,104,1.05 [0.82-1.33],0.7169726018271976
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PPY,Pancreatic prohormone,18426,130,1.03 [0.89-1.20],0.7134392888749617
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PQBP1,Polyglutamine-binding protein 1,18072,126,1.03 [0.79-1.35],0.8316848381990225
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRAME,Melanoma antigen preferentially expressed in tumors,15494,101,1.07 [0.50-2.32],0.8546001725326237
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRAP1,Proline-rich acidic protein 1,16062,108,1.07 [0.66-1.74],0.787469059369521
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRC1,Protein regulator of cytokinesis 1,15996,108,1.22 [0.89-1.67],0.212211692894508
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRCP,Lysosomal Pro-X carboxypeptidase,18601,127,0.72 [0.43-1.19],0.2004476601535291
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRDX1,Peroxiredoxin-1,17963,123,1.16 [0.98-1.38],0.0891449597626762
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRDX2,Peroxiredoxin-2,15809,104,0.93 [0.68-1.26],0.6414675032886368
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",18183,127,0.85 [0.68-1.06],0.1573422572147462
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRDX5,"Peroxiredoxin-5, mitochondrial",18712,130,1.00 [0.80-1.27],0.9672085281541104
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRDX6,Peroxiredoxin-6,18664,128,1.09 [0.85-1.39],0.5187800564919812
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PREB,Prolactin regulatory element-binding protein,18183,127,1.38 [0.83-2.30],0.2209718609361655
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRELP,Prolargin,18462,130,2.09 [1.09-4.00],0.0268722543678545
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRG2,Bone marrow proteoglycan,16062,108,0.91 [0.63-1.32],0.6118948508149464
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRG3,Proteoglycan 3,16062,108,0.78 [0.53-1.14],0.1960153915288642
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,18183,127,1.04 [0.78-1.39],0.7979412127868122
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,15643,104,1.04 [0.58-1.88],0.8837941634028068
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,18492,130,0.95 [0.79-1.14],0.5698863407056451
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,15989,107,1.16 [0.92-1.47],0.2021224702990358
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRKCQ,Protein kinase C theta type,18183,127,1.12 [0.80-1.58],0.5085998716020048
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRKD2,Serine/threonine-protein kinase D2,15526,102,1.07 [0.70-1.65],0.748300670174918
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRKG1,cGMP-dependent protein kinase 1,15698,103,1.12 [0.96-1.30],0.1533576661035825
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,18072,126,1.08 [0.86-1.36],0.5132720688255179
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRL,Prolactin,18657,131,0.94 [0.76-1.16],0.5435631496755966
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRND,Prion-like protein doppel,16023,107,1.18 [0.81-1.73],0.3937077778731479
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PROC,Vitamin K-dependent protein C,18558,129,0.86 [0.46-1.60],0.638291349522833
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PROCR,Endothelial protein C receptor,15526,102,1.13 [0.65-1.95],0.6607709855348107
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PROK1,Prokineticin-1,18488,132,0.97 [0.71-1.33],0.8506610305071451
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PROS1,Vitamin K-dependent protein S,16076,107,0.70 [0.34-1.44],0.3287486350288246
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRR4,Proline-rich protein 4,15588,103,1.10 [0.84-1.43],0.4999938938325193
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRR5,Proline-rich protein 5,15570,103,1.20 [0.82-1.76],0.3417123413475974
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRRT3,Proline-rich transmembrane protein 3,15602,101,1.15 [0.68-1.94],0.5913216930608385
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRSS2,Trypsin-2,18580,129,1.27 [0.97-1.66],0.0808413273231563
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRSS22,Brain-specific serine protease 4,15570,103,1.51 [1.01-2.26],0.0449300978962396
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRSS27,Serine protease 27,18432,130,0.78 [0.52-1.16],0.2245723431479204
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRSS53,Serine protease 53,16023,107,0.86 [0.52-1.41],0.5453745096557092
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRSS8,Prostasin,18410,130,1.11 [0.75-1.62],0.6082863990389764
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,18093,124,1.10 [0.95-1.27],0.2103881667278446
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRTG,Protogenin,18664,128,1.36 [0.72-2.58],0.3438948397845571
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRTN3,Myeloblastin,18034,126,0.96 [0.69-1.33],0.801614640103089
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PRUNE2,Protein prune homolog 2,15770,101,0.83 [0.41-1.67],0.5956376204174594
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PSAP,Prosaposin,15924,108,1.29 [0.65-2.52],0.4656046583448946
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PSAPL1,Proactivator polypeptide-like 1,16000,108,1.55 [1.08-2.22],0.0175859941629164
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PSCA,Prostate stem cell antigen,16000,108,1.05 [0.98-1.13],0.166864812466068
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PSG1,Pregnancy-specific beta-1-glycoprotein 1,18340,127,1.05 [0.91-1.21],0.4803596397977883
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PSIP1,PC4 and SFRS1-interacting protein,18488,132,1.08 [0.87-1.35],0.4809280670330972
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PSMA1,Proteasome subunit alpha type-1,18072,126,0.78 [0.54-1.14],0.2028780459379241
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PSMC3,26S proteasome regulatory subunit 6A,15494,101,0.78 [0.41-1.49],0.4588198860685364
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PSMD1,26S proteasome non-ATPase regulatory subunit 1,16031,108,1.07 [0.75-1.53],0.6953308971916574
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PSMD5,26S proteasome non-ATPase regulatory subunit 5,15643,104,0.94 [0.65-1.37],0.7539920887457657
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PSMD9,26S proteasome non-ATPase regulatory subunit 9,18402,129,0.95 [0.71-1.26],0.7203760351000916
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PSME1,Proteasome activator complex subunit 1,18310,127,0.90 [0.59-1.39],0.6475946322193279
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PSME2,Proteasome activator complex subunit 2,18265,127,1.09 [0.70-1.68],0.7006903483579576
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PSMG3,Proteasome assembly chaperone 3,18488,132,0.80 [0.59-1.09],0.1630120345741236
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PSMG4,Proteasome assembly chaperone 4,15570,103,0.87 [0.61-1.24],0.4442499109661981
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PSPN,Persephin,18488,132,1.11 [0.93-1.33],0.2281498886857448
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PSRC1,Proline/serine-rich coiled-coil protein 1,18072,126,1.13 [0.88-1.45],0.3440446140205994
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,15138,97,1.11 [0.92-1.34],0.2726950805829021
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",18093,124,0.99 [0.58-1.68],0.9694109095592792
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTGDS,Prostaglandin-H2 D-isomerase,18382,127,1.91 [1.22-2.98],0.0046645103173038
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTGES2,Prostaglandin E synthase 2,15456,102,1.31 [0.94-1.85],0.1135922696524086
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTGR1,Prostaglandin reductase 1,16050,105,0.83 [0.66-1.04],0.1025054025263826
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTH,Parathyroid hormone,15643,104,1.13 [0.90-1.43],0.3005614919477792
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,18488,132,1.20 [0.85-1.69],0.30606056880942
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTK7,Inactive tyrosine-protein kinase 7,18093,124,0.97 [0.63-1.48],0.882939217777248
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTN,Pleiotrophin,18163,124,1.37 [1.01-1.87],0.0455319142873887
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTP4A3,Protein tyrosine phosphatase type IVA 3,15570,103,0.74 [0.49-1.13],0.1677486282389615
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,18340,127,1.10 [0.90-1.34],0.3461397829013947
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,18531,130,0.97 [0.82-1.14],0.6914532701498216
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,15544,103,1.03 [0.64-1.65],0.9079160489786507
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTPRB,Receptor-type tyrosine-protein phosphatase beta,16050,105,0.80 [0.42-1.50],0.4817413299113183
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTPRC,Receptor-type tyrosine-protein phosphatase C,16062,108,1.52 [0.68-3.42],0.3119576052560215
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTPRF,Receptor-type tyrosine-protein phosphatase F,18719,128,1.20 [0.69-2.07],0.517308789524197
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTPRH,Receptor-type tyrosine-protein phosphatase H,16000,108,1.16 [0.80-1.68],0.4433070161185849
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,16000,108,1.10 [0.47-2.56],0.8332031269182347
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTPRM,Receptor-type tyrosine-protein phosphatase mu,18456,132,0.99 [0.52-1.88],0.9730603504021968
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,18277,125,1.64 [1.03-2.64],0.0387679313850049
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTPRR,Receptor-type tyrosine-protein phosphatase R,16023,107,1.21 [0.75-1.96],0.4361967722278456
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTPRS,Receptor-type tyrosine-protein phosphatase S,18719,128,1.79 [0.97-3.30],0.0646647852597537
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,16050,105,1.33 [0.74-2.41],0.3412780056675267
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,15698,103,1.15 [0.83-1.59],0.3871087472635042
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTS,6-pyruvoyl tetrahydrobiopterin synthase,18000,124,1.09 [0.81-1.47],0.5606874587643557
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTTG1,Securin,15770,101,0.96 [0.61-1.53],0.8786050947365079
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PTX3,Pentraxin-related protein PTX3,18488,132,0.93 [0.69-1.26],0.6448624095513033
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PVALB,Parvalbumin alpha,18588,127,1.01 [0.88-1.15],0.9410802485691748
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PVR,Poliovirus receptor,18657,131,1.07 [0.70-1.65],0.7465795546629084
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PXDNL,Peroxidasin-like protein,15996,108,0.96 [0.69-1.35],0.8283338560511329
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PXN,Paxillin,18093,124,1.02 [0.75-1.37],0.9221086348944232
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PYDC1,Pyrin domain-containing protein 1,15602,101,1.30 [0.84-2.01],0.2345715979213583
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PYY,Peptide YY,15526,102,0.99 [0.82-1.19],0.884891663832857
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,PZP,Pregnancy zone protein,16076,107,1.05 [0.61-1.81],0.849173478396468
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,QDPR,Dihydropteridine reductase,18400,130,1.02 [0.70-1.47],0.9267355424907242
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,QPCT,Glutaminyl-peptide cyclotransferase,18503,127,1.27 [0.69-2.33],0.4359146257072044
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,QSOX1,Sulfhydryl oxidase 1,15753,103,1.09 [0.71-1.68],0.6998991700242447
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RAB10,Ras-related protein Rab-10,16050,105,1.17 [0.83-1.65],0.3681959862557148
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RAB11FIP3,Rab11 family-interacting protein 3,16050,105,1.19 [1.00-1.42],0.0545359538199611
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RAB27B,Ras-related protein Rab-27B,16050,105,1.16 [0.92-1.47],0.203051822111443
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RAB2B,Ras-related protein Rab-2B,15996,108,1.20 [0.89-1.61],0.226292829494681
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RAB33A,Ras-related protein Rab-33A,15526,102,1.20 [0.90-1.59],0.2101477647363545
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RAB37,Ras-related protein Rab-37,18183,127,0.98 [0.80-1.19],0.8211440944217977
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RAB39B,Ras-related protein Rab-39B,15526,102,1.20 [1.03-1.39],0.0163459258789223
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,15563,101,1.13 [0.86-1.47],0.3901753687367607
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RAB44,Ras-related protein Rab-44,15996,108,1.00 [0.67-1.49],0.9986377774978796
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RAB6A,Ras-related protein Rab-6A,18488,132,0.90 [0.63-1.28],0.5465860171510001
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RAB6B,Ras-related protein Rab-6B,18093,124,1.19 [0.89-1.61],0.2456494878445114
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RABEP1,Rab GTPase-binding effector protein 1,15698,103,1.14 [0.89-1.47],0.2840255617639283
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RABEPK,Rab9 effector protein with kelch motifs,18072,126,1.12 [0.87-1.44],0.3780937162427932
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RABGAP1L,Rab GTPase-activating protein 1-like,18183,127,0.94 [0.71-1.23],0.6301106427359839
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RAC3,Ras-related C3 botulinum toxin substrate 3,15643,104,1.14 [0.89-1.44],0.2955959611370065
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RAD23B,UV excision repair protein RAD23 homolog B,18072,126,0.87 [0.61-1.23],0.4312629673212038
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RAD51,DNA repair protein RAD51 homolog 1,15770,101,1.12 [0.83-1.52],0.4672682162325949
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RALB,Ras-related protein Ral-B,15570,103,1.05 [0.56-1.98],0.8784552885190327
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RALY,RNA-binding protein Raly,15996,108,1.26 [0.93-1.72],0.1373306148773543
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RANBP1,Ran-specific GTPase-activating protein,15602,101,0.82 [0.56-1.19],0.2974831962251106
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RANBP2,E3 SUMO-protein ligase RanBP2,15563,101,0.84 [0.46-1.52],0.5641669669700826
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RANGAP1,Ran GTPase-activating protein 1,18072,126,0.94 [0.66-1.32],0.705313631154634
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RAP1A,Ras-related protein Rap-1A,15570,103,1.05 [0.80-1.38],0.7235263511975665
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RAPGEF2,Rap guanine nucleotide exchange factor 2,15770,101,1.24 [0.88-1.75],0.2253147828974311
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RARRES1,Retinoic acid receptor responder protein 1,18072,126,1.23 [0.81-1.86],0.328731734695784
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RARRES2,Retinoic acid receptor responder protein 2,18613,129,1.22 [0.90-1.65],0.2101687546179961
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RASA1,Ras GTPase-activating protein 1,18093,124,1.21 [0.77-1.92],0.4118482968611689
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,15494,101,1.24 [0.82-1.88],0.3027483542696367
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RASSF2,Ras association domain-containing protein 2,18072,126,1.08 [0.83-1.39],0.5795415769295733
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RBFOX3,RNA binding protein fox-1 homolog 3,16031,108,1.65 [1.16-2.36],0.0053682717880796
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RBKS,Ribokinase,18065,122,0.94 [0.68-1.29],0.6886089116525562
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RBM17,Splicing factor 45,16031,108,1.02 [0.80-1.29],0.8834289577642873
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RBM19,Probable RNA-binding protein 19,15526,102,1.14 [0.77-1.67],0.5132354497767475
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RBM25,RNA-binding protein 25,15494,101,1.18 [0.80-1.76],0.3972838250900643
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RBP1,Retinol-binding protein 1,15643,104,1.13 [0.90-1.42],0.3037521083358525
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RBP2,Retinol-binding protein 2,18402,129,1.23 [1.01-1.50],0.0351210310520294
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RBP5,Retinol-binding protein 5,18402,129,1.15 [0.86-1.53],0.3376260921563166
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RBP7,Retinoid-binding protein 7,16000,108,1.35 [1.05-1.73],0.0188257767859333
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RBPMS,RNA-binding protein with multiple splicing,15570,103,1.01 [0.76-1.35],0.9470329163112358
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RBPMS2,RNA-binding protein with multiple splicing 2,15602,101,1.27 [1.05-1.52],0.0124658552481148
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RCC1,Regulator of chromosome condensation,15996,108,1.18 [0.85-1.63],0.3278236199992493
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RCOR1,REST corepressor 1,18163,124,0.89 [0.58-1.35],0.5698953338499517
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,15602,101,1.99 [0.83-4.81],0.1245692945834066
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,REEP4,Receptor expression-enhancing protein 4,16031,108,1.27 [0.97-1.67],0.0822480790414418
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,REG1A,Lithostathine-1-alpha,18404,128,1.39 [1.04-1.87],0.026387873094304
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,REG1B,Lithostathine-1-beta,18719,128,1.29 [1.00-1.67],0.0495272189354247
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,REG3A,Regenerating islet-derived protein 3-alpha,18719,128,1.03 [0.80-1.32],0.8320020882594994
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,REG3G,Regenerating islet-derived protein 3-gamma,15996,108,1.26 [0.81-1.95],0.3097927201215853
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,REG4,Regenerating islet-derived protein 4,18492,130,1.06 [0.78-1.44],0.7271718997810039
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RELB,Transcription factor RelB,15570,103,1.03 [0.69-1.53],0.8996483370584513
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RELT,Tumor necrosis factor receptor superfamily member 19L,18493,131,2.17 [1.34-3.51],0.0016771293185348
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,REN,Renin,18492,130,1.04 [0.86-1.26],0.6687425521084727
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,REPS1,RalBP1-associated Eps domain-containing protein 1,15570,103,1.24 [0.80-1.92],0.3438695075982387
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,REST,RE1-silencing transcription factor,15494,101,1.02 [0.59-1.79],0.9369241083783896
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,18402,129,0.74 [0.48-1.13],0.1590421224303667
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RETN,Resistin,18456,127,1.36 [0.97-1.90],0.0753134665759784
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,REXO2,"Oligoribonuclease, mitochondrial",15526,102,0.86 [0.55-1.33],0.4872552006373839
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RFC4,Replication factor C subunit 4,15996,108,0.95 [0.39-2.28],0.9021467625220404
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RGCC,Regulator of cell cycle RGCC,16031,108,1.06 [0.83-1.34],0.6458163044735981
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,15770,101,1.06 [0.80-1.40],0.7068086187425662
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RGMA,Repulsive guidance molecule A,18657,131,1.60 [0.99-2.59],0.0563269269305719
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RGMB,RGM domain family member B,18657,131,2.36 [1.39-3.98],0.0013829722304007
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RGS10,Regulator of G-protein signaling 10,16031,108,1.13 [0.84-1.54],0.4213771680902825
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RGS8,Regulator of G-protein signaling 8,18183,127,0.79 [0.59-1.06],0.1199927598601755
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RHOC,Rho-related GTP-binding protein RhoC,18245,127,1.06 [0.93-1.21],0.3991125781374141
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RICTOR,Rapamycin-insensitive companion of mTOR,15570,103,1.07 [0.73-1.56],0.7356611137672937
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,15698,103,1.12 [0.76-1.65],0.5602227415364418
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RILP,Rab-interacting lysosomal protein,18615,128,0.92 [0.70-1.20],0.5280918561468568
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RILPL2,RILP-like protein 2,16050,105,1.14 [0.94-1.38],0.1949251456452873
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,15526,102,1.14 [0.89-1.45],0.2991231800307191
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RLN1,Prorelaxin H1,16031,108,1.06 [0.72-1.54],0.7776848430052371
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RLN2,Prorelaxin H2,15674,103,1.32 [0.96-1.81],0.085127041518843
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RNASE1,Ribonuclease pancreatic,16073,108,1.44 [0.72-2.91],0.3031568323236925
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RNASE10,Inactive ribonuclease-like protein 10,15602,101,1.18 [0.80-1.75],0.3986812090045408
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RNASE3,Eosinophil cationic protein,18402,129,0.94 [0.82-1.09],0.4285930468775284
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RNASE4,Ribonuclease 4,15566,105,2.06 [1.12-3.78],0.020558898838566
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RNASE6,Ribonuclease K6,15966,108,1.51 [0.98-2.32],0.0602892103687492
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RNASEH2A,Ribonuclease H2 subunit A,16031,108,1.09 [0.77-1.54],0.6457253403058147
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RNASET2,Ribonuclease T2,18633,127,1.83 [1.04-3.22],0.035025969121453
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RNF149,E3 ubiquitin-protein ligase RNF149,15602,101,1.79 [0.97-3.30],0.0617088251341101
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RNF168,E3 ubiquitin-protein ligase RNF168,15570,103,0.93 [0.57-1.51],0.7676627370460933
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RNF31,E3 ubiquitin-protein ligase RNF31,15570,103,1.37 [0.93-2.02],0.1086435835967994
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RNF4,E3 ubiquitin-protein ligase RNF4,15770,101,1.00 [0.76-1.33],0.9973945202050778
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RNF41,E3 ubiquitin-protein ligase NRDP1,18072,126,1.08 [0.85-1.37],0.541472321655268
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RNF43,E3 ubiquitin-protein ligase RNF43,15770,101,1.10 [0.82-1.49],0.526011662224098
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RNF5,E3 ubiquitin-protein ligase RNF5,15602,101,1.08 [0.82-1.41],0.5892464259868662
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ROBO1,Roundabout homolog 1,18492,130,1.11 [0.57-2.15],0.7592856885283985
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ROBO2,Roundabout homolog 2,18657,131,0.82 [0.41-1.65],0.5763368271796421
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ROBO4,Roundabout homolog 4,15602,101,1.47 [0.50-4.32],0.479875365558816
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,18492,130,1.76 [1.08-2.87],0.0231790359332053
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RP2,Protein XRP2,18402,129,1.03 [0.71-1.48],0.8758064607046522
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RPA2,Replication protein A 32 kDa subunit,15570,103,1.35 [0.80-2.30],0.2629810803780404
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RPE,Ribulose-phosphate 3-epimerase,15770,101,1.03 [0.80-1.34],0.8033170598884509
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RPGR,X-linked retinitis pigmentosa GTPase regulator,15643,104,1.05 [0.67-1.65],0.8243969388102175
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RPL14,60S ribosomal protein L14,15602,101,1.06 [0.65-1.71],0.8248772576099004
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RPS10,40S ribosomal protein S10,15526,102,1.25 [0.84-1.86],0.2779333287815508
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RRAS,Ras-related protein R-Ras,15643,104,1.06 [0.92-1.23],0.4120849311673459
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RRM2,Ribonucleoside-diphosphate reductase subunit M2,18072,126,1.00 [0.71-1.41],0.9848194005686044
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,18072,126,0.95 [0.75-1.21],0.7034399157044009
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RRP15,RRP15-like protein,15563,101,1.18 [0.98-1.43],0.088978525028943
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RSPO1,R-spondin-1,18340,127,1.23 [0.77-1.95],0.3806693646968238
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RSPO3,R-spondin-3,18664,128,1.72 [0.99-3.00],0.0549621639618271
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RTBDN,Retbindin,18402,129,1.25 [0.73-2.15],0.4152881796454469
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RTKN2,Rhotekin-2,15526,102,0.83 [0.54-1.29],0.4103836736567167
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",16031,108,0.98 [0.81-1.20],0.8816165939510023
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RTN4R,Reticulon-4 receptor,18664,128,0.95 [0.59-1.53],0.8320573016930056
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RUVBL1,RuvB-like 1,18072,126,0.97 [0.83-1.14],0.7175819325271124
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RWDD1,RWD domain-containing protein 1,18657,131,1.02 [0.80-1.31],0.8453995846985186
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,RYR1,Ryanodine receptor 1,15526,102,0.52 [0.26-1.02],0.0573652862549401
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,S100A11,Protein S100-A11,18356,129,0.91 [0.64-1.29],0.5864798688461494
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,S100A12,Protein S100-A12,18220,125,0.94 [0.75-1.17],0.5663878379817051
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,S100A13,Protein S100-A13,15570,103,1.73 [1.08-2.78],0.023720802024929
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,S100A14,Protein S100-A14,16031,108,1.21 [0.87-1.68],0.2580824419217833
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,S100A16,Protein S100-A16,18063,124,1.09 [0.85-1.40],0.5092607782497639
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,S100A3,Protein S100-A3,15996,108,0.61 [0.33-1.12],0.1139754878444155
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,S100A4,Protein S100-A4,18535,130,0.90 [0.68-1.19],0.4605533040475917
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,S100G,Protein S100-G,16031,108,1.18 [0.83-1.67],0.3596663345978815
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,S100P,Protein S100-P,18163,124,1.12 [0.86-1.46],0.4006518089993828
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SAA4,Serum amyloid A-4 protein,16076,107,0.44 [0.14-1.43],0.1733473939552998
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SAFB2,Scaffold attachment factor B2,16031,108,1.32 [0.75-2.31],0.3372140630458901
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SAG,S-arrestin,15563,101,0.74 [0.50-1.10],0.1403248830802919
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SAMD9L,Sterile alpha motif domain-containing protein 9-like,18488,132,1.09 [0.89-1.35],0.3996541812576396
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SAP18,Histone deacetylase complex subunit SAP18,15770,101,1.08 [0.85-1.38],0.5052784076643329
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SARG,Specifically androgen-regulated gene protein,16000,104,1.11 [0.93-1.31],0.2561933270833439
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SART1,U4/U6.U5 tri-snRNP-associated protein 1,15526,102,1.39 [0.97-1.99],0.0724233464451041
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SAT1,Diamine acetyltransferase 1,15526,102,1.06 [0.73-1.53],0.7616309266938242
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SAT2,Thialysine N-epsilon-acetyltransferase,15770,101,1.22 [0.96-1.54],0.0990947629067377
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SATB1,DNA-binding protein SATB1,16031,108,0.86 [0.44-1.65],0.6466121149914994
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SBSN,Suprabasin,16032,108,1.33 [0.80-2.23],0.2755802458126405
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCAMP3,Secretory carrier-associated membrane protein 3,18402,129,1.04 [0.86-1.25],0.6740439323583332
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCARA5,Scavenger receptor class A member 5,18657,131,1.10 [0.65-1.85],0.7272935112246601
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCARB1,Scavenger receptor class B member 1,18093,124,0.85 [0.61-1.19],0.3516777126599563
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCARB2,Lysosome membrane protein 2,17986,123,1.88 [1.16-3.04],0.0098070024785696
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCARF1,Scavenger receptor class F member 1,18719,128,1.13 [0.78-1.63],0.5309703858002135
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCARF2,Scavenger receptor class F member 2,18657,131,1.70 [0.99-2.92],0.0539134596208692
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCG2,Secretogranin-2,18587,128,1.17 [0.72-1.90],0.5352882488618815
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCG3,Secretogranin-3,18492,130,1.19 [0.74-1.90],0.4693791725866577
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCGB1A1,Uteroglobin,18498,129,1.25 [0.92-1.70],0.1478405822998627
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCGB2A2,Mammaglobin-A,15526,102,1.41 [0.88-2.27],0.1516542166025961
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCGB3A1,Secretoglobin family 3A member 1,15698,103,1.49 [0.72-3.09],0.283676548127438
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCGB3A2,Secretoglobin family 3A member 2,18531,130,1.01 [0.82-1.23],0.9605290995790676
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCGN,Secretagogin,18183,127,1.67 [1.20-2.32],0.0023479636963574
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCIN,Adseverin,15563,101,1.15 [0.91-1.44],0.2389263857844275
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCLY,Selenocysteine lyase,18615,128,0.88 [0.62-1.24],0.4651269464043319
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCN2A,Sodium channel protein type 2 subunit alpha,15563,101,0.96 [0.64-1.44],0.8337183061669459
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCN2B,Sodium channel subunit beta-2,15643,104,0.78 [0.38-1.60],0.4950093511674556
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCN3A,Sodium channel protein type 3 subunit alpha,15643,104,0.67 [0.36-1.25],0.2111742974946878
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCN3B,Sodium channel subunit beta-3,15563,101,1.33 [0.97-1.81],0.0740549073897399
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCN4B,Sodium channel subunit beta-4,15602,101,1.24 [0.78-1.97],0.3551248498862176
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCP2,Non-specific lipid-transfer protein,18072,126,1.06 [0.87-1.30],0.5406003805532468
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCPEP1,Retinoid-inducible serine carboxypeptidase,15552,101,1.23 [0.84-1.79],0.2845820472159853
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCRG1,Scrapie-responsive protein 1,16050,105,1.99 [1.23-3.21],0.0049749491721774
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCRIB,Protein scribble homolog,15602,101,1.23 [1.03-1.45],0.0193125678755591
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCRN1,Secernin-1,18488,132,1.12 [0.85-1.48],0.4098791712393285
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SCT,Secretin,15643,104,1.37 [0.94-2.00],0.0968435720518908
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SDC1,Syndecan-1,18492,130,0.77 [0.51-1.17],0.2244603927521654
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SDC4,Syndecan-4,18492,130,0.76 [0.55-1.05],0.0972386490640955
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SDCCAG8,Serologically defined colon cancer antigen 8,15996,108,1.18 [1.01-1.39],0.0429087273105433
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SDHB,Succinate dehydrogenase,16000,108,1.04 [0.78-1.39],0.7806911468670348
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SDK2,Protein sidekick-2,15698,103,1.22 [0.75-1.98],0.4263534175387163
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SEC31A,Protein transport protein Sec31A,15602,101,1.18 [0.92-1.52],0.1978162048597764
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SEL1L,Protein sel-1 homolog 1,15602,101,1.37 [0.86-2.18],0.183497623240613
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SELE,E-selectin,18719,128,1.14 [0.83-1.57],0.407506787424584
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SELENOP,Selenoprotein P,16076,107,0.66 [0.29-1.50],0.3246601214595972
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SELL,L-selectin,16076,107,1.36 [0.60-3.10],0.4669970578200672
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SELP,P-selectin,18580,129,0.96 [0.72-1.27],0.7617856064182678
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SELPLG,P-selectin glycoprotein ligand 1,18488,132,0.81 [0.45-1.44],0.4706724796299515
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SEMA3F,Semaphorin-3F,18492,130,1.61 [0.89-2.91],0.1145533420290414
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SEMA3G,Semaphorin-3G,15698,103,1.41 [0.95-2.10],0.0920340704495613
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SEMA4C,Semaphorin-4C,18402,129,1.29 [0.79-2.11],0.3125216408644647
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SEMA4D,Semaphorin-4D,18657,131,1.02 [0.61-1.69],0.953393747855888
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SEMA6C,Semaphorin-6C,15570,103,1.34 [0.70-2.59],0.3741791983351532
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SEMA7A,Semaphorin-7A,18659,128,1.12 [0.63-2.01],0.6918599867954212
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SEPTIN3,Neuronal-specific septin-3,16031,108,0.98 [0.77-1.25],0.8988214595432302
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SEPTIN7,Septin-7,15770,101,1.08 [0.78-1.50],0.6213761592273883
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SEPTIN8,Septin-8,15991,107,1.34 [0.78-2.32],0.2865924512226261
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SEPTIN9,Septin-9,18402,129,1.28 [0.78-2.09],0.3333221297668831
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SERPINA1,Alpha-1-antitrypsin,15781,105,0.72 [0.07-7.69],0.7842061129541986
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SERPINA11,Serpin A11,18719,128,1.01 [0.69-1.49],0.9423186072535368
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SERPINA12,Serpin A12,17971,124,0.84 [0.69-1.03],0.087517385986114
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SERPINA3,Alpha-1-antichymotrypsin,16033,107,1.03 [0.30-3.54],0.962394286573925
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SERPINA4,Kallistatin,15787,106,0.74 [0.34-1.64],0.4637443333037602
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SERPINA5,Plasma serine protease inhibitor,15840,106,1.16 [0.64-2.09],0.6333913368954701
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SERPINA6,Corticosteroid-binding globulin,16076,107,0.73 [0.22-2.42],0.6053221493179228
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SERPINA7,Thyroxine-binding globulin,16076,107,0.53 [0.19-1.45],0.2149162188679249
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SERPINA9,Serpin A9,18324,129,0.88 [0.70-1.11],0.2653009463316183
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SERPINB1,Leukocyte elastase inhibitor,18437,130,1.06 [0.90-1.26],0.4780463149674718
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SERPINB5,Serpin B5,18163,124,0.95 [0.68-1.32],0.7588140356922323
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SERPINB6,Serpin B6,18595,131,1.09 [0.83-1.41],0.5433073006228717
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SERPINB8,Serpin B8,18712,130,0.96 [0.73-1.25],0.7377820450938396
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SERPINB9,Serpin B9,18340,127,1.38 [0.85-2.24],0.1943145790447448
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SERPINC1,Antithrombin-III,16051,107,0.98 [0.28-3.48],0.9731331766727276
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SERPIND1,Heparin cofactor 2,16051,107,0.59 [0.31-1.13],0.1120043642483826
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SERPINE1,Plasminogen activator inhibitor 1,18719,128,0.90 [0.71-1.13],0.358188012243174
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SERPINE2,Glia-derived nexin,16050,105,1.00 [0.75-1.34],0.9923020375837492
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SERPINF1,Pigment epithelium-derived factor,15838,105,1.00 [0.49-2.05],0.9977252509396884
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SERPINF2,Alpha-2-antiplasmin,15771,105,0.71 [0.17-2.94],0.6394520878577338
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SERPING1,Plasma protease C1 inhibitor,16051,107,1.09 [0.40-3.01],0.8652082677821862
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SERPINH1,Serpin H1,15770,101,1.17 [1.00-1.35],0.0448600225320742
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SERPINI1,Neuroserpin,15671,103,1.39 [0.73-2.66],0.3155343647334888
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SERPINI2,Serpin I2,16000,108,1.15 [0.83-1.60],0.392901652400911
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,18093,124,1.21 [0.96-1.52],0.1117207573014828
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SETMAR,Histone-lysine N-methyltransferase SETMAR,18270,124,1.02 [0.60-1.74],0.9442224226674816
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SEZ6,Seizure protein 6 homolog,15643,104,1.01 [0.54-1.89],0.9763272084819834
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SEZ6L,Seizure 6-like protein,18535,130,1.51 [0.86-2.66],0.1483729630695965
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SEZ6L2,Seizure 6-like protein 2,18402,129,1.59 [0.85-2.98],0.1451420784309454
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SF3B4,Splicing factor 3B subunit 4,18402,129,1.01 [0.82-1.25],0.9028784324232904
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SFRP1,Secreted frizzled-related protein 1,18268,122,1.26 [0.87-1.81],0.2168833686685637
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SFRP4,Secreted frizzled-related protein 4,15698,103,1.20 [0.73-1.95],0.4698085156106665
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SFTPA1,Pulmonary surfactant-associated protein A1,18072,126,1.05 [0.80-1.38],0.7332431191818063
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SFTPA2,Pulmonary surfactant-associated protein A2,18072,126,1.02 [0.75-1.39],0.8819551655527351
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SFTPD,Pulmonary surfactant-associated protein D,18492,130,1.04 [0.82-1.31],0.7457837228385285
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SGSH,N-sulphoglucosamine sulphohydrolase,15801,104,1.08 [0.77-1.50],0.6681175324768964
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SH2B3,SH2B adapter protein 3,18072,126,1.03 [0.88-1.21],0.7241325666374219
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SH2D1A,SH2 domain-containing protein 1A,18488,132,0.87 [0.65-1.16],0.3287444028327265
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,15563,101,0.94 [0.68-1.31],0.7349472221843283
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SH3BP1,SH3 domain-binding protein 1,16000,108,1.10 [0.78-1.54],0.583255617135675
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SH3GL3,Endophilin-A3,15674,100,1.02 [0.81-1.28],0.8567654520036029
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SH3GLB2,Endophilin-B2,16023,107,0.98 [0.74-1.30],0.8972865207328837
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SHBG,Sex hormone-binding globulin,16073,108,0.86 [0.57-1.28],0.4548863576729607
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SHC1,SHC-transforming protein 1,15494,101,0.89 [0.74-1.07],0.2201768917864476
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SHD,SH2 domain-containing adapter protein D,15498,102,0.94 [0.73-1.20],0.6048256890858128
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SHH,Sonic hedgehog protein,15570,103,0.68 [0.42-1.09],0.11131462154106
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SHISA5,Protein shisa-5,16062,108,1.61 [0.83-3.13],0.1571652524173761
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SHMT1,"Serine hydroxymethyltransferase, cytosolic",18531,130,0.94 [0.78-1.13],0.5016638335112629
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SHPK,Sedoheptulokinase,15770,101,1.31 [0.88-1.95],0.1778330918678838
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SIAE,Sialate O-acetylesterase,18506,130,1.07 [0.76-1.51],0.6797834313564863
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SIGLEC1,Sialoadhesin,18552,130,1.22 [0.84-1.79],0.3000689515662586
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SIGLEC10,Sialic acid-binding Ig-like lectin 10,18488,132,1.26 [0.79-2.02],0.3392559723384577
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SIGLEC15,Sialic acid-binding Ig-like lectin 15,18093,124,0.90 [0.71-1.15],0.3997433200968363
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SIGLEC5,Sialic acid-binding Ig-like lectin 5,18493,131,1.13 [0.97-1.32],0.1203693233704685
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SIGLEC6,Sialic acid-binding Ig-like lectin 6,18664,128,1.78 [1.12-2.82],0.0146274897071578
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SIGLEC7,Sialic acid-binding Ig-like lectin 7,18492,130,0.81 [0.46-1.44],0.4726762526558251
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SIGLEC8,Sialic acid-binding Ig-like lectin 8,15602,101,1.37 [0.90-2.11],0.1460035931694009
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SIGLEC9,Sialic acid-binding Ig-like lectin 9,18638,128,1.08 [0.63-1.83],0.7851874742749592
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SIL1,Nucleotide exchange factor SIL1,15602,101,1.10 [0.64-1.89],0.7209493665241403
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,18538,128,1.04 [0.79-1.38],0.7708022607123444
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SIRPB1,Signal-regulatory protein beta-1,18428,130,1.32 [0.95-1.83],0.095588280195502
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SIRT1,NAD-dependent protein deacetylase sirtuin-1,15570,103,0.97 [0.77-1.22],0.787093730124395
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SIRT2,NAD-dependent protein deacetylase sirtuin-2,18402,129,1.00 [0.84-1.20],0.9954436572379132
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",18093,124,0.79 [0.56-1.11],0.1731148325609794
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SIT1,Signaling threshold-regulating transmembrane adapter 1,18183,127,0.91 [0.68-1.22],0.5229104829217778
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SKAP1,Src kinase-associated phosphoprotein 1,18312,127,0.88 [0.70-1.09],0.2406076270102339
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SKAP2,Src kinase-associated phosphoprotein 2,18552,130,1.00 [0.86-1.16],0.9618696303860484
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SKIV2L,Helicase SKI2W,15526,102,0.95 [0.57-1.58],0.854429013846807
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLA2,Src-like-adapter 2,16031,108,1.03 [0.87-1.23],0.7019399868762306
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLAMF1,Signaling lymphocytic activation molecule,18183,127,1.06 [0.81-1.39],0.6513819541085735
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLAMF6,SLAM family member 6,18072,126,1.20 [0.79-1.83],0.3998124170734053
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLAMF7,SLAM family member 7,18488,132,1.02 [0.78-1.33],0.892957975238436
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLAMF8,SLAM family member 8,18072,126,1.06 [0.78-1.44],0.7149684244651611
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLC12A2,Solute carrier family 12 member 2,15526,102,1.46 [0.86-2.49],0.1644332222842023
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLC13A1,Solute carrier family 13 member 1,15996,108,0.98 [0.71-1.35],0.8942701908476387
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLC16A1,Monocarboxylate transporter 1,18093,124,1.29 [1.02-1.64],0.0325997412077104
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLC1A4,Neutral amino acid transporter A,15643,104,1.08 [0.76-1.52],0.6741453624602622
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLC27A4,Long-chain fatty acid transport protein 4,18093,124,1.10 [0.87-1.38],0.4230833710321457
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLC28A1,Sodium/nucleoside cotransporter 1,15494,101,0.81 [0.56-1.18],0.2732774818642383
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLC34A3,Sodium-dependent phosphate transport protein 2C,15494,101,1.04 [0.70-1.56],0.8431203266470638
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLC39A14,Zinc transporter ZIP14,18093,124,1.25 [0.80-1.94],0.3292019815664339
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLC39A5,Zinc transporter ZIP5,18488,132,1.00 [0.74-1.36],0.976606765636733
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLC44A4,Choline transporter-like protein 4,15643,104,0.95 [0.71-1.28],0.7367268643739755
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLC4A1,Band 3 anion transport protein,16062,108,0.73 [0.49-1.09],0.1187093626220824
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLC51B,Organic solute transporter subunit beta,15526,102,1.09 [0.84-1.41],0.5073334470064207
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,15698,103,1.10 [0.88-1.37],0.4034028934608749
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,16000,108,0.89 [0.60-1.33],0.5782848640401794
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",15494,101,0.85 [0.58-1.23],0.3848917078607203
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLIT2,Slit homolog 2 protein,18093,124,1.10 [0.83-1.46],0.520439269346018
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLITRK1,SLIT and NTRK-like protein 1,15570,103,1.05 [0.58-1.88],0.8715083773379545
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLITRK2,SLIT and NTRK-like protein 2,18664,128,0.89 [0.60-1.31],0.5447490087741643
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLITRK6,SLIT and NTRK-like protein 6,18163,124,1.32 [0.85-2.06],0.2188327279609587
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLK,STE20-like serine/threonine-protein kinase,15770,101,0.94 [0.73-1.22],0.6671965147119084
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLMAP,Sarcolemmal membrane-associated protein,16000,108,1.26 [1.02-1.57],0.032203275783764
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SLURP1,Secreted Ly-6/uPAR-related protein 1,15949,108,1.46 [0.94-2.26],0.0896423067215215
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SMAD1,Mothers against decapentaplegic homolog 1,18072,126,1.08 [0.89-1.30],0.428814820182941
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SMAD2,Mothers against decapentaplegic homolog 2,15996,108,1.06 [0.81-1.38],0.6839275748429855
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SMAD3,Mothers against decapentaplegic homolog 3,15996,108,1.33 [0.95-1.86],0.0943496216850595
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SMAD5,Mothers against decapentaplegic homolog 5,18402,129,0.74 [0.34-1.60],0.4415692280796344
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SMARCA2,Probable global transcription activator SNF2L2,18093,124,0.93 [0.74-1.17],0.5389212024104191
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SMC3,Structural maintenance of chromosomes protein 3,15494,101,0.95 [0.65-1.39],0.8093857148700494
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SMNDC1,Survival of motor neuron-related-splicing factor 30,16000,108,1.24 [0.98-1.57],0.079853575919223
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SMOC1,SPARC-related modular calcium-binding protein 1,18664,128,0.98 [0.60-1.59],0.9327655195443036
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SMOC2,SPARC-related modular calcium-binding protein 2,18552,130,1.64 [1.10-2.43],0.0145836417255314
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SMPD1,Sphingomyelin phosphodiesterase,18564,131,1.17 [0.87-1.57],0.3028595037466606
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SMPD3,Sphingomyelin phosphodiesterase 3,15570,103,1.02 [0.73-1.41],0.9222282407766428
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,18518,130,1.05 [0.83-1.32],0.707469561539104
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,15996,108,1.14 [0.93-1.39],0.1991386085508975
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SMS,Spermine synthase,15563,101,1.23 [0.96-1.58],0.1001260927520042
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SMTN,Smoothelin,15991,107,1.30 [1.08-1.57],0.0054196841952427
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SNAP23,Synaptosomal-associated protein 23,18492,130,1.00 [0.84-1.20],0.9929771481647612
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SNAP25,Synaptosomal-associated protein 25,15563,101,1.18 [0.80-1.75],0.4023905132440086
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SNAP29,Synaptosomal-associated protein 29,18535,130,1.00 [0.85-1.19],0.986368094565744
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SNAPIN,SNARE-associated protein Snapin,16031,108,1.37 [1.02-1.85],0.0389269467156728
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SNCA,Alpha-synuclein,15698,103,1.14 [0.96-1.34],0.1305262679086516
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SNCG,Gamma-synuclein,18340,127,1.41 [1.10-1.80],0.0068281568790243
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",15602,101,1.28 [0.73-2.24],0.3921325514610703
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SNRPB2,U2 small nuclear ribonucleoprotein B'',16023,107,1.22 [0.93-1.61],0.1527610789154714
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SNU13,NHP2-like protein 1,15526,102,1.11 [0.84-1.47],0.4689207380132086
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SNX15,Sorting nexin-15,15698,103,0.93 [0.65-1.34],0.7074158324479207
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SNX18,Sorting nexin-18,16000,108,1.33 [0.93-1.90],0.1185219010184353
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SNX2,Sorting nexin-2,15996,108,1.19 [0.99-1.44],0.0686439473579391
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SNX5,Sorting nexin-5,15602,101,1.46 [0.82-2.60],0.1960193263264309
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SNX9,Sorting nexin-9,18492,130,1.12 [0.89-1.41],0.3306923727563902
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SOD1,Superoxide dismutase [Cu-Zn],18148,126,1.02 [0.73-1.42],0.9223520142143028
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SOD2,"Superoxide dismutase [Mn], mitochondrial",18493,131,1.37 [0.93-2.04],0.1125827267655033
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SOD3,Extracellular superoxide dismutase,16073,108,1.10 [0.84-1.44],0.4945256936371777
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SORBS1,Sorbin and SH3 domain-containing protein 1,16031,108,1.42 [1.03-1.94],0.0316814551174926
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SORCS2,VPS10 domain-containing receptor SorCS2,18072,126,1.41 [0.89-2.23],0.143236870119773
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SORD,Sorbitol dehydrogenase,18582,128,0.87 [0.69-1.09],0.2179888382587342
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SORT1,Sortilin,18472,130,0.92 [0.61-1.40],0.7064503759600615
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SOST,Sclerostin,18472,130,1.17 [0.78-1.75],0.4403686097441335
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,15643,104,1.00 [0.69-1.47],0.9857227290664188
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SOX2,Transcription factor SOX-2,15993,108,0.63 [0.28-1.43],0.2743874176564568
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SOX9,Transcription factor SOX-9,15643,104,0.84 [0.41-1.71],0.6346938301723264
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,16031,108,1.37 [0.81-2.34],0.2434889399152685
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPAG1,Sperm-associated antigen 1,16031,108,1.10 [0.83-1.45],0.5025310938019676
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPARC,SPARC,18535,130,0.89 [0.72-1.10],0.2760914392944418
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPARCL1,SPARC-like protein 1,18516,129,1.31 [0.79-2.15],0.2947343906025544
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPART,Spartin,15698,103,1.22 [0.96-1.55],0.1099439937754651
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPESP1,Sperm equatorial segment protein 1,16050,105,1.14 [0.67-1.95],0.6219700896374191
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPINK1,Serine protease inhibitor Kazal-type 1,18493,131,1.55 [1.08-2.23],0.0179864105640665
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPINK2,Serine protease inhibitor Kazal-type 2,15698,103,1.47 [0.87-2.48],0.1517133548193405
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPINK4,Serine protease inhibitor Kazal-type 4,18488,132,0.99 [0.77-1.26],0.9109372799052152
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPINK5,Serine protease inhibitor Kazal-type 5,18493,131,1.31 [0.85-2.03],0.2245869853203759
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPINK6,Serine protease inhibitor Kazal-type 6,18664,128,1.24 [0.92-1.68],0.1587752591355571
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPINK8,Serine protease inhibitor Kazal-type 8,15526,102,0.90 [0.51-1.60],0.7244342833406949
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPINT1,Kunitz-type protease inhibitor 1,18424,128,1.13 [0.59-2.14],0.7142157230309643
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPINT2,Kunitz-type protease inhibitor 2,18552,130,0.95 [0.64-1.42],0.814111796175963
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPINT3,Kunitz-type protease inhibitor 3,16000,108,0.95 [0.85-1.06],0.3598381636765596
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPOCK1,Testican-1,18340,127,0.94 [0.51-1.73],0.8427167052487903
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPON1,Spondin-1,18492,130,1.56 [0.98-2.51],0.063085982640168
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPON2,Spondin-2,18411,130,1.35 [0.85-2.14],0.2044025142379246
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPP1,Osteopontin,18689,128,1.03 [0.71-1.50],0.8604218660192191
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",15570,103,1.42 [0.97-2.09],0.0734210087706909
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPRING1,SREBP regulating gene protein,15494,101,1.12 [0.85-1.47],0.4333803315701217
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPRR1B,Cornifin-B,15770,101,0.94 [0.74-1.19],0.598603149248883
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPRR3,Small proline-rich protein 3,16023,107,1.04 [0.77-1.41],0.796752602030228
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPRY2,Protein sprouty homolog 2,18183,127,1.10 [0.93-1.30],0.2801070143119454
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",15563,101,0.75 [0.39-1.44],0.3862564298010875
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SPTLC1,Serine palmitoyltransferase 1,16023,107,1.15 [0.76-1.76],0.5078770057500863
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SRC,Proto-oncogene tyrosine-protein kinase Src,18506,130,1.04 [0.91-1.18],0.5843132445275974
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SRP14,Signal recognition particle 14 kDa protein,18402,129,1.06 [0.82-1.37],0.6406759377128031
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SRPK2,SRSF protein kinase 2,18488,132,1.06 [0.89-1.27],0.5099737665316553
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SRPX,Sushi repeat-containing protein SRPX,16050,105,1.23 [0.75-2.02],0.4184463519716253
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SSB,Lupus La protein,18093,124,1.04 [0.80-1.35],0.7620193236755203
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",15570,103,1.08 [0.64-1.83],0.7654849561811501
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,18472,130,0.95 [0.83-1.08],0.4044008285486307
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,18580,129,0.96 [0.67-1.39],0.8296264017865208
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SSH3,Protein phosphatase Slingshot homolog 3,15494,101,1.62 [0.93-2.82],0.0861772432915544
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SSNA1,Sjoegren syndrome nuclear autoantigen 1,16000,108,0.89 [0.61-1.29],0.5448368678008424
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ST13,Hsc70-interacting protein,15698,103,0.92 [0.65-1.31],0.6502225592679098
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",18402,129,1.21 [0.87-1.68],0.2665687798217969
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",18719,128,1.09 [0.66-1.82],0.736800906612276
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",15570,103,0.93 [0.63-1.38],0.717950195406976
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,STAB2,Stabilin-2,16062,108,1.03 [0.53-2.00],0.9325722418991912
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,STAM,Signal transducing adapter molecule 1,15996,108,1.38 [0.89-2.15],0.1452592235362168
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,STAMBP,STAM-binding protein,18312,127,1.07 [0.83-1.37],0.6136285727612608
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,STAT2,Signal transducer and activator of transcription 2,15570,103,1.14 [0.89-1.46],0.297713318856956
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,STAT5B,Signal transducer and activator of transcription 5B,18402,129,0.97 [0.87-1.09],0.6348331856556122
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,15494,101,1.15 [0.88-1.49],0.3057096262888333
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,STC1,Stanniocalcin-1,18657,131,1.48 [1.07-2.04],0.0163468433274799
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,STC2,Stanniocalcin-2,18471,131,1.34 [0.69-2.60],0.3925333414014093
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,STEAP4,Metalloreductase STEAP4,15563,101,0.94 [0.70-1.25],0.6568507371973912
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,STIP1,Stress-induced-phosphoprotein 1,18457,130,1.08 [0.85-1.38],0.5046304969054282
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,STK11,Serine/threonine-protein kinase STK11,18163,124,1.10 [0.88-1.37],0.4055390400237108
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,STK24,Serine/threonine-protein kinase 24,18093,124,1.18 [0.92-1.53],0.1975226389966224
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,STK4,Serine/threonine-protein kinase 4,18492,130,1.03 [0.86-1.23],0.7769036417213845
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,STOML2,"Stomatin-like protein 2, mitochondrial",15494,101,1.08 [0.89-1.30],0.4507956482229527
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,STX16,Syntaxin-16,18072,126,0.94 [0.70-1.25],0.6587612218099046
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,STX1B,Syntaxin-1B,15643,104,1.42 [1.03-1.96],0.0328071200633895
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,STX3,Syntaxin-3,16023,107,0.83 [0.49-1.41],0.4954369887290021
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,STX4,Syntaxin-4,18402,129,1.18 [0.94-1.49],0.1600155816957635
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,STX5,Syntaxin-5,15570,103,0.89 [0.53-1.49],0.6644994252885899
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,STX6,Syntaxin-6,18072,126,1.11 [0.88-1.39],0.3741574435285655
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,STX7,Syntaxin-7,15570,103,1.08 [0.73-1.59],0.7063606291792863
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,STX8,Syntaxin-8,18488,132,1.10 [0.80-1.51],0.5613131270617491
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,STXBP1,Syntaxin-binding protein 1,16031,108,1.14 [0.90-1.44],0.2871075518769455
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,STXBP3,Syntaxin-binding protein 3,18072,126,0.99 [0.69-1.44],0.9740747406686469
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SUGP1,SURP and G-patch domain-containing protein 1,16000,108,1.66 [1.12-2.46],0.0111326412254022
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SUGT1,Protein SGT1 homolog,18072,126,1.05 [0.86-1.28],0.6299674815001111
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SULT1A1,Sulfotransferase 1A1,18657,131,1.01 [0.89-1.13],0.9105997668626196
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SULT2A1,Bile salt sulfotransferase,18488,132,1.13 [0.87-1.47],0.3635105627975207
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SUMF1,Formylglycine-generating enzyme,15570,103,1.09 [0.83-1.43],0.5225539183974557
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,18657,131,1.13 [0.83-1.52],0.4382500454649344
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SUOX,"Sulfite oxidase, mitochondrial",16031,108,0.95 [0.70-1.28],0.7187320589210919
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SUSD1,Sushi domain-containing protein 1,18163,124,1.24 [0.88-1.73],0.2133947811556358
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SUSD2,Sushi domain-containing protein 2,18493,131,1.27 [0.74-2.18],0.3894033660808614
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SUSD4,Sushi domain-containing protein 4,15996,108,1.13 [0.71-1.80],0.5945896862429029
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SUSD5,Sushi domain-containing protein 5,15627,103,0.99 [0.56-1.75],0.9696742664843204
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SV2A,Synaptic vesicle glycoprotein 2A,15643,104,1.15 [0.86-1.52],0.3468007279568883
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SWAP70,Switch-associated protein 70,16000,108,1.50 [1.02-2.22],0.0403470278644851
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SYAP1,Synapse-associated protein 1,15698,103,1.18 [0.86-1.63],0.3120727972907329
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,15563,101,0.75 [0.50-1.12],0.1609997403302357
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SYT1,Synaptotagmin-1,16023,107,1.27 [0.89-1.80],0.1906729014601327
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,SYTL4,Synaptotagmin-like protein 4,16050,105,1.21 [0.94-1.54],0.1343044251024698
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,15770,101,1.14 [0.95-1.37],0.1725195773560563
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TACC3,Transforming acidic coiled-coil-containing protein 3,18402,129,0.99 [0.86-1.13],0.8414482186726977
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TACSTD2,Tumor-associated calcium signal transducer 2,16382,108,1.43 [0.78-2.62],0.252966952726916
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TADA3,Transcriptional adapter 3,15996,108,1.52 [1.01-2.28],0.0436971206627218
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TAFA5,Chemokine-like protein TAFA-5,18402,129,1.51 [0.98-2.30],0.0591940527686465
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TAGLN3,Transgelin-3,15494,101,0.80 [0.58-1.12],0.1993189991410192
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TALDO1,Transaldolase,16014,108,1.17 [0.77-1.76],0.4663005805643807
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TANK,TRAF family member-associated NF-kappa-B activator,18183,127,1.02 [0.82-1.28],0.8446703723654158
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TAP1,Antigen peptide transporter 1,15770,101,1.06 [0.78-1.45],0.706221129431954
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TARBP2,RISC-loading complex subunit TARBP2,18093,124,1.14 [0.93-1.40],0.2034188530072202
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",15643,104,1.17 [0.94-1.45],0.154231019879396
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",15996,108,1.15 [0.73-1.82],0.5457181653072614
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TAX1BP1,Tax1-binding protein 1,16023,107,1.39 [1.05-1.82],0.0193632583997616
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TBC1D17,TBC1 domain family member 17,18093,124,1.05 [0.73-1.51],0.8097792795073544
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TBC1D23,TBC1 domain family member 23,18402,129,1.03 [0.86-1.22],0.7719936638093792
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TBC1D5,TBC1 domain family member 5,18488,132,1.09 [0.90-1.32],0.3730571105341994
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TBCA,Tubulin-specific chaperone A,15698,103,1.12 [0.89-1.41],0.3195830828346408
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TBCB,Tubulin-folding cofactor B,18340,127,1.02 [0.87-1.19],0.8339328679725456
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TBCC,Tubulin-specific chaperone C,18340,127,1.01 [0.83-1.23],0.901718464498528
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TBL1X,F-box-like/WD repeat-containing protein TBL1X,18072,126,1.13 [0.94-1.37],0.1965199761950191
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TBR1,T-box brain protein 1,15643,104,1.17 [0.83-1.64],0.3627393612423841
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TCL1A,T-cell leukemia/lymphoma protein 1A,18317,127,0.93 [0.79-1.08],0.3323184953143495
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TCL1B,T-cell leukemia/lymphoma protein 1B,18163,124,0.84 [0.65-1.07],0.1557473633031064
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TCN1,Transcobalamin-1,15758,108,0.94 [0.54-1.63],0.8305856866608919
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TCN2,Transcobalamin-2,18689,128,1.31 [0.80-2.16],0.286054174031271
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TCOF1,Treacle protein,16050,105,0.73 [0.39-1.39],0.3394196354193465
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TCP11,T-complex protein 11 homolog,15770,101,0.92 [0.63-1.33],0.6507275399327509
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TCTN3,Tectonic-3,16050,105,1.04 [0.56-1.92],0.912312702228038
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TDGF1,Teratocarcinoma-derived growth factor 1,18093,124,1.01 [0.91-1.13],0.8118604528945831
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TDO2,"Tryptophan 2,3-dioxygenase",15643,104,0.83 [0.48-1.44],0.5082336401315608
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TDP1,Tyrosyl-DNA phosphodiesterase 1,15996,108,1.14 [0.92-1.42],0.2384166049439267
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TDRKH,Tudor and KH domain-containing protein,18093,124,1.12 [0.93-1.34],0.2453274278331171
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TEF,Thyrotroph embryonic factor,15526,102,0.94 [0.59-1.48],0.7810579309543668
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TEK,Angiopoietin-1 receptor,18535,130,1.34 [0.67-2.70],0.4058125241759895
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TERF1,Telomeric repeat-binding factor 1,15570,103,1.13 [0.59-2.16],0.716114233668623
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TET2,Methylcytosine dioxygenase TET2,15741,101,0.99 [0.82-1.20],0.9049645762049804
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TEX101,Testis-expressed protein 101,15643,104,0.92 [0.67-1.25],0.5907799290709277
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TEX33,Testis-expressed protein 33,15770,101,1.21 [0.80-1.84],0.3705376082801559
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TF,Serotransferrin,16076,107,0.59 [0.25-1.39],0.2257841648076839
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TFAP2A,Transcription factor AP-2-alpha,15563,101,1.05 [0.78-1.42],0.7481026109638248
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TFF1,Trefoil factor 1,18417,131,1.06 [0.87-1.28],0.5826128285643213
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TFF2,Trefoil factor 2,18531,130,1.08 [0.82-1.42],0.5766565131958462
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TFF3,Trefoil factor 3,18497,128,1.33 [0.90-1.94],0.1479501971453838
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TFPI,Tissue factor pathway inhibitor,18467,129,1.00 [0.60-1.67],0.9856693953522528
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TFPI2,Tissue factor pathway inhibitor 2,18481,130,0.97 [0.64-1.48],0.8885436867139628
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TFRC,Transferrin receptor protein 1,18581,129,1.23 [0.82-1.86],0.3127645297668543
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TG,Thyroglobulin,15996,108,0.93 [0.77-1.12],0.4514345489085603
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TGFA,Protransforming growth factor alpha,18488,132,1.03 [0.73-1.45],0.8809691968937671
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TGFB1,Transforming growth factor beta-1 proprotein,18678,129,1.12 [0.75-1.67],0.5773146577562319
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TGFB2,Transforming growth factor beta-2 proprotein,15996,108,0.97 [0.68-1.38],0.8705253472927823
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TGFBI,Transforming growth factor-beta-induced protein ig-h3,18409,128,1.48 [0.83-2.65],0.1880620812123907
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TGFBR1,TGF-beta receptor type-1,15570,103,1.54 [0.79-3.00],0.2090270972325116
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TGFBR2,TGF-beta receptor type-2,18535,130,1.97 [1.30-2.98],0.0013351222459751
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TGFBR3,Transforming growth factor beta receptor type 3,18719,128,1.50 [0.89-2.53],0.129609578283269
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TGM2,Protein-glutamine gamma-glutamyltransferase 2,18460,130,0.91 [0.74-1.12],0.3654591322208871
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TGOLN2,Trans-Golgi network integral membrane protein 2,16073,108,1.32 [0.66-2.65],0.4371480069029945
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,THAP12,52 kDa repressor of the inhibitor of the protein kinase,15467,101,0.95 [0.75-1.20],0.6582021504593814
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,THBD,Thrombomodulin,18492,130,1.57 [0.98-2.54],0.063297897862861
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,THBS2,Thrombospondin-2,18493,131,1.29 [0.85-1.94],0.2323186599877271
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,THBS4,Thrombospondin-4,18526,129,1.19 [0.84-1.69],0.3161908392583554
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,THOP1,Thimet oligopeptidase,18409,130,0.75 [0.44-1.26],0.2780334879997974
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,THPO,Thrombopoietin,18163,124,1.05 [0.70-1.58],0.8131894087100899
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,THRAP3,Thyroid hormone receptor-associated protein 3,15526,102,1.09 [0.93-1.28],0.3086261570838481
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,THSD1,Thrombospondin type-1 domain-containing protein 1,15451,102,1.06 [0.61-1.86],0.8271774745153675
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,THTPA,Thiamine-triphosphatase,15957,108,1.17 [0.95-1.45],0.1500225068012651
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,THY1,Thy-1 membrane glycoprotein,18657,131,1.99 [1.17-3.37],0.0107091242840252
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TIA1,Nucleolysin TIA-1 isoform p40,17960,124,1.02 [0.89-1.16],0.7818552615973868
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TIE1,Tyrosine-protein kinase receptor Tie-1,18719,128,0.90 [0.63-1.28],0.5574891536158264
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",18065,124,1.01 [0.72-1.43],0.9433521821009564
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,15770,101,1.40 [0.97-2.02],0.0704838908115842
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,18580,129,1.21 [0.83-1.74],0.3189380137718759
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,16050,105,1.25 [0.79-1.96],0.3387859012392298
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,16023,107,1.23 [1.00-1.52],0.0519652038422795
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TIMP1,Metalloproteinase inhibitor 1,18322,127,1.63 [0.94-2.83],0.0831620025111821
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TIMP2,Metalloproteinase inhibitor 2,16050,105,1.19 [0.70-2.03],0.5151276725806623
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TIMP3,Metalloproteinase inhibitor 3,18552,130,0.92 [0.81-1.04],0.1650870881383682
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TIMP4,Metalloproteinase inhibitor 4,18493,131,1.46 [1.00-2.12],0.0483890952902436
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TINAGL1,Tubulointerstitial nephritis antigen-like,18443,130,1.20 [0.59-2.46],0.6123817031226334
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TJAP1,Tight junction-associated protein 1,18535,130,1.05 [0.87-1.27],0.5895600006948833
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TJP3,Tight junction protein ZO-3,15563,101,0.87 [0.53-1.42],0.5777637647445785
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TK1,"Thymidine kinase, cytosolic",15770,101,1.00 [0.65-1.54],0.9942343930730196
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TLR1,Toll-like receptor 1,15570,103,1.49 [0.76-2.91],0.248163667327134
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TLR2,Toll-like receptor 2,15770,101,1.00 [0.44-2.27],0.9906421871656756
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TLR3,Toll-like receptor 3,18712,130,0.93 [0.73-1.20],0.5866263062876937
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TLR4,Toll-like receptor 4,15570,103,2.33 [1.29-4.20],0.0050446684726334
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,15643,104,1.13 [0.82-1.56],0.4418462902318095
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TMED1,Transmembrane emp24 domain-containing protein 1,15770,101,0.76 [0.51-1.12],0.1667090753102094
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TMED10,Transmembrane emp24 domain-containing protein 10,15526,102,0.88 [0.54-1.43],0.6061608559920382
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TMED4,Transmembrane emp24 domain-containing protein 4,15526,102,1.08 [0.79-1.48],0.6307156449314822
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TMED8,Protein TMED8,16000,108,1.10 [0.91-1.31],0.322452892484091
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TMEM106A,Transmembrane protein 106A,15996,108,1.25 [0.98-1.58],0.0672558227602784
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TMEM132A,Transmembrane protein 132A,15602,101,0.92 [0.67-1.25],0.5791255859394694
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TMEM25,Transmembrane protein 25,16031,108,1.13 [0.78-1.63],0.516778791162623
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TMOD4,Tropomodulin-4,15494,101,0.94 [0.57-1.55],0.8148806742283438
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TMPRSS11B,Transmembrane protease serine 11B,15563,101,0.73 [0.53-1.01],0.0568092042571259
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TMPRSS11D,Transmembrane protease serine 11D,15991,107,1.03 [0.63-1.67],0.917076598186078
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TMPRSS15,Enteropeptidase,18402,129,1.04 [0.87-1.24],0.6409113515812517
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TMPRSS5,Transmembrane protease serine 5,18249,124,1.20 [0.79-1.83],0.3909011539352635
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TMSB10,Thymosin beta-10,18493,131,1.09 [0.89-1.34],0.4091963922101532
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNC,Tenascin,18580,129,1.17 [0.84-1.61],0.3524914970918523
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNF,Tumor necrosis factor,18138,124,1.05 [0.66-1.67],0.8420337280240529
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,16000,108,1.37 [1.00-1.88],0.0517677266338926
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,18183,127,1.06 [0.69-1.63],0.787231476089552
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,15698,103,1.09 [0.81-1.47],0.5607668427726411
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,18340,127,1.12 [0.69-1.83],0.647507092405459
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,18340,127,1.24 [0.97-1.58],0.082857124370527
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,18533,128,1.25 [0.90-1.73],0.191225414580829
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,18712,130,1.38 [0.93-2.04],0.1073918290950259
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,18462,130,1.26 [0.73-2.15],0.4021367097254118
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,18535,130,2.26 [1.52-3.35],5.13994348492447e-05
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,18492,130,1.64 [1.07-2.52],0.0230831666954213
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,18183,127,1.43 [0.98-2.10],0.0637610958731329
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,18492,130,1.78 [1.10-2.89],0.0187936507277016
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,15698,103,1.52 [0.96-2.43],0.0762874524520458
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,18664,128,2.22 [1.46-3.40],0.0002193760531616
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,18493,131,2.15 [1.36-3.41],0.0010835904187867
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,18493,131,1.48 [1.07-2.06],0.0189336210947307
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,18657,131,1.92 [1.12-3.29],0.0184062302961014
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,18678,129,1.30 [0.85-1.98],0.2238551826800706
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,18340,127,1.23 [0.94-1.60],0.1301242348387833
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,18657,131,1.04 [0.73-1.49],0.8115443383696155
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,18340,127,1.63 [1.16-2.29],0.004906528468432
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFSF10,Tumor necrosis factor ligand superfamily member 10,18712,130,0.81 [0.44-1.50],0.5074895546202562
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFSF11,Tumor necrosis factor ligand superfamily member 11,18488,132,0.95 [0.73-1.22],0.6672072361399726
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFSF12,Tumor necrosis factor ligand superfamily member 12,18712,130,0.93 [0.53-1.62],0.7939743683120881
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFSF13,Tumor necrosis factor ligand superfamily member 13,18552,130,0.83 [0.46-1.50],0.5375598067703542
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,18688,128,0.92 [0.51-1.67],0.7784313792230394
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFSF14,Tumor necrosis factor ligand superfamily member 14,18340,127,1.06 [0.81-1.39],0.6668407417224185
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNFSF8,Tumor necrosis factor ligand superfamily member 8,16062,108,1.03 [0.62-1.72],0.9025467500148862
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNIP1,TNFAIP3-interacting protein 1,16023,107,1.23 [1.01-1.51],0.0388046534488072
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNN,Tenascin-N,16062,108,0.79 [0.51-1.21],0.2745316260025213
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNNI3,"Troponin I, cardiac muscle",18163,124,0.97 [0.80-1.18],0.782195850146012
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNPO1,Transportin-1,15770,101,1.24 [0.73-2.10],0.4331250071637782
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNR,Tenascin-R,18340,127,1.25 [0.87-1.80],0.2323632562095433
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TNXB,Tenascin-X,18493,131,0.95 [0.52-1.75],0.8758944594973341
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,16050,105,1.25 [0.99-1.58],0.055429232148297
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TOP1,DNA topoisomerase 1,16000,108,1.17 [1.00-1.37],0.0540352591708617
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TOP1MT,"DNA topoisomerase I, mitochondrial",15494,101,1.14 [0.79-1.63],0.483656673468289
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TOP2B,DNA topoisomerase 2-beta,15570,103,1.12 [0.89-1.42],0.3297118508405419
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TOR1AIP1,Torsin-1A-interacting protein 1,15602,101,1.04 [0.74-1.47],0.8085731183265185
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TP53,Cellular tumor antigen p53,18072,126,1.03 [0.72-1.48],0.8546903356379372
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TP53BP1,TP53-binding protein 1,15570,103,0.99 [0.79-1.23],0.9095330535048004
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TP53I3,Quinone oxidoreductase PIG3,15355,100,1.28 [0.89-1.84],0.1890598778596836
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TP53INP1,Tumor protein p53-inducible nuclear protein 1,18163,124,0.80 [0.44-1.48],0.4854701373855923
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TP73,Tumor protein p73,15643,104,0.82 [0.47-1.44],0.493082687567432
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TPBGL,Trophoblast glycoprotein-like,15643,104,1.24 [0.84-1.83],0.2779391598721032
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TPD52L2,Tumor protein D54,15698,103,1.05 [0.88-1.25],0.5890177258040181
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TPK1,Thiamin pyrophosphokinase 1,16050,105,1.16 [0.59-2.28],0.6647449837059252
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TPM3,Tropomyosin alpha-3 chain,15526,102,1.01 [0.66-1.53],0.9689206495859825
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TPMT,Thiopurine S-methyltransferase,18072,126,1.16 [0.94-1.43],0.1593443170931843
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TPP1,Tripeptidyl-peptidase 1,18345,129,1.12 [0.80-1.56],0.5108846459944678
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TPPP2,Tubulin polymerization-promoting protein family member 2,15770,101,0.99 [0.77-1.27],0.9133843895028892
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TPPP3,Tubulin polymerization-promoting protein family member 3,18093,124,0.89 [0.58-1.39],0.6172814773968006
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TPR,Nucleoprotein TPR,15526,102,1.28 [0.98-1.67],0.0689305586618264
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TPRKB,EKC/KEOPS complex subunit TPRKB,15494,101,1.26 [1.03-1.54],0.0225735541437996
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TPSAB1,Tryptase alpha/beta-1,18685,129,0.96 [0.71-1.29],0.7971515280646984
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TPSD1,Tryptase delta,16031,108,0.59 [0.32-1.08],0.085576712843774
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TPSG1,Tryptase gamma,15570,103,0.80 [0.38-1.67],0.5462136303931252
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TPT1,Translationally-controlled tumor protein,18183,127,0.94 [0.73-1.21],0.6346082839411469
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TRAF2,TNF receptor-associated factor 2,18488,132,1.09 [0.87-1.36],0.4400563321483686
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TRAF3,"TNF receptor-associated factor 3, Isoform 2",15570,103,1.07 [0.66-1.72],0.7820773083713197
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,15526,102,0.96 [0.64-1.45],0.8448967745779181
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,15770,101,1.17 [0.96-1.42],0.1298751448321026
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TREH,Trehalase,16062,108,0.80 [0.63-1.01],0.0579478439416276
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TREM2,Triggering receptor expressed on myeloid cells 2,18462,130,1.11 [0.82-1.49],0.4987171482619327
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TREML1,Trem-like transcript 1 protein,16073,108,1.13 [0.80-1.60],0.4838770829591502
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TREML2,Trem-like transcript 2 protein,18493,131,1.50 [0.96-2.34],0.0771793781576576
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TRIAP1,TP53-regulated inhibitor of apoptosis 1,18664,128,1.10 [0.85-1.41],0.4667864491562994
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TRIM21,E3 ubiquitin-protein ligase TRIM21,18488,132,1.06 [0.85-1.31],0.6139413291066946
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TRIM24,Transcription intermediary factor 1-alpha,15743,101,1.16 [0.87-1.54],0.3113632062971768
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,16000,108,1.16 [0.98-1.38],0.083081141500453
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TRIM26,Tripartite motif-containing protein 26,15494,101,1.22 [0.92-1.61],0.1592923742774492
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TRIM40,E3 ubiquitin ligase TRIM40,15643,104,0.80 [0.61-1.06],0.1203169642555308
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TRIM5,Tripartite motif-containing protein 5,18488,132,1.01 [0.84-1.20],0.9484821231271736
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TRIM58,E3 ubiquitin-protein ligase TRIM58,15996,108,1.32 [1.07-1.63],0.0106351944232524
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TRPV3,Transient receptor potential cation channel subfamily V member 3,15526,102,1.48 [1.11-1.97],0.0072452186588273
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TSC1,Hamartin,15570,103,0.91 [0.68-1.20],0.4945828981623426
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TSC22D1,TSC22 domain family protein 1,16031,108,1.17 [0.89-1.53],0.2604306420305359
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TSHB,Thyrotropin subunit beta,18492,130,1.02 [0.81-1.27],0.8946632983402435
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TSLP,Thymic stromal lymphopoietin,18163,124,0.99 [0.76-1.31],0.9699473111980172
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TSNAX,Translin-associated protein X,15526,102,0.97 [0.60-1.59],0.912704292037832
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TSPAN1,Tetraspanin-1,18163,124,1.24 [1.06-1.44],0.0072363204613898
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TSPAN15,Tetraspanin-15,15526,102,1.11 [0.79-1.57],0.5491625591576623
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TSPAN7,Tetraspanin-7,15563,101,1.10 [0.93-1.32],0.2683629693783037
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TSPAN8,Tetraspanin-8,16000,108,1.10 [0.90-1.34],0.3636133713410358
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TSPYL1,Testis-specific Y-encoded-like protein 1,15570,103,1.00 [0.61-1.63],0.9991821175360536
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TST,Thiosulfate sulfurtransferase,18064,124,1.00 [0.81-1.24],0.9878088254535418
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TTF2,Transcription termination factor 2,15643,104,1.16 [0.80-1.69],0.4416853346929406
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TTN,Titin,15526,102,1.12 [0.87-1.45],0.3621983813791428
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TTR,Transthyretin,15913,107,0.38 [0.18-0.78],0.0091129945768931
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TUBB3,Tubulin beta-3 chain,15563,101,0.69 [0.35-1.36],0.2807829102233209
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TWF2,Twinfilin-2,16062,108,1.11 [0.90-1.38],0.3367635254050563
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TXK,Tyrosine-protein kinase TXK,15770,101,0.97 [0.75-1.26],0.8166568710234553
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TXLNA,Alpha-taxilin,18340,127,1.02 [0.85-1.22],0.8410550443623708
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TXN,Thioredoxin,15815,105,1.25 [0.84-1.86],0.2658692548720205
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TXNDC15,Thioredoxin domain-containing protein 15,18535,130,1.29 [0.74-2.26],0.3746990834397868
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TXNDC5,Thioredoxin domain-containing protein 5,18657,131,1.10 [0.88-1.38],0.4032128666994753
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TXNDC9,Thioredoxin domain-containing protein 9,16023,107,1.03 [0.72-1.46],0.8858434890620827
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TXNL1,Thioredoxin-like protein 1,15536,101,1.03 [0.86-1.23],0.7418227145043124
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",18493,131,1.02 [0.73-1.43],0.9071005857671688
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TYMP,Thymidine phosphorylase,18379,130,0.94 [0.74-1.19],0.6216417855790801
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TYRO3,Tyrosine-protein kinase receptor TYRO3,18492,130,1.85 [1.07-3.19],0.0269556550973361
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",15570,103,1.37 [1.00-1.87],0.0497124722640273
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,UBAC1,Ubiquitin-associated domain-containing protein 1,18402,129,0.91 [0.57-1.44],0.6770402497067547
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,UBE2B,Ubiquitin-conjugating enzyme E2 B,15996,108,1.09 [0.58-2.01],0.7954604246220642
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,16050,105,1.27 [0.94-1.72],0.1119575283039633
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,15570,103,1.11 [0.82-1.51],0.4899573864455397
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,UBQLN3,Ubiquilin-3,15526,102,0.87 [0.59-1.27],0.4618274113135995
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,UBXN1,UBX domain-containing protein 1,15698,103,1.14 [0.87-1.51],0.3477729346083775
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,16000,108,1.07 [0.94-1.23],0.2947446378863735
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,UGDH,UDP-glucose 6-dehydrogenase,15526,102,0.99 [0.81-1.20],0.9102513524402362
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,UHRF2,E3 ubiquitin-protein ligase UHRF2,15526,102,0.74 [0.39-1.40],0.3605468283373354
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ULBP2,UL16-binding protein 2,18340,127,1.70 [1.15-2.51],0.0079856031547405
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,UMOD,Uromodulin,18655,128,0.77 [0.58-1.02],0.0692867974936718
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,UNC5D,Netrin receptor UNC5D,15570,103,1.11 [0.54-2.27],0.7780487721539756
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,UNC79,Protein unc-79 homolog,15494,101,1.38 [1.01-1.88],0.0421604486424266
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,UNG,Uracil-DNA glycosylase,15996,108,1.20 [0.75-1.91],0.4494327765445657
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,UPB1,Beta-ureidopropionase,16050,105,1.01 [0.81-1.25],0.9428498101888054
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,UPK3A,Uroplakin-3a,15563,101,1.06 [0.72-1.55],0.7772942599116759
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,UPK3BL1,Uroplakin-3b-like protein 1,15732,101,1.05 [0.74-1.50],0.7882785047256404
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,UROD,Uroporphyrinogen decarboxylase,15698,103,0.92 [0.70-1.23],0.5910260766850315
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,UROS,Uroporphyrinogen-III synthase,15643,104,1.12 [0.86-1.46],0.4014415291920272
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,USO1,General vesicular transport factor p115,18402,129,1.02 [0.86-1.22],0.8200180595223501
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,USP25,Ubiquitin carboxyl-terminal hydrolase 25,15996,108,1.24 [0.96-1.60],0.09573325941179
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,USP28,Ubiquitin carboxyl-terminal hydrolase 28,16023,107,1.59 [1.11-2.29],0.0124833912818231
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,USP47,Ubiquitin carboxyl-terminal hydrolase 47,15526,102,1.06 [0.86-1.30],0.5942176173725323
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,USP8,Ubiquitin carboxyl-terminal hydrolase 8,18163,124,1.09 [0.92-1.29],0.3220061284820398
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,UXS1,UDP-glucuronic acid decarboxylase 1,18072,126,0.90 [0.65-1.24],0.513158042581372
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VAMP5,Vesicle-associated membrane protein 5,18163,124,0.78 [0.54-1.13],0.1843829593506744
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VAMP8,Vesicle-associated membrane protein 8,15570,103,1.16 [0.93-1.43],0.1866436840203371
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VASH1,Tubulinyl-Tyr carboxypeptidase 1,18488,132,1.01 [0.84-1.22],0.8860822455986711
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VASN,Vasorin,18221,127,1.35 [0.75-2.41],0.3122187774938992
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VASP,Vasodilator-stimulated phosphoprotein,16073,108,1.18 [0.91-1.51],0.2077491719740164
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,18402,129,1.28 [0.57-2.87],0.5501476774041139
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VAV3,Guanine nucleotide exchange factor VAV3,15563,101,1.22 [1.01-1.48],0.040015758835943
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VCAM1,Vascular cell adhesion protein 1,18558,129,1.47 [0.82-2.63],0.1932833480435817
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VCAN,Versican core protein,18657,131,1.73 [1.04-2.89],0.0349659799773349
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VCPKMT,Protein-lysine methyltransferase METTL21D,15494,101,1.13 [0.93-1.36],0.224467910756996
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VEGFA,Vascular endothelial growth factor A,18657,130,1.03 [0.78-1.35],0.8450944001363427
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VEGFB,Vascular endothelial growth factor B,15570,103,1.63 [0.85-3.12],0.1414481216635887
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VEGFC,Vascular endothelial growth factor C,18535,130,0.93 [0.71-1.23],0.6150693682340226
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VEGFD,Vascular endothelial growth factor D,18685,130,1.54 [1.02-2.34],0.0394289922096053
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VGF,Neurosecretory protein VGF,16031,108,0.94 [0.51-1.73],0.8433015120918526
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VIM,Vimentin,18163,124,0.96 [0.85-1.10],0.5932148981514749
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VIPR1,Vasoactive intestinal polypeptide receptor 1,15602,101,0.61 [0.25-1.47],0.268108459871706
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VIT,Vitrin,16050,105,1.79 [1.09-2.94],0.0214632390950145
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VMO1,Vitelline membrane outer layer protein 1 homolog,18402,129,1.26 [0.99-1.62],0.065179042109249
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VNN1,Pantetheinase,16073,108,1.01 [0.78-1.31],0.9226087369028328
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VNN2,Vascular non-inflammatory molecule 2,18402,129,0.74 [0.54-1.02],0.0655808396396471
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VPS28,Vacuolar protein sorting-associated protein 28 homolog,15770,101,1.26 [0.96-1.66],0.1025323282458705
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VPS37A,Vacuolar protein sorting-associated protein 37A,18402,129,1.00 [0.82-1.22],0.998405553217986
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VPS4B,Vacuolar protein sorting-associated protein 4B,15996,108,1.10 [0.91-1.34],0.329533611753495
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VPS53,Vacuolar protein sorting-associated protein 53 homolog,18402,129,1.05 [0.86-1.28],0.6232761699680514
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VSIG10,V-set and immunoglobulin domain-containing protein 10,15996,108,1.20 [0.73-1.95],0.4758620926741828
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,15526,102,1.24 [0.73-2.10],0.4164873153413395
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VSIG2,V-set and immunoglobulin domain-containing protein 2,15996,108,1.17 [0.89-1.53],0.2671395861392097
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VSIG4,V-set and immunoglobulin domain-containing protein 4,18471,131,1.42 [0.98-2.07],0.0637149952539395
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,18462,129,0.96 [0.74-1.25],0.7797398586148476
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VSNL1,Visinin-like protein 1,16023,107,1.06 [0.65-1.73],0.8100957998978717
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VSTM1,V-set and transmembrane domain-containing protein 1,18093,124,1.22 [0.92-1.63],0.1690706446187773
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VSTM2B,V-set and transmembrane domain-containing protein 2B,15770,101,1.18 [0.79-1.76],0.4206080077641422
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,18163,124,0.93 [0.70-1.23],0.6064561566971842
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,18657,131,0.91 [0.73-1.14],0.4241164746326934
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VTCN1,V-set domain-containing T-cell activation inhibitor 1,18072,126,0.72 [0.42-1.23],0.2269778796898407
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,15698,103,1.19 [0.87-1.64],0.2821556310659799
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VWA1,von Willebrand factor A domain-containing protein 1,18641,128,1.39 [0.96-2.00],0.082257191321774
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VWA5A,von Willebrand factor A domain-containing protein 5A,15494,101,0.89 [0.68-1.18],0.4310998119843436
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VWC2,Brorin,18275,124,1.13 [0.75-1.69],0.5569895815597761
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VWC2L,von Willebrand factor C domain-containing protein 2-like,16031,108,1.00 [0.67-1.49],0.9955204963606866
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,VWF,von Willebrand factor,18719,128,1.04 [0.85-1.29],0.6874335745856057
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,WARS,"Tryptophan--tRNA ligase, cytoplasmic",18493,131,0.94 [0.62-1.43],0.7862220525255951
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,WAS,Wiskott-Aldrich syndrome protein,18183,127,1.06 [0.83-1.35],0.6468072627498747
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,WASF1,Wiskott-Aldrich syndrome protein family member 1,18163,124,1.12 [0.95-1.33],0.1701731882987192
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,WASF3,Wiskott-Aldrich syndrome protein family member 3,18093,124,1.04 [0.86-1.26],0.6779675211583958
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,WASHC3,WASH complex subunit 3,16023,107,1.22 [0.98-1.53],0.0794847754658195
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,WASL,Neural Wiskott-Aldrich syndrome protein,15570,103,1.05 [0.77-1.43],0.751231288954411
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,WDR46,WD repeat-containing protein 46,15996,108,1.17 [0.72-1.88],0.5223839499049543
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,WFDC1,WAP four-disulfide core domain protein 1,15659,106,1.10 [0.80-1.50],0.5599853884957033
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,WFDC12,WAP four-disulfide core domain protein 12,18628,127,1.19 [0.93-1.52],0.1756622060564769
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,WFDC2,WAP four-disulfide core domain protein 2,17557,123,1.55 [1.05-2.27],0.0255729719064808
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",18270,124,0.74 [0.50-1.10],0.1359914759562359
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",18492,130,1.36 [0.85-2.16],0.1956859919952305
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,WIF1,Wnt inhibitory factor 1,18664,128,1.29 [0.81-2.04],0.2859593668187165
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,WNT9A,Protein Wnt-9a,18183,127,1.41 [0.85-2.35],0.1866849715381907
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,18340,127,1.02 [0.76-1.37],0.9061402790134916
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,XCL1,Lymphotactin,18664,128,0.88 [0.65-1.19],0.4076779451362701
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,XG,Glycoprotein Xg,18630,127,1.69 [1.06-2.71],0.0271935164378616
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,XIAP,E3 ubiquitin-protein ligase XIAP,15570,103,1.42 [1.04-1.93],0.0260615183078164
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,XPNPEP2,Xaa-Pro aminopeptidase 2,18535,130,1.04 [0.90-1.21],0.5757841586016162
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,XRCC4,DNA repair protein XRCC4,18093,124,1.13 [0.75-1.71],0.5474690976080314
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,YAP1,Transcriptional coactivator YAP1,16023,107,1.86 [1.02-3.39],0.0436944914527624
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",16000,108,1.09 [0.96-1.24],0.1808232851297733
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,YES1,Tyrosine-protein kinase Yes,18402,129,0.99 [0.86-1.14],0.8940612361625939
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,YJU2,Splicing factor YJU2,15996,108,1.32 [0.76-2.26],0.3219869909836207
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,YOD1,Ubiquitin thioesterase OTU1,15526,102,1.00 [0.73-1.36],0.9836777988498228
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,YTHDF3,YTH domain-containing family protein 3,18183,127,1.02 [0.85-1.23],0.8057124907709523
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,YWHAQ,14-3-3 protein theta,15698,103,1.23 [0.96-1.59],0.107916082835247
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,YY1,Transcriptional repressor protein YY1,15570,103,0.70 [0.35-1.41],0.3186019542085969
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ZBP1,Z-DNA-binding protein 1,15570,103,1.26 [0.82-1.92],0.2893494444582848
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ZBTB16,Zinc finger and BTB domain-containing protein 16,18072,126,1.01 [0.81-1.25],0.951521645784529
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ZBTB17,Zinc finger and BTB domain-containing protein 17,18163,124,1.36 [0.99-1.85],0.0544284540390173
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ZCCHC8,Zinc finger CCHC domain-containing protein 8,15526,102,1.07 [0.80-1.44],0.6415844447772159
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ZFYVE19,Abscission/NoCut checkpoint regulator,16000,108,1.06 [0.86-1.30],0.5970056175719783
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ZHX2,Zinc fingers and homeoboxes protein 2,16023,107,1.40 [0.97-2.02],0.0696127370760438
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ZNF174,Zinc finger protein 174,15570,103,1.29 [0.87-1.91],0.1995157574977757
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ZNF75D,Zinc finger protein 75D,15770,101,0.90 [0.64-1.26],0.5238355300547684
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ZNF830,Zinc finger protein 830,15996,108,1.09 [0.87-1.35],0.4514433771358883
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ZNRD2,Protein ZNRD2,16000,108,1.31 [1.02-1.68],0.0336149768952488
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,15996,108,0.95 [0.67-1.34],0.7772602971719165
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ZP3,Zona pellucida sperm-binding protein 3,15602,101,0.97 [0.91-1.04],0.4320480951398915
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ZP4,Zona pellucida sperm-binding protein 4,15494,101,0.73 [0.36-1.47],0.3752942203435605
Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,ZPR1,Zinc finger protein ZPR1,15563,101,0.85 [0.67-1.09],0.1977154865954246
